INSERT INTO `elements_sites` VALUES (9586,9586,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Chapter References</h2><ol><li>Centers for Disease Control and Prevention (CDC). Public Health Professionals Gateway: HealthDepartment Governance. <a href=\\\"https://www.cdc.gov/publichealthgateway/sitesgovernance/index.html\\\">https://www.cdc.gov/publichealthgateway/sitesgovernance/index.html</a></li><li>Centers for Disease Control and Prevention (CDC). State Based HAI Prevention Activities. <a href=\\\"https://www.cdc.gov/hai/state-based/index.html\\\">https://www.cdc.gov/hai/state-based/index.html</a></li><li>Franklin SM, Crist MB, Perkins KM, Perz JF. Outbreak response capacity assessments and improvements among public health department health care-associated infection programs— United States, 2015-2017. J Public Health Manag Pract. 2020;2022; 28(2):116-125. DOI: 10.1097/PHH.0000000000001148</li><li>Centers for Disease Control and Prevention (CDC). Epidemic Intelligence Service: Urgent Assistance (Epi-Aids). <a href=\\\"https://www.cdc.gov/eis/request-services/epiaids.html\\\">https://www.cdc.gov/eis/request-services/epiaids.html</a></li><li>U.S. Food &amp; Drug Administration. Information Sharing. <a href=\\\"https://www.fda.gov/federal-state-localtribal-and-territorial-officials/communications-outreach/information-sharing\\\">https://www.fda.gov/federal-state-localtribal-and-territorial-officials/communications-outreach/information-sharing</a></li><li>Holt JD, Ghosh SN, Black JR. Legal Considerations. In: Rasmussen SA, Goodman RA, eds. The CDC Field Epidemiology Manual. US Department of Health and Human Services Centers for Disease Control and Prevention (CDC); 2018:chap 13. <a href=\\\"https://www.cdc.gov/eis/field-epimanual/chapters/Legal.html\\\">https://www.cdc.gov/eis/field-epimanual/chapters/Legal.html</a></li><li>California Hospital Association. Emergency Preparedness: Drills and Exercises. <a href=\\\"https://www.calhospitalprepare.org/exercises\\\">https://www.calhospitalprepare.org/exercises</a></li><li>Centers for Disease Control and Prevention (CDC). Healthcare-associated infections (HAIs): Infection Control Assessment Tools. <a href=\\\"https://www.cdc.gov/hai/prevent/infection-controlassessment-tools.html\\\">https://www.cdc.gov/hai/prevent/infection-controlassessment-tools.html</a></li><li>Centers for Disease Control and Prevention (CDC). Quick Observation Tools (QUOTs) for Infection Prevention. <a href=\\\"https://www.cdc.gov/infectioncontrol/tools/quots.html\\\">https://www.cdc.gov/infectioncontrol/tools/quots.html</a></li><li>Heymann DL, ed. Control of Communicable Diseases Manual. 20th ed. APHA Press; 2015.</li><li>Centers for Medicare and Medicaid Services (CMS). Emergency Preparedness Rule. <a href=\\\"https://www.cms.gov/Medicare/Provider-Enrollment-andCertification/SurveyCertEmergPrep/Emergency-Prep-Rule.html\\\">https://www.cms.gov/Medicare/Provider-Enrollment-andCertification/SurveyCertEmergPrep/Emergency-Prep-Rule.html</a></li><li>Christensen BE, Fagan RP. Healthcare Settings. In: Rasmussen SA, Goodman RA, eds. The CDC Field Epidemiology Manual. US Department of Health and Human Services Centers for Disease Control and Prevention (CDC); 2018:chap 18. <a href=\\\"https://www.cdc.gov/eis/field-epimanual/chapters/Healthcare-Settings.html\\\">https://www.cdc.gov/eis/field-epimanual/chapters/Healthcare-Settings.html</a></li><li>Centers for Disease Control and Prevention (CDC). Outpatient Settings Policy Options for Improving Infection Prevention. October 2015. <a href=\\\"https://www.cdc.gov/hai/pdfs/prevent/Outpatient-Settings-Policy-Options.pdf\\\">https://www.cdc.gov/hai/pdfs/prevent/Outpatient-Settings-Policy-Options.pdf</a></li><li>US Department of Health &amp; Human Services(HHS). Public Health. 45 CFR 164.512(b). <a href=\\\"https://www.hhs.gov/hipaa/for-professionals/special-topics/public-health/index.html\\\">https://www.hhs.gov/hipaa/for-professionals/special-topics/public-health/index.html</a> </li><li>US Department of Health &amp; Human Services(HHS). Summary of the HIPAA Privacy Rule. https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html</li></ol>\"}',1,'2024-05-17 19:30:28','2024-05-17 19:30:28','ed39f863-8bca-4548-860f-c100bc2e6160'),(9589,9589,1,'6 - Notification & Communication','notification-communication','chapters/notification-communication',NULL,1,'2024-05-17 19:36:04','2024-05-17 19:36:04','df28114d-b33d-4e0e-8420-9dc20e1bc437'),(9591,9591,1,'8 - Notification & Communication','notification-communication','chapters/notification-communication',NULL,1,'2024-05-17 19:36:13','2024-05-17 19:36:13','30864d00-cf9f-46ee-9b9a-95ef2c826b47'),(9592,9592,1,'B - Infection Control Breach Investigations','infection-control-breach-investigations','chapters/infection-control-breach-investigations','{\"0c9be173-318a-42f5-b27d-86204f3dfa65\": \"Breach Investigations\", \"68c04e47-b499-4e50-88f0-a409394e673e\": 10, \"ee09d78e-63c3-4bdf-aaf4-4c05789851fb\": \"Supplement B\"}',1,'2024-05-17 19:36:23','2024-06-06 18:51:29','7faa814f-a739-4bd4-af4c-ae538e529cf3'),(9593,9593,1,NULL,'__temp_nqkwshuylhdhqqmoivvvlrjkfpirmztefkis',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Learn about resources to help investigate reports of substandard care such as unsafe injections practices or drug diversion.</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Infection Control Breach Investigations\"}',1,'2024-05-17 19:36:23','2024-06-11 19:05:55','89371f7d-4935-4f65-a17a-01a70ae3b71a'),(9594,9594,1,NULL,'__temp_uxhddmhwkizogroqbksalvbtxabhgdfoxefk',NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For infection prevention specialists\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for epidemiologists\"}',1,'2024-05-17 19:36:23','2024-06-06 18:19:12','360822b2-ed9e-4743-858a-62895a3dcfb3'),(9595,9595,1,NULL,'__temp_vbrohdlkmzpiwvjleuprviieiytnbxezpztu',NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For health departments & healthcare facilities\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for associated specialists\"}',1,'2024-05-17 19:36:23','2024-06-06 18:19:12','cbe30461-98d2-4ede-96c6-a1380c6b8cc6'),(9596,9596,1,NULL,'__temp_hgkhyozhsarlohdrcacgfttwamiyggarbcat',NULL,NULL,1,'2024-05-17 19:36:23','2024-06-06 18:19:12','444b6883-e1b2-40ec-9759-c087b947b91e'),(9597,9597,1,NULL,'__temp_zndcllrqbbkmdhgtcxffcefnczzzgfpbqfuf',NULL,'{\"4ef0d8f2-6c32-41b6-8648-80abbba8adaf\": {\"date\": \"2022-10-01 07:00:00\"}, \"ce38096b-1714-4d43-ae46-d75b6150ba1a\": {\"date\": \"2022-10-01 07:00:00\"}}',1,'2024-05-17 19:36:23','2024-06-06 18:35:07','a9f03ccb-d663-404c-9776-93408a374321'),(9598,9598,1,NULL,'__temp_cmmrtzhoflhxoilyvskzvdhzzkmuognnshub',NULL,NULL,1,'2024-05-17 19:36:23','2024-06-06 18:19:12','8fb4be28-5b4d-459f-9174-235296859515'),(9600,9600,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:23','2024-05-17 19:36:23','7ceb8de0-d886-4456-b920-2f118d6b050d'),(9601,9601,1,NULL,'__temp_nypbbzixewyfgltmbqucndljmmxjzshxzlja',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Chapter Summary</h2><p>Outbreak investigation has long been a core public health function, and deficits in infection control practices are frequently identified during healthcare outbreak investigations. In contrast, the investigation of isolated reports of serious infection control breaches, in the absence of known patient infections, represents relatively new territory. </p><p>In Supplement B, Infection Control Breach Investigations, we describe resources available to assist investigators responding to reports of substandard care practices, such as reuse of single-use devices or the failure to follow requirements for reprocessing reusable medical equipment.</p><p>The aims of this type of response activity include assessing the degree of departure from recommended practices, evaluating the risk of communicable disease transmission associated with the breach, and identifying potentially exposed individuals who have not yet developed or been diagnosed with infection or colonization. </p><p>This supplement takes the form of an annotated bibliography and includes:</p><ul><li>Key resources providing materials and advice to assist in the investigation of and response to infection control breaches, including patient notification, with examples of publications in which breach investigators describe their specific findings and experiences</li><li>General resources outlining infection control guidelines plus some detailed resources relevant to specific types of higher risk infection control breaches </li><li>Resources offering guidance and useful background for the investigation of healthcare drug diversion events, such as when tampering or substitution may have introduced infection risks</li></ul>\"}',1,'2024-05-17 19:36:23','2024-06-06 18:19:12','b33e11ba-b237-477e-96df-539fe9d064e5'),(9602,9602,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:23','2024-05-17 19:36:23','083ed2c9-e6c2-4461-8edd-d535dc8637f0'),(9603,9603,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Introduction</h3>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','0af77265-0cf4-46fb-a288-e1b1ca54c9c1'),(9604,9604,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What are the general roles and responsibilities of various agencies during an outbreak?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','e3cbdc29-e3e5-40dd-a117-b3218d9e2681'),(9605,9605,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What individual roles should the outbreak response team consist of, and what are their responsibilities?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','849a2a48-ea69-403c-b59d-fdba07956b44'),(9606,9606,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What equipment, supplies, documents, toolkits, and other resources should a response team have?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','1c7b9a0b-2175-494a-ab29-cd23d2f0147d'),(9607,9607,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:23','2024-05-17 19:36:23','25d362c1-3156-4af1-9820-83a4302eb91a'),(9608,9608,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Protocol &amp; Responsibilities</h3>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','6c74506f-e056-4ed3-a45d-4dcaf159bc4c'),(9609,9609,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What communication needs should an outbreak response team be prepared for?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','e0e96b3c-1b4f-4240-ab82-f87dc47ae166'),(9610,9610,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How should an outbreak response team manage their records?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','43caa2dd-a79d-4b73-abf7-8ed27ca93d59'),(9611,9611,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"When should an outbreak response team ask for help, and who can provide it?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','7e2532a8-35f2-4bd7-9dd8-a30d752210e2'),(9612,9612,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What is an incident command center?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','f52b771d-d0d5-400c-8c85-24891b335151'),(9613,9613,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:23','2024-05-17 19:36:23','372b3172-dc31-4c0a-aeef-837dcfa79da1'),(9614,9614,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Additional Topics</h3>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','0741f586-ac91-4990-8149-8724bf1e6cf6'),(9615,9615,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What other legal, ethical, or privacy concerns should be considered?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','1c7e3976-09d8-4545-9a8b-40de056b558a'),(9616,9616,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How can an outbreak response team plan for recovery and follow up?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:23','2024-05-17 19:36:23','7f8a115e-6026-4dab-8511-2d033fa4321e'),(9617,9617,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:24','2024-05-17 19:36:24','fbd58cc5-448b-47ad-828a-2de51ae6044b'),(9618,9618,1,NULL,'__temp_ljvoyezwfawuifwshsjqwjidotzjrysmomoq',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>As advances occur in outbreak protocols, this guidance document will be updated. Previous changes can be tracked below:</p><ul><li>Interim Version Published October 2022  </li></ul>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Change Log\"}',1,'2024-05-17 19:36:24','2024-06-06 18:19:13','717d8cd1-ec8f-4666-ac1b-5089b78681ef'),(9619,9619,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:24','2024-05-17 19:36:24','c7711c88-9592-4ff7-b0f0-b4b683d224f7'),(9620,9620,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>January 5, 2024</h3><ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:36:24','2024-05-17 19:36:24','d749aa66-f853-400f-8fbb-bee353a4402f'),(9621,9621,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:24','2024-05-17 19:36:24','5a121b69-821b-4edd-8b63-ac01e17acfa3'),(9622,9622,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Previous Changes</h3>\"}',1,'2024-05-17 19:36:24','2024-05-17 19:36:24','c2826521-bce6-4d8e-a195-a6fb48677f13'),(9623,9623,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"December 10, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:36:24','2024-05-17 19:36:24','696da484-c6ec-4179-863c-1c2fd43438b9'),(9624,9624,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"April 23, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:36:24','2024-05-17 19:36:24','d440743f-c177-4b80-b705-e2b815b83ddd'),(9625,9625,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"September 05, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:36:24','2024-05-17 19:36:24','12fc31e1-51bb-46d7-ba81-5df982b71d57'),(9626,9626,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"February 19, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:36:24','2024-05-17 19:36:24','5a85b9fb-0012-46b5-9f8c-e6af551f881d'),(9627,9627,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:24','2024-05-17 19:36:24','ac81fdda-9f68-4acb-b54c-e3f13ce84640'),(9628,9628,1,NULL,'__temp_jdqwbmkzygirizxsyvzskgnambxjdbofxthn',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p><strong>Investigation of Infection Control Breaches </strong></p><p>This section lists some key resources that provide useful background, materials, and advice to assist with the investigation and response to infection control breaches, as well as some examples of publications in which infection control breach investigators described their specific findings and experiences. </p><p>1. Schaefer MK, Perkins KM, Link-Gelles R, Kallen AJ, Patel PR, Perz JF. Outbreaks and infection control breaches in health care settings: Considerations for patient notification. Am J Infect Control. 2020 Jun;48(6):718-724. Available at: <a href=\\\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894041/\\\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894041/</a>  </p><p><i>This paper provides a useful framework for patient notification considerations, including a description of triggers for performing a notification when investigating an infection control breach, as well as examples of commonly encountered scenarios. </i></p><p>2. Patel PR, Srinivasan A, Perz JF. Developing a broader approach to management of infection control breaches in healthcare settings. Am J Infect Control. 2008;36:685–90. Available at: <a href=\\\"https://www.ajicjournal.org/article/S0196-6553(08)00683-4/fulltext.\\\">https://www.ajicjournal.org/article/S0196-6553(08)00683-4/fulltext.</a> </p><p><i>This paper introduced a number of useful concepts and suggested approaches for investigating infection control breaches, many of which were revisited and expanded upon by Schaefer et al (reference 1 from this section). </i></p><p>3. Centers for Medicare and Medicaid Services (CMS). Infection control breaches which warrant referral to public health authorities. Available at: <a href=\\\"https://www.cms.gov/Medicare/ProviderEnrollment-and-Certification/SurveyCertificationGenInfo/Downloads/Survey-and-Cert-Letter14-36.pdf\\\">https://www.cms.gov/Medicare/ProviderEnrollment-and-Certification/SurveyCertificationGenInfo/Downloads/Survey-and-Cert-Letter14-36.pdf</a></p><p><i>Beginning in 2014, CMS required the reporting of infection control breaches discovered during accrediting or certification survey visits to public health agencies. </i></p><p>4. Braun BI, Chitavi SO, Perkins KM, Perz JF et al. Referrals of Infection Control Breaches to Public Health Authorities: Ambulatory Care Settings Experience, 2017. Available at <a href=\\\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876613/\\\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876613/</a>  </p><p><i>The authors characterized and summarized the IPC breaches that were identified by Joint Commission surveyors during the ambulatory health care and office-based surgery accreditation process and reported to state health departments in 2017. </i></p><p>5. CDC. Injection Safety: Patient Notification Toolkit. Available at: <a href=\\\"https://www.cdc.gov/injectionsafety/pntoolkit/index.html.\\\">https://www.cdc.gov/injectionsafety/pntoolkit/index.html.</a> </p><p><i>This toolkit provides step-wise guidance to assist public health agencies and healthcare facilities with conducting a patient notification following identification of an infection control breach. The toolkit is intended to be used after the decision has been made to notify patients and offers resources and template materials (such as sample notification letters) as well as some essential tips and strategies. </i></p><p>6. Schoonover H, Haydon K. Incident command structure using a daily management system and the Centers for Disease Control and Prevention\'s Patient Notification Toolkit drives effective response to an infection control breach. J Healthc Risk Manag. 2018 Oct;38(2):19-26. Available at: <a href=\\\"https://onlinelibrary.wiley.com/doi/abs/10.1002/jhrm.21323.\\\">https://onlinelibrary.wiley.com/doi/abs/10.1002/jhrm.21323.</a>  </p><p><i>The authors describe how an incident command structure, information management system, and CDC Patient Notification Toolkit were used to drive an effective response to an infection control breach—resulting in 92% of affected patients completing the recommended testing. </i></p><p>7. Arnold S, Melville SK, Morehead B, Vaughan G, Moorman A, Crist MB. Notes from the Field. Hepatitis C Transmission from Inappropriate Reuse of Saline Flush Syringes for Multiple Patients in an Acute Care General Hospital — Texas, 2015. MMWR Morb Mortal Wkly Rep 2017;66:258– 260. Available at: <a href=\\\"https://www.cdc.gov/mmwr/volumes/66/wr/mm6609a4.htm.\\\">https://www.cdc.gov/mmwr/volumes/66/wr/mm6609a4.htm.</a> </p><p><i>This report provides an example of an infection control breach investigation which uncovered hepatitis C virus transmission. </i></p><p>8. Rasmussen SA, Goodman RA (editors). (2018) The CDC Field Epidemiology Manual. Available at: <a href=\\\"https://www.cdc.gov/eis/field-epi-manual/index.html.\\\">https://www.cdc.gov/eis/field-epi-manual/index.html.</a></p><p><i>This reference does not address infection control breaches specifically, but provides a comprehensive resource for responding to outbreaks, with many principles that can also be applied to infection control breach investigations. Particularly relevant chapters to healthcare infection control breach investigations include Chapters 3 (Conducting a Field Investigation), 12 (Communicating During an Outbreak or Public Health Investigation), and 18 (Healthcare Settings). </i></p><p><strong>Selected Infection Control Resources and References</strong></p><p>This section provides general resources for understanding the basic principles of infection control as well as some detailed resources that are relevant to some of the more commonly reported infection control breaches.</p><p>1. Centers for Disease Control and Prevention (CDC). Infection Control. Available at: <a href=\\\"https://www.cdc.gov/infectioncontrol/index.html.\\\">https://www.cdc.gov/infectioncontrol/index.html.</a></p><p><i>This webpage is the base directory for CDC infection control resources, including links to resources for standard and transmission-based precautions, infection control guidelines (reference 2 in this section), training and education resources, and tools for specific healthcare setting types. </i></p><p>2. Centers for Disease Control and Prevention (CDC). Infection Control: Guidelines &amp; Guidance Library. Available at: <a href=\\\"https://www.cdc.gov/infectioncontrol/guidelines/index.html.\\\">https://www.cdc.gov/infectioncontrol/guidelines/index.html.</a></p><p><i>This webpage contains links to a variety of CDC infection control guidelines and documents including those developed under the auspices of the Healthcare Infection Control Practices Advisory Committee (HICPAC). </i></p><p>3. Association for Professionals in Infection Control and Epidemiology (APIC). The APIC Text. Available at: <a href=\\\"https://apic.org/resources/apic-text/.\\\">https://apic.org/resources/apic-text/.</a></p><p><i>A comprehensive infection control resource organized by chapter. Subscription required.</i></p><p>4 .Centers for Disease Control and Prevention (CDC). Essential Elements of a Reprocessing Program for Flexible Endoscopes ─ RecommendaƟons of the HICPAC. Available at: <a href=\\\"https://www.cdc.gov/hicpac/recommendations/flexible-endoscope-reprocessing.html.\\\">https://www.cdc.gov/hicpac/recommendations/flexible-endoscope-reprocessing.html.</a></p><p><i>Because many breaches involve medical device reprocessing techniques, this resource can assist public health agencies in related investigations and can be a useful document to share with and help educate facilities. </i></p><p>5. Centers for Disease Control and Prevention (CDC). Infection Prevention during Blood Glucose Monitoring and Insulin Administration. Available at: <a href=\\\"https://www.cdc.gov/injectionsafety/bloodglucose-monitoring.html.\\\">https://www.cdc.gov/injectionsafety/bloodglucose-monitoring.html.</a></p><p><i>This CDC resource provides essential background when investigating infection control breaches associated with blood glucose monitoring (or other forms of point of care testing involving capillary blood samples) or insulin pens and other medication cartridges. </i></p><p>6. Centers for Disease Control and Prevention (CDC). Injection Safety. Available at: <a href=\\\"https://www.cdc.gov/injectionsafety/index.html.\\\">https://www.cdc.gov/injectionsafety/index.html.</a></p><p><i>A website landing page for information about safe injection practices. Safe injection practices are part of standard precautions and are aimed at maintaining basic levels of patient safety and healthcare provider protections. </i></p><p>7. Dolan SA, Arias KM, Felizardo G, Barnes S, Kraska S, et.al. APIC position paper: Safe injection, infusion, and medication vial practices in health care. Am J Infect Control. 2016 Jul 1;44(7):750- 7. Available at: <a href=\\\"https://apic.org/Resource_/TinyMceFileManager/Position_Statements/2016APICSIPPositionPap%20er.pdf\\\">https://apic.org/Resource_/TinyMceFileManager/Position_Statements/2016APICSIPPositionPap er.pdf  </a></p><p><i>Position paper from the Association for Professionals in Infection Control and Epidemiology describing risks and outbreaks associated with unsafe injection practices and associated recommendations. </i></p><p><strong>Investigation of a Drug Diversion Event</strong></p><p>Broadly speaking, when prescription medicines are obtained or used illegally, it is called drug diversion. Healthcare providers who steal prescription medicines such as opioids for their own use put patients at risk for harms. This can include exposure to infectious diseases. For example, when a provider commits diversion by tampering with or otherwise misusing injection supplies, medications or other equipment, these items might become contaminated with hepatitis B or C virus, HIV, or bacteria. Drug diversion investigations involve assessments and actions that are akin to infection control breach investigations, but with many special considerations. The resources below provide guidance and useful background for investigation of healthcare drug diversion events. </p><p>1. Schaefer MK, Perz JF. Outbreaks of Infections Associated With Drug Diversion by US Health Care Personnel. Mayo Clin Proc. 2014. 89(7):878-87. Available at: <a href=\\\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669560/\\\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669560/</a> </p><p><i>This review article summarizes a variety of drug diversion-related outbreak investigations and includes a table describing key investigation steps. </i></p><p>2. Centers for Disease Control and Prevention (CDC). Injection Safety: Drug Diversion. Available at: <a href=\\\"https://www.cdc.gov/injectionsafety/drugdiversion/index.html.\\\">https://www.cdc.gov/injectionsafety/drugdiversion/index.html.</a></p><p><i>This website provides information on drug diversion including outbreaks associated with drug diversion, resources for clinicians, and additional resources. </i></p><p>3. Council of State and Territorial Epidemiologists. (2019) Healthcare-Associated Infections (HAI) Drug Diversion Planning and Response Toolkit for State and Local Health Departments. Available at <a href=\\\"https://www.cste.org/page/Drug-Diversion-Toolkit.\\\">https://www.cste.org/page/Drug-Diversion-Toolkit.</a></p><p><i>This toolkit provides information on best practices when responding to a drug diversion, and provides resources informed by past drug diversion investigations. </i></p><p>4. Brummond PW, Chen DF, Churchill WW, Clark JS, Dillon KR, et. al. ASHP Guidelines on Preventing Diversion of Controlled Substances. Am J Health Syst Pharm. 2017 Mar 1;74(5):325- 348. Available at: <a href=\\\"https://www.ashp.org/-/media/assets/policyguidelines/docs/guidelines/preventing-diversion-of-controlled-substances.ashx\\\">https://www.ashp.org/-/media/assets/policyguidelines/docs/guidelines/preventing-diversion-of-controlled-substances.ashx</a></p><p><i>This guidance document is a framework from the American Society of Health-System Pharmacists describing controlled substance diversion prevention programs and provides useful context for public health partners and others charged with investigating a drug diversion report.</i></p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Chapter References\"}',1,'2024-05-17 19:36:24','2024-06-06 18:19:13','a840f08f-2d16-4f4a-9991-bff65c594a8c'),(9629,9629,1,'8 - Notification & Communication','notification-communication-2','chapters/notification-communication-2',NULL,1,'2024-05-17 19:36:24','2024-05-17 19:36:24','2a2a72b1-0f58-4ca4-bd21-a33883afd617'),(9630,9630,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\"}',1,'2024-05-17 19:36:24','2024-05-17 19:36:24','75fb2e90-6fe4-479d-ac84-21e199ff531b'),(9631,9631,1,NULL,NULL,NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For infection prevention specialists\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for epidemiologists\"}',1,'2024-05-17 19:36:24','2024-05-17 19:36:24','cbdbb1cc-05c1-408c-aa82-7b86959b9450'),(9632,9632,1,NULL,NULL,NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For health departments & healthcare facilities\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for associated specialists\"}',1,'2024-05-17 19:36:24','2024-05-17 19:36:24','47b83dfd-e5d3-412a-93b1-90ff204b2f1b'),(9633,9633,1,NULL,NULL,NULL,'{\"1e722570-9511-4fa1-8aef-4415e13072e1\": \"<p><a href=\\\"#\\\">Optional: Committee</a></p>\"}',1,'2024-05-17 19:36:24','2024-05-17 19:36:24','91921679-0c37-4355-91fb-596ead089f56'),(9634,9634,1,NULL,NULL,NULL,'{\"4ef0d8f2-6c32-41b6-8648-80abbba8adaf\": {\"date\": \"2021-09-01 07:00:00\"}, \"ce38096b-1714-4d43-ae46-d75b6150ba1a\": {\"date\": \"2024-01-05 08:00:00\"}}',1,'2024-05-17 19:36:24','2024-05-17 19:36:24','2da374ed-3966-4475-bbed-e9d9c461e0c2'),(9635,9635,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:24','2024-05-17 19:36:24','3df35fd1-8f81-4f75-a529-2bb629a3bb80'),(9637,9637,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:25','2024-05-17 19:36:25','4ed939a7-4f03-4419-9283-1b3bf9d481de'),(9638,9638,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Chapter Summary</h2><p>Preparations made ahead of a healthcare-associated infection (HAI) or antimicrobial-resistant (AR) pathogen outbreak lay the groundwork for actions taken during the outbreak response. Activities that prepare public health agencies to respond to outbreaks involving healthcare delivery include developing the capacity to rapidly collect and analyze large amounts of information, take rapid action to stop transmission, and communicate effectively with stakeholders.</p>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','d09275e6-e597-4313-a41e-89679d251886'),(9639,9639,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:25','2024-05-17 19:36:25','ca648760-0706-4b21-b817-582b96ae6b08'),(9640,9640,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Introduction</h3>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','ca05f859-907d-45f7-9214-65c3beb8e500'),(9641,9641,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What are the general roles and responsibilities of various agencies during an outbreak?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','1ea2f7ac-ae1d-459d-980b-0e7ca3ba54f5'),(9642,9642,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What individual roles should the outbreak response team consist of, and what are their responsibilities?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','ff91db00-c495-487c-a81d-174355c3fb8a'),(9643,9643,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What equipment, supplies, documents, toolkits, and other resources should a response team have?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','6876f79c-71d9-46bb-a71f-612ae9dfec06'),(9644,9644,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:25','2024-05-17 19:36:25','db1ad0f6-ace0-44bf-a83b-17efca579f23'),(9645,9645,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Protocol &amp; Responsibilities</h3>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','91e7fe56-d87f-4f51-8773-414128bdd517'),(9646,9646,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What communication needs should an outbreak response team be prepared for?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','684962a4-79e4-48ce-953a-5a2b7b9db0c6'),(9647,9647,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How should an outbreak response team manage their records?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','242a82d6-0435-4a37-a92d-280666c70b20'),(9648,9648,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"When should an outbreak response team ask for help, and who can provide it?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','5085de4b-e41f-4b37-a1c2-a0ac2ac8ce0a'),(9649,9649,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What is an incident command center?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','74ab47b4-b07a-407e-b276-f501b5ce5e16'),(9650,9650,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:25','2024-05-17 19:36:25','61a254d8-b82a-4e66-8637-e16ff3b6e260'),(9651,9651,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Additional Topics</h3>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','fb3f3c9f-eb83-4272-8aab-bd010e8a9efc'),(9652,9652,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What other legal, ethical, or privacy concerns should be considered?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','dd212bbc-a9c8-40f5-ae94-62eadf20a271'),(9653,9653,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How can an outbreak response team plan for recovery and follow up?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','a09dd916-3cef-4539-9e62-cf9f02db5045'),(9654,9654,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:25','2024-05-17 19:36:25','8d92e62a-641e-48bf-9226-5ac59ff4240a'),(9655,9655,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Change Log</h2><p>As advances occur in outbreak protocols, this guidance document will be updated. Previous changes can be tracked below:</p>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','18a9bc5b-6b4a-4c77-893a-e13a8aabbc9b'),(9656,9656,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:25','2024-05-17 19:36:25','6c8955c4-9e8a-460d-8b8e-efdf730f46e7'),(9657,9657,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>January 5, 2024</h3><ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:36:25','2024-05-17 19:36:25','e2ccb3d5-8c4f-4cd6-9fa6-b7ba2c61da1f'),(9658,9658,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:25','2024-05-17 19:36:25','b4b95409-9888-4a01-9177-e5209ea0a05c'),(9659,9659,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Previous Changes</h3>\"}',1,'2024-05-17 19:36:26','2024-05-17 19:36:26','57f9f092-20ec-4e5e-b6b4-b77e63b94586'),(9660,9660,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"December 10, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:36:26','2024-05-17 19:36:26','30173946-4733-4527-9f36-516cbe5ea00b'),(9661,9661,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"April 23, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:36:26','2024-05-17 19:36:26','c2302421-3c85-47b1-9be3-b9f1f815903a'),(9662,9662,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"September 05, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:36:26','2024-05-17 19:36:26','fb39b9c7-9770-48d3-a989-3bafe4fe1d87'),(9663,9663,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"February 19, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:36:26','2024-05-17 19:36:26','8a9b717d-d53b-4bb2-9b71-8fe0c42e55f6'),(9664,9664,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:36:26','2024-05-17 19:36:26','4a781cef-35fd-4a42-84ab-cda0f473ba83'),(9665,9665,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Chapter References</h2><ol><li>Centers for Disease Control and Prevention (CDC). Public Health Professionals Gateway: HealthDepartment Governance. <a href=\\\"https://www.cdc.gov/publichealthgateway/sitesgovernance/index.html\\\">https://www.cdc.gov/publichealthgateway/sitesgovernance/index.html</a></li><li>Centers for Disease Control and Prevention (CDC). State Based HAI Prevention Activities. <a href=\\\"https://www.cdc.gov/hai/state-based/index.html\\\">https://www.cdc.gov/hai/state-based/index.html</a></li><li>Franklin SM, Crist MB, Perkins KM, Perz JF. Outbreak response capacity assessments and improvements among public health department health care-associated infection programs— United States, 2015-2017. J Public Health Manag Pract. 2020;2022; 28(2):116-125. DOI: 10.1097/PHH.0000000000001148</li><li>Centers for Disease Control and Prevention (CDC). Epidemic Intelligence Service: Urgent Assistance (Epi-Aids). <a href=\\\"https://www.cdc.gov/eis/request-services/epiaids.html\\\">https://www.cdc.gov/eis/request-services/epiaids.html</a></li><li>U.S. Food &amp; Drug Administration. Information Sharing. <a href=\\\"https://www.fda.gov/federal-state-localtribal-and-territorial-officials/communications-outreach/information-sharing\\\">https://www.fda.gov/federal-state-localtribal-and-territorial-officials/communications-outreach/information-sharing</a></li><li>Holt JD, Ghosh SN, Black JR. Legal Considerations. In: Rasmussen SA, Goodman RA, eds. The CDC Field Epidemiology Manual. US Department of Health and Human Services Centers for Disease Control and Prevention (CDC); 2018:chap 13. <a href=\\\"https://www.cdc.gov/eis/field-epimanual/chapters/Legal.html\\\">https://www.cdc.gov/eis/field-epimanual/chapters/Legal.html</a></li><li>California Hospital Association. Emergency Preparedness: Drills and Exercises. <a href=\\\"https://www.calhospitalprepare.org/exercises\\\">https://www.calhospitalprepare.org/exercises</a></li><li>Centers for Disease Control and Prevention (CDC). Healthcare-associated infections (HAIs): Infection Control Assessment Tools. <a href=\\\"https://www.cdc.gov/hai/prevent/infection-controlassessment-tools.html\\\">https://www.cdc.gov/hai/prevent/infection-controlassessment-tools.html</a></li><li>Centers for Disease Control and Prevention (CDC). Quick Observation Tools (QUOTs) for Infection Prevention. <a href=\\\"https://www.cdc.gov/infectioncontrol/tools/quots.html\\\">https://www.cdc.gov/infectioncontrol/tools/quots.html</a></li><li>Heymann DL, ed. Control of Communicable Diseases Manual. 20th ed. APHA Press; 2015.</li><li>Centers for Medicare and Medicaid Services (CMS). Emergency Preparedness Rule. <a href=\\\"https://www.cms.gov/Medicare/Provider-Enrollment-andCertification/SurveyCertEmergPrep/Emergency-Prep-Rule.html\\\">https://www.cms.gov/Medicare/Provider-Enrollment-andCertification/SurveyCertEmergPrep/Emergency-Prep-Rule.html</a></li><li>Christensen BE, Fagan RP. Healthcare Settings. In: Rasmussen SA, Goodman RA, eds. The CDC Field Epidemiology Manual. US Department of Health and Human Services Centers for Disease Control and Prevention (CDC); 2018:chap 18. <a href=\\\"https://www.cdc.gov/eis/field-epimanual/chapters/Healthcare-Settings.html\\\">https://www.cdc.gov/eis/field-epimanual/chapters/Healthcare-Settings.html</a></li><li>Centers for Disease Control and Prevention (CDC). Outpatient Settings Policy Options for Improving Infection Prevention. October 2015. <a href=\\\"https://www.cdc.gov/hai/pdfs/prevent/Outpatient-Settings-Policy-Options.pdf\\\">https://www.cdc.gov/hai/pdfs/prevent/Outpatient-Settings-Policy-Options.pdf</a></li><li>US Department of Health &amp; Human Services(HHS). Public Health. 45 CFR 164.512(b). <a href=\\\"https://www.hhs.gov/hipaa/for-professionals/special-topics/public-health/index.html\\\">https://www.hhs.gov/hipaa/for-professionals/special-topics/public-health/index.html</a> </li><li>US Department of Health &amp; Human Services(HHS). Summary of the HIPAA Privacy Rule. https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html</li></ol>\"}',1,'2024-05-17 19:36:26','2024-05-17 19:36:26','1d66bba3-6a1c-4492-8e7a-0f11aac7a031'),(9668,9668,1,'Infection Control Breach Investigations','infection-control-breach-investigations','chapters/infection-control-breach-investigations',NULL,1,'2024-05-17 19:37:24','2024-05-17 19:37:24','0b580b94-aaf2-4e95-9606-9118d60d0f1b'),(9670,9670,1,'7 - Multi-Facility & Jurisdiction','special-considerations-for-multi-facility-multi-jurisdiction-outbreaks','chapters/special-considerations-for-multi-facility-multi-jurisdiction-outbreaks','{\"0c9be173-318a-42f5-b27d-86204f3dfa65\": \"Multi-Facility & Jurisdiction\", \"68c04e47-b499-4e50-88f0-a409394e673e\": 7, \"ee09d78e-63c3-4bdf-aaf4-4c05789851fb\": \"Chapter Seven - Coming soon\"}',1,'2024-05-17 19:37:34','2024-06-06 18:34:44','4e542d43-ebc0-473a-94ee-b768a9740c8c'),(9671,9671,1,NULL,'__temp_ausejupduxtxezbexaaizuccutjwolcsmqvy',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Learn about the complexities and challenges when a healthcare outbreak involves more than one facility or local/state/federal jurisdiction.</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Special Considerations for Multi-Facility & Multi-Jurisdiction Outbreaks\"}',1,'2024-05-17 19:37:34','2024-06-11 19:01:37','9e3d958f-edfe-48b5-9176-fc177b6940c2'),(9672,9672,1,NULL,'__temp_mtjndlamwxqfzxalrlovxzbatescuphmoosm',NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For infection prevention specialists\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for epidemiologists\"}',1,'2024-05-17 19:37:34','2024-06-06 17:54:34','9aad1f0c-93e0-4422-87f1-f7e8772dee17'),(9673,9673,1,NULL,'__temp_bweoyjhjwgxgbjzslmcqegumcwrqtyuydjky',NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For health departments & healthcare facilities\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for associated specialists\"}',1,'2024-05-17 19:37:34','2024-06-06 17:54:34','27cb5c5b-5004-4f16-b2ba-baf089b49f56'),(9674,9674,1,NULL,'__temp_zsjjizcpzydrswarnpnwxsgclzfhugszvega',NULL,NULL,1,'2024-05-17 19:37:34','2024-06-06 17:54:34','bc9dcf7d-f309-4bf8-b2b5-210616a2c76b'),(9675,9675,1,NULL,'__temp_xiynhoggqqbqadktrcrtbwphojhinxrnvsyh',NULL,'{\"4ef0d8f2-6c32-41b6-8648-80abbba8adaf\": {\"date\": \"2024-06-06 07:00:00\"}, \"ce38096b-1714-4d43-ae46-d75b6150ba1a\": {\"date\": \"2024-06-06 07:00:00\"}}',1,'2024-05-17 19:37:34','2024-06-06 18:34:05','aaaedd1c-ca38-48eb-96c8-c7542b12d9b4'),(9676,9676,1,NULL,'__temp_enwjwatphuhiplymgubssgdqybvpcbiwjffa',NULL,NULL,1,'2024-05-17 19:37:34','2024-06-06 17:54:34','0d11e124-5ffc-4472-af0e-0449cb1834c1'),(9678,9678,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:34','2024-05-17 19:37:34','94e5cbc8-ebe8-401a-81f3-6a59196b4c63'),(9679,9679,1,NULL,'__temp_ncxbbqimijnmsgrepwrakpxezzgpsemxuqcj',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Chapter Summary</h2><p>Compared with outbreaks affecting a single healthcare facility with responsibility for investigation falling squarely within the jurisdiction of a single local/state/federal agency, outbreaks involving multiple healthcare facilities or multiple jurisdictions are more complex and often more difficult to detect, coordinate, and investigate. </p><p>In Chapter 7, Multi-Facility and Multi-Jurisdictional Outbreaks, we examine the unique aspects of these types of investigations. Compared with single facility outbreaks, those that involve multiple facilities or multiple jurisdictions are more complex and are often more difficult to detect, coordinate, and investigate. As the numbers of involved facilities, agencies, and levels of organizations across jurisdictions increase, the need for special efforts to maintain effective communication and coordination increases as well.</p><p>This chapter contains information on: </p><ul><li>Example scenarios investigators may encounter</li><li>Coordination and information sharing needs beginning with initial detection of a potential multi-facility/multi-jurisdictional outbreak </li><li>Designation of a coordinating agency, assembly and management of a multidisciplinary outbreak response team, and regular assessment of the scope of the outbreak and the resources needed</li><li>Considerations for ramping down and concluding an interagency response</li></ul>\"}',1,'2024-05-17 19:37:34','2024-06-09 00:33:14','40455ac0-be82-41d9-816d-c9120a6662d2'),(9680,9680,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:34','2024-05-17 19:37:34','d1ea4ba5-bb2e-49c1-aed4-a386b6b93ac0'),(9681,9681,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Introduction</h3>\"}',1,'2024-05-17 19:37:34','2024-05-17 19:37:34','6ea44744-4955-43c4-a6de-4e930e37f2e6'),(9682,9682,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What are the general roles and responsibilities of various agencies during an outbreak?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:34','2024-05-17 19:37:34','07a2b1b3-5b69-4240-9193-0f7ee1f5e6a2'),(9683,9683,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What individual roles should the outbreak response team consist of, and what are their responsibilities?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:34','2024-05-17 19:37:34','ef390094-61da-4389-9d64-253e0800a523'),(9684,9684,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What equipment, supplies, documents, toolkits, and other resources should a response team have?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:34','2024-05-17 19:37:34','de8b810e-1898-4658-8671-c04acf5c5193'),(9685,9685,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:34','2024-05-17 19:37:34','fff4818a-38c1-4c07-87a2-dfcbc0b328af'),(9686,9686,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Protocol &amp; Responsibilities</h3>\"}',1,'2024-05-17 19:37:34','2024-05-17 19:37:34','52938974-241d-42d8-a59e-95e530061b06'),(9687,9687,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What communication needs should an outbreak response team be prepared for?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:34','2024-05-17 19:37:34','cb5b3d4d-2031-4dd7-96bf-44d2f5c239dc'),(9688,9688,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How should an outbreak response team manage their records?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:34','2024-05-17 19:37:34','bc3b3b23-429d-4c51-b5a1-e34c049daacd'),(9689,9689,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"When should an outbreak response team ask for help, and who can provide it?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:34','2024-05-17 19:37:34','b2c8c3f5-9a05-4947-82cc-69c927652cd3'),(9690,9690,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What is an incident command center?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:35','2024-05-17 19:37:35','6a870016-1ab3-469c-9315-191697b1b761'),(9691,9691,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:35','2024-05-17 19:37:35','908e7798-5d5d-4930-b341-a0c4165ecc96'),(9692,9692,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Additional Topics</h3>\"}',1,'2024-05-17 19:37:35','2024-05-17 19:37:35','19f3d045-c54f-45fb-b02c-4c2a48fa4d17'),(9693,9693,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What other legal, ethical, or privacy concerns should be considered?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:35','2024-05-17 19:37:35','27e71a8e-7bb7-45ea-a375-4b1409ba00be'),(9694,9694,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How can an outbreak response team plan for recovery and follow up?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:35','2024-05-17 19:37:35','827900a7-e9b4-4659-ba70-0f3cdecf2abf'),(9695,9695,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:35','2024-05-17 19:37:35','debbeb4e-5fb9-4f03-a873-2a765fb30892'),(9696,9696,1,NULL,'__temp_ayygttpdyeztxdmlamcapplduajwpkixahxq',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>This chapter is currently under review and will be available soon.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Change Log\"}',1,'2024-05-17 19:37:35','2024-06-06 17:54:34','50e26ead-4fa9-4dbd-b85f-e58e538ce7bc'),(9697,9697,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:35','2024-05-17 19:37:35','f9c53232-e646-4d66-bd4f-1512e997bd39'),(9698,9698,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>January 5, 2024</h3><ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:37:35','2024-05-17 19:37:35','1e626779-98b1-4e96-b4f7-c88eebf04ef8'),(9699,9699,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:35','2024-05-17 19:37:35','05a042d0-08f5-40c2-95de-78cd4183e40c'),(9700,9700,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Previous Changes</h3>\"}',1,'2024-05-17 19:37:35','2024-05-17 19:37:35','72e6cec5-cce2-4c12-b417-7f34acf76226'),(9701,9701,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"December 10, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:37:35','2024-05-17 19:37:35','0d8b1709-c61b-4be0-9553-a336339d8c09'),(9702,9702,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"April 23, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:37:35','2024-05-17 19:37:35','cbdb9e53-3eb2-4906-afd0-2929d2ac8107'),(9703,9703,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"September 05, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:37:35','2024-05-17 19:37:35','f3ad9335-af9f-4d9b-91a7-a1c3a66bdcc0'),(9704,9704,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"February 19, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:37:35','2024-05-17 19:37:35','6017d30e-514a-4794-859b-6b106dd813f6'),(9705,9705,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:35','2024-05-17 19:37:35','75d68576-1d9b-4f6f-9ca1-744c6433f2fd'),(9706,9706,1,NULL,'__temp_dehgbsmofjgbnbkbdkkndkcmllvzejcdtrij',NULL,'{\"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Chapter References\"}',1,'2024-05-17 19:37:35','2024-06-06 17:54:35','2af464bd-6670-4651-89d2-7fcee49f17cf'),(9707,9707,1,'8 - Notification & Communication','notification-communication-2','chapters/notification-communication-2',NULL,1,'2024-05-17 19:37:36','2024-05-17 19:37:36','268ccd5b-c2af-49a1-bc0b-5f809d68acde'),(9708,9708,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','e56c25dc-76a6-49e4-bb97-44710bad37bd'),(9709,9709,1,NULL,NULL,NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For infection prevention specialists\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for epidemiologists\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','eccde7f2-4ca4-45d5-9f19-6bd22fd05722'),(9710,9710,1,NULL,NULL,NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For health departments & healthcare facilities\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for associated specialists\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','e07b5ef5-e0d8-4dc9-8554-0964418212a3'),(9711,9711,1,NULL,NULL,NULL,'{\"1e722570-9511-4fa1-8aef-4415e13072e1\": \"<p><a href=\\\"#\\\">Optional: Committee</a></p>\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','6fb8f858-3efa-46a4-b1d1-eb82ff512966'),(9712,9712,1,NULL,NULL,NULL,'{\"4ef0d8f2-6c32-41b6-8648-80abbba8adaf\": {\"date\": \"2021-09-01 07:00:00\"}, \"ce38096b-1714-4d43-ae46-d75b6150ba1a\": {\"date\": \"2024-01-05 08:00:00\"}}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','65248afd-c47a-413c-9bc1-3c22b5e4cc24'),(9713,9713,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:36','2024-05-17 19:37:36','f5599ed3-670c-4030-9b06-f583b42060f2'),(9715,9715,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:36','2024-05-17 19:37:36','697edcb7-8ebd-402e-b341-8fcb92195542'),(9716,9716,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Chapter Summary</h2><p>Preparations made ahead of a healthcare-associated infection (HAI) or antimicrobial-resistant (AR) pathogen outbreak lay the groundwork for actions taken during the outbreak response. Activities that prepare public health agencies to respond to outbreaks involving healthcare delivery include developing the capacity to rapidly collect and analyze large amounts of information, take rapid action to stop transmission, and communicate effectively with stakeholders.</p>\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','3b5a0d0f-ad3b-44d7-b68e-c15c45bd5f5e'),(9717,9717,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:36','2024-05-17 19:37:36','011869f0-227d-4cfe-9d7e-741fc1aba053'),(9718,9718,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Introduction</h3>\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','3e3cd91e-d6eb-4e07-88c9-76701c43c836'),(9719,9719,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What are the general roles and responsibilities of various agencies during an outbreak?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','30532499-b655-4658-bc77-b5262f313a76'),(9720,9720,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What individual roles should the outbreak response team consist of, and what are their responsibilities?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','64e4b28a-9deb-4801-aa5d-f8b8ec1ecbd2'),(9721,9721,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What equipment, supplies, documents, toolkits, and other resources should a response team have?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','79e7038e-2c31-4342-82ae-dbc11d4e7d9d'),(9722,9722,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:36','2024-05-17 19:37:36','7ec85969-4604-44c8-a6ac-6fc69cd1a3de'),(9723,9723,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Protocol &amp; Responsibilities</h3>\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','253a5ea7-e961-4279-ab5b-6cfc618b98ff'),(9724,9724,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What communication needs should an outbreak response team be prepared for?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','58a2f156-529d-46d0-8c28-8aee39406fab'),(9725,9725,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How should an outbreak response team manage their records?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:36','2024-05-17 19:37:36','219f807c-559d-4064-8834-14e270a0ebbc'),(9726,9726,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"When should an outbreak response team ask for help, and who can provide it?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','f1d26c5e-d9c1-4618-9a07-7cb1249455be'),(9727,9727,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What is an incident command center?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','4c567083-b8f6-4e00-82bc-98258f366082'),(9728,9728,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:37','2024-05-17 19:37:37','738a2e86-d91a-46c9-acb1-a7fd77eae707'),(9729,9729,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Additional Topics</h3>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','71717c64-a792-449f-afe4-829d02f4bd07'),(9730,9730,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What other legal, ethical, or privacy concerns should be considered?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','0cc4c569-bc10-4aeb-a5c9-d12500f34a42'),(9731,9731,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How can an outbreak response team plan for recovery and follow up?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','c8d0bcb6-a31a-4954-bdc9-ae4e12195be1'),(9732,9732,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:37','2024-05-17 19:37:37','fc2d436c-f883-4616-8cf7-56689c677355'),(9733,9733,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Change Log</h2><p>As advances occur in outbreak protocols, this guidance document will be updated. Previous changes can be tracked below:</p>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','622155cd-8890-462c-9e0e-1b66075bba5e'),(9734,9734,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:37','2024-05-17 19:37:37','52d77e46-7c5e-4755-854f-3b85cf8b197b'),(9735,9735,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>January 5, 2024</h3><ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','3cb91e66-7bd5-45e3-b856-2fa0fedb9ccc'),(9736,9736,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:37','2024-05-17 19:37:37','c2501469-5705-4af5-9d54-c0506bb82550'),(9737,9737,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Previous Changes</h3>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','b0aee124-e532-461f-8016-b7d4eacc8a32'),(9738,9738,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"December 10, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','808c66da-ea16-44c2-8547-a82c736ae0ce'),(9739,9739,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"April 23, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','cb03ff9a-14fe-44f9-a24e-0657bbe3da57'),(9740,9740,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"September 05, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','1a7a43c9-391e-4dcb-9d4b-2a8b8decdbef'),(9741,9741,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"February 19, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','9c0b33ef-d0ec-4662-94b0-af3ffd7918b6'),(9742,9742,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:37:37','2024-05-17 19:37:37','b6729b16-6a12-4891-ab2f-8364033548f2'),(9743,9743,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Chapter References</h2><ol><li>Centers for Disease Control and Prevention (CDC). Public Health Professionals Gateway: HealthDepartment Governance. <a href=\\\"https://www.cdc.gov/publichealthgateway/sitesgovernance/index.html\\\">https://www.cdc.gov/publichealthgateway/sitesgovernance/index.html</a></li><li>Centers for Disease Control and Prevention (CDC). State Based HAI Prevention Activities. <a href=\\\"https://www.cdc.gov/hai/state-based/index.html\\\">https://www.cdc.gov/hai/state-based/index.html</a></li><li>Franklin SM, Crist MB, Perkins KM, Perz JF. Outbreak response capacity assessments and improvements among public health department health care-associated infection programs— United States, 2015-2017. J Public Health Manag Pract. 2020;2022; 28(2):116-125. DOI: 10.1097/PHH.0000000000001148</li><li>Centers for Disease Control and Prevention (CDC). Epidemic Intelligence Service: Urgent Assistance (Epi-Aids). <a href=\\\"https://www.cdc.gov/eis/request-services/epiaids.html\\\">https://www.cdc.gov/eis/request-services/epiaids.html</a></li><li>U.S. Food &amp; Drug Administration. Information Sharing. <a href=\\\"https://www.fda.gov/federal-state-localtribal-and-territorial-officials/communications-outreach/information-sharing\\\">https://www.fda.gov/federal-state-localtribal-and-territorial-officials/communications-outreach/information-sharing</a></li><li>Holt JD, Ghosh SN, Black JR. Legal Considerations. In: Rasmussen SA, Goodman RA, eds. The CDC Field Epidemiology Manual. US Department of Health and Human Services Centers for Disease Control and Prevention (CDC); 2018:chap 13. <a href=\\\"https://www.cdc.gov/eis/field-epimanual/chapters/Legal.html\\\">https://www.cdc.gov/eis/field-epimanual/chapters/Legal.html</a></li><li>California Hospital Association. Emergency Preparedness: Drills and Exercises. <a href=\\\"https://www.calhospitalprepare.org/exercises\\\">https://www.calhospitalprepare.org/exercises</a></li><li>Centers for Disease Control and Prevention (CDC). Healthcare-associated infections (HAIs): Infection Control Assessment Tools. <a href=\\\"https://www.cdc.gov/hai/prevent/infection-controlassessment-tools.html\\\">https://www.cdc.gov/hai/prevent/infection-controlassessment-tools.html</a></li><li>Centers for Disease Control and Prevention (CDC). Quick Observation Tools (QUOTs) for Infection Prevention. <a href=\\\"https://www.cdc.gov/infectioncontrol/tools/quots.html\\\">https://www.cdc.gov/infectioncontrol/tools/quots.html</a></li><li>Heymann DL, ed. Control of Communicable Diseases Manual. 20th ed. APHA Press; 2015.</li><li>Centers for Medicare and Medicaid Services (CMS). Emergency Preparedness Rule. <a href=\\\"https://www.cms.gov/Medicare/Provider-Enrollment-andCertification/SurveyCertEmergPrep/Emergency-Prep-Rule.html\\\">https://www.cms.gov/Medicare/Provider-Enrollment-andCertification/SurveyCertEmergPrep/Emergency-Prep-Rule.html</a></li><li>Christensen BE, Fagan RP. Healthcare Settings. In: Rasmussen SA, Goodman RA, eds. The CDC Field Epidemiology Manual. US Department of Health and Human Services Centers for Disease Control and Prevention (CDC); 2018:chap 18. <a href=\\\"https://www.cdc.gov/eis/field-epimanual/chapters/Healthcare-Settings.html\\\">https://www.cdc.gov/eis/field-epimanual/chapters/Healthcare-Settings.html</a></li><li>Centers for Disease Control and Prevention (CDC). Outpatient Settings Policy Options for Improving Infection Prevention. October 2015. <a href=\\\"https://www.cdc.gov/hai/pdfs/prevent/Outpatient-Settings-Policy-Options.pdf\\\">https://www.cdc.gov/hai/pdfs/prevent/Outpatient-Settings-Policy-Options.pdf</a></li><li>US Department of Health &amp; Human Services(HHS). Public Health. 45 CFR 164.512(b). <a href=\\\"https://www.hhs.gov/hipaa/for-professionals/special-topics/public-health/index.html\\\">https://www.hhs.gov/hipaa/for-professionals/special-topics/public-health/index.html</a> </li><li>US Department of Health &amp; Human Services(HHS). Summary of the HIPAA Privacy Rule. https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html</li></ol>\"}',1,'2024-05-17 19:37:37','2024-05-17 19:37:37','382f2fd1-4a52-441e-9efb-5bf3433431e9'),(9748,9748,1,'Home','home','__home__',NULL,1,'2024-05-17 19:38:06','2024-05-17 19:38:06','0e72bf6d-b9ed-4e23-8615-05d64270072d'),(9749,9749,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:38:06','2024-05-17 19:38:06','00eac450-4013-456f-b97e-b3e791e5e0af'),(9750,9750,1,'7 - Special Considerations for Multi-Facility & Multi-Jurisdiction Outbreaks','special-considerations-for-multi-facility-multi-jurisdiction-outbreaks','chapters/special-considerations-for-multi-facility-multi-jurisdiction-outbreaks',NULL,1,'2024-05-17 19:38:21','2024-05-17 19:38:21','33a14d15-c8a1-4985-85ff-885be742b157'),(9758,9758,1,'Principles practices 1',NULL,NULL,NULL,1,'2024-05-17 19:47:14','2024-05-17 19:47:14','1b82ef81-acc4-4575-8589-6c7489773e2f'),(9759,9759,1,'1 - Overview','overview','chapters/overview',NULL,1,'2024-05-17 19:47:26','2024-05-17 19:47:26','603de170-6755-421f-9967-b00b72465a1c'),(9760,9760,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\"}',1,'2024-05-17 19:47:26','2024-05-17 19:47:26','8c7c5745-bdd8-4e01-881a-9b6204042ece'),(9762,9762,1,'Principles practices 1',NULL,NULL,NULL,1,'2024-05-17 19:47:49','2024-05-17 19:47:49','39b5dd8b-6134-4695-b354-2425960ac9c3'),(9763,9763,1,'Principles practices 2',NULL,NULL,NULL,1,'2024-05-17 19:47:50','2024-05-17 19:47:50','0be7c315-e3cf-486c-9c9f-dea7b5c16c33'),(9764,9764,1,'Principles practices 3',NULL,NULL,NULL,1,'2024-05-17 19:47:51','2024-05-17 19:47:51','28b973d5-c78b-4000-85b4-ab191063aa43'),(9765,9765,1,'1',NULL,NULL,NULL,1,'2024-05-17 19:49:05','2024-05-17 19:49:05','099ea01b-4e28-476e-b939-1ef244ac6c28'),(9766,9766,1,'2',NULL,NULL,NULL,1,'2024-05-17 19:49:06','2024-05-17 19:49:06','fe09d364-db43-4eb9-967d-1c776ad9f926'),(9767,9767,1,'3',NULL,NULL,NULL,1,'2024-05-17 19:49:06','2024-05-17 19:49:06','451c17f8-38c5-4cdf-a34e-ecf79c986f95'),(9768,9768,1,'1 - Overview','overview','chapters/overview',NULL,1,'2024-05-17 19:49:24','2024-05-17 19:49:24','3d9c26cf-7dc8-48ee-89cd-9502fc52f4de'),(9771,9771,1,'2 - Fundamental Concepts','fundamental-concepts','chapters/fundamental-concepts',NULL,1,'2024-05-17 19:49:40','2024-05-17 19:49:40','c6d34dde-c87a-4cbb-9373-3ff378483ec4'),(9772,9772,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\"}',1,'2024-05-17 19:49:40','2024-05-17 19:49:40','a7c9d342-e9c4-4197-aded-2f8ac9356320'),(9773,9773,1,'4',NULL,NULL,NULL,1,'2024-05-17 19:50:33','2024-05-17 19:50:33','bff350e4-fbdc-4a23-9f7f-de8901abd721'),(9774,9774,1,'5',NULL,NULL,NULL,1,'2024-05-17 19:50:34','2024-05-17 19:50:34','1252a76c-3b54-499a-b92b-6578d2c35e3a'),(9775,9775,1,'6',NULL,NULL,NULL,1,'2024-05-17 19:50:43','2024-05-17 19:50:43','ba53fad1-76f6-4dcc-93c9-d578561df718'),(9776,9776,1,'7',NULL,NULL,NULL,1,'2024-05-17 19:50:44','2024-05-17 19:50:44','7aa9012e-91b5-460f-9659-c944be538754'),(9777,9777,1,'8',NULL,NULL,NULL,1,'2024-05-17 19:50:44','2024-05-17 19:50:44','a35e0e1e-cce9-4809-9129-67ff55040412'),(9778,9778,1,'Medical product investigations',NULL,NULL,NULL,1,'2024-05-17 19:50:44','2024-05-17 19:50:44','ffeb903f-2732-4196-a659-f51e65a0c4be'),(9779,9779,1,'Supplement b',NULL,NULL,NULL,1,'2024-05-17 19:50:45','2024-05-17 19:50:45','ea12d82b-ec1e-44ee-8a7d-a0e5c8f8e6c0'),(9781,9781,1,'3 - Planning & Preparation','planning-preparation','chapters/planning-preparation',NULL,1,'2024-05-17 19:51:11','2024-05-17 19:51:11','7c07dd83-2fe5-490f-bd1d-0978514055ab'),(9783,9783,1,'4 - Outbreak Detection & Reporting','outbreak-detection-reporting','chapters/outbreak-detection-reporting',NULL,1,'2024-05-17 19:51:26','2024-05-17 19:51:26','c8b0d8db-c117-4e08-ac50-02eae2b6de9d'),(9785,9785,1,'5 - Investigation & Control','investigation-control','chapters/investigation-control',NULL,1,'2024-05-17 19:51:39','2024-05-17 19:51:39','9b6731fc-0e9d-4992-a820-65a2ee5cbea4'),(9787,9787,1,'6 - Laboratory Best Practices','laboratory-best-practices','chapters/laboratory-best-practices',NULL,1,'2024-05-17 19:51:52','2024-05-17 19:51:52','6f023272-4180-4aa3-b385-c5c6fab82b63'),(9789,9789,1,'7 - Special Considerations for Multi-Facility & Multi-Jurisdiction Outbreaks','special-considerations-for-multi-facility-multi-jurisdiction-outbreaks','chapters/special-considerations-for-multi-facility-multi-jurisdiction-outbreaks',NULL,1,'2024-05-17 19:52:05','2024-05-17 19:52:05','723654ab-aa0c-4d9e-9bc4-ab284a69bda7'),(9791,9791,1,'8 - Notification & Communication','notification-communication','chapters/notification-communication',NULL,1,'2024-05-17 19:52:24','2024-05-17 19:52:24','54237326-ef98-46f1-8a6b-0c37d863ddaf'),(9793,9793,1,'Infection Control Breach Investigations','infection-control-breach-investigations','chapters/infection-control-breach-investigations',NULL,1,'2024-05-17 19:52:40','2024-05-17 19:52:40','27d33ae7-db38-4b62-918f-b5cf2fdd06cc'),(9794,9794,1,'A - Medical Product Investigations','medical-product-investigations','chapters/medical-product-investigations','{\"0c9be173-318a-42f5-b27d-86204f3dfa65\": \"Medical Product Investigations\", \"68c04e47-b499-4e50-88f0-a409394e673e\": 9, \"ee09d78e-63c3-4bdf-aaf4-4c05789851fb\": \"Supplement A\"}',1,'2024-05-17 19:52:46','2024-06-06 18:29:50','708216b2-8335-47fd-938b-eb83affcef4f'),(9795,9795,1,NULL,'__temp_mmumqcfxinobcukqqopefyharqkhkkjptzpk',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Learn how contaminated drugs, devices, and other medical products can cause outbreaks and the actions needed to prevent further harm.</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Medical Product Investigations\"}',1,'2024-05-17 19:52:46','2024-06-11 19:04:35','99b898ea-3e34-4aaf-986c-3bf95eb46431'),(9796,9796,1,NULL,'__temp_lmznhsrbkwjitqzzlcwdgzkdtjjwqqjthfce',NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For infection prevention specialists\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for epidemiologists\"}',1,'2024-05-17 19:52:46','2024-06-06 18:29:50','d1e786ad-c932-4583-a25f-4eba39781b0d'),(9797,9797,1,NULL,'__temp_bvizcvynzvriobglsubbzowufvzxnmilbqvn',NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For health departments & healthcare facilities\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for associated specialists\"}',1,'2024-05-17 19:52:46','2024-06-06 18:29:50','43f85d80-8b60-4410-a530-7fb3d59dd91a'),(9798,9798,1,NULL,'__temp_crvbbblrqmoslxzwmayofwcuvvznezkegnfs',NULL,NULL,1,'2024-05-17 19:52:46','2024-06-06 18:29:50','0b14517c-fb5d-4cd6-9a7e-0c7d6f64da26'),(9799,9799,1,NULL,'__temp_afcejsjkicrdfkrrksbkwxvvdxidykcxexwq',NULL,'{\"4ef0d8f2-6c32-41b6-8648-80abbba8adaf\": {\"date\": \"2024-03-01 08:00:00\"}, \"ce38096b-1714-4d43-ae46-d75b6150ba1a\": {\"date\": \"2024-03-01 08:00:00\"}}',1,'2024-05-17 19:52:46','2024-06-06 18:35:41','29000fe5-9374-4f94-95d9-0b2989a611ec'),(9800,9800,1,NULL,'__temp_elfdpznmnralswdqvniohmvsslqnxzksiorx',NULL,NULL,1,'2024-05-17 19:52:46','2024-06-06 18:29:50','4259953c-08ee-4d6e-87b8-6579d4b927fa'),(9802,9802,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:46','2024-05-17 19:52:46','b2abcd58-0ec4-4fe6-8f4f-380466117338'),(9803,9803,1,NULL,'__temp_gvhphhqianiqsivckmoruibnkugqqfbmphqd',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Chapter Summary</h2><p>Healthcare-associated infections (HAIs) and outbreaks can be caused by use of contaminated medical products. These medical products include devices (also known as instruments or equipment) and drugs (also known as medications), as well as biological products, nutrition products, and patient care items. </p><p>The general principles outlined in the CORHA Principles and Practices can be employed when responding to events related to medical product contamination. These investigations often involve infection control assessments and require the active coordination of investigation partners across multiple jurisdictions. </p><p>In Supplement A, Medical Product Investigations, we address some unique challenges associated with identifying and responding to outbreaks related to contamination events. </p><p>This supplement contains information on:</p><ul><li>Intrinsic contamination, which occurs before a medical product arrives at its point of use in a healthcare facility </li><li>Extrinsic contamination, which results from errors made during a medical product’s storage, preparation, and use in a healthcare facility</li><li>Advice on recognizing and evaluating possible causes of product-related transmission relative to clinical illness and other factors </li><li>Investigation procedures for outbreaks that potentially involve drugs and devices, with an emphasis on intrinsic product contamination</li><li>Additional “Keys to Success” related to medical product investigations</li></ul>\"}',1,'2024-05-17 19:52:46','2024-06-06 18:29:50','2a885f53-e23f-4701-a5df-b32ea6750919'),(9804,9804,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:46','2024-05-17 19:52:46','7bd9b63e-8db7-42fb-82d2-09577ad83b50'),(9805,9805,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Introduction</h3>\"}',1,'2024-05-17 19:52:46','2024-05-17 19:52:46','f29c32cb-f1f3-47a3-9ae2-8d743e72e195'),(9806,9806,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What are the general roles and responsibilities of various agencies during an outbreak?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:46','2024-05-17 19:52:46','7fd026bc-2ea7-4923-9a0e-248c3f248e62'),(9807,9807,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What individual roles should the outbreak response team consist of, and what are their responsibilities?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:46','2024-05-17 19:52:46','586f74d9-86af-4585-869a-37efde573c8e'),(9808,9808,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What equipment, supplies, documents, toolkits, and other resources should a response team have?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','00841771-6f8d-42ae-925d-0f9c612cf560'),(9809,9809,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:47','2024-05-17 19:52:47','6bd76754-a04c-48a2-8e9d-c52cd888856b'),(9810,9810,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Protocol &amp; Responsibilities</h3>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','578476e7-076b-473e-9017-41561d4e024d'),(9811,9811,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What communication needs should an outbreak response team be prepared for?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','d0806656-5b59-472e-97fe-ae0d43ac7bf4'),(9812,9812,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How should an outbreak response team manage their records?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','73bcb79a-8738-4562-9b4d-8508f0ec37a8'),(9813,9813,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"When should an outbreak response team ask for help, and who can provide it?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','8cc14f95-1cf1-42c8-a792-7c9c92d8e251'),(9814,9814,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What is an incident command center?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','f6f882f9-61be-4160-b402-47b3fddce090'),(9815,9815,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:47','2024-05-17 19:52:47','188e76c8-e78d-480a-8f59-80e645c3c275'),(9816,9816,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Additional Topics</h3>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','c57cfe50-4fae-4adc-967e-8980255cce30'),(9817,9817,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What other legal, ethical, or privacy concerns should be considered?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','783c01e8-0d17-40b3-9f9a-194fe74ac6d9'),(9818,9818,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How can an outbreak response team plan for recovery and follow up?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','03556e79-5481-46a5-bdbb-c06c666cf8a0'),(9819,9819,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:47','2024-05-17 19:52:47','42f84861-2d58-498f-a03b-fc8973b25196'),(9820,9820,1,NULL,'__temp_cybgvddijrrftkbuutprhbrugnblolclejoh',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>As advances occur in outbreak protocols, this guidance document will be updated. Previous changes can be tracked below:</p><ul><li>1st Edition – Published March 2024</li><li>URLs in this document are valid as of March 2024.</li></ul>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Change Log\"}',1,'2024-05-17 19:52:47','2024-06-06 18:29:50','c3dd9d3f-3c5f-4fc1-b81e-ceff4f4f433f'),(9821,9821,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:47','2024-05-17 19:52:47','3b085030-9207-410b-839a-113c03cfa673'),(9822,9822,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>January 5, 2024</h3><ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','1758ab03-4235-45f5-90f2-6449bc02aebc'),(9823,9823,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:47','2024-05-17 19:52:47','0cedf4ca-c70b-4e9f-8020-f55566858b47'),(9824,9824,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Previous Changes</h3>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','656be5b6-d356-42f4-b863-9b93d24a24a0'),(9825,9825,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"December 10, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','45360f31-47dd-46df-89b6-e2244b66198f'),(9826,9826,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"April 23, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','e84ead93-50e4-470d-9a63-c6b7126c2f50'),(9827,9827,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"September 05, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','79e113d0-0fe7-429b-95db-59eb3406de6e'),(9828,9828,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"February 19, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:52:47','2024-05-17 19:52:47','3774b394-e3a4-43ec-9870-3d0db8e8b262'),(9829,9829,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:47','2024-05-17 19:52:47','d7011e7d-fa48-4bcc-9256-67e73056c132'),(9830,9830,1,NULL,'__temp_etntecsaneliwxhfpdnbcwvxzehmjrzboxgv',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p><strong>Medical Product Investigations – Key Resources</strong></p><p>1. Dolan SA, Arias KM, Felizardo G et.al. APIC position paper: Safe injection, infusion, and<br />medication vial practices in health care. Am J Infect Control. 2016 Jul 1;44(7):750-7.</p><p>2. FDA. MedWatch. Accessed at: <a href=\\\"https://www.accessdata.fda.gov/scripts/medwatch/index.cfm.\\\">https://www.accessdata.fda.gov/scripts/medwatch/index.cfm.</a></p><p>3. FDA. Sharing Non-Public Information. Available at:<br /><a href=\\\"https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Pharmacy%20Compounding/UCM446165.pdf\\\">https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Pharmacy</a><br /><a href=\\\"https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Pharmacy%20Compounding/UCM446165.pdf\\\">Compounding/UCM446165.pdf</a>.</p><p><strong>Contaminated Medical Products – Selected Examples</strong></p><p><i>Endoscopes</i></p><p>1. Botana-Rial M, Leiro-Fernández V, Núñez-Delgado M, Álvarez-Fernández M, Otero-Fernández S,<br />et. al. A Pseudo-Outbreak of Pseudomonas putida and Stenotrophomonas maltophilia in a<br />Bronchoscopy Unit. 2016;92(4):274-278.</p><p>2. FDA. Infections Associated with Reprocessed Duodenoscopes. Available at:<br /><a href=\\\"https://www.fda.gov/medical-devices/reprocessing-reusable-medical-devices/infectionsassociated-reprocessed-duodenoscopes\\\">https://www.fda.gov/medical-devices/reprocessing-reusable-medical-devices/infectionsassociated-reprocessed-duodenoscopes</a> </p><p>3. Guy M, Vanhems P, Dananché C, Perraud M, Regard A, et. al. Outbreak of pulmonary<br />Pseudomonas aeruginosa and Stenotrophomonas maltophilia infections related to<br />contaminated bronchoscope suction valves, Lyon, France, 2014. Euro Surveill. 2016 Jul<br />14;21(28).</p><p>4. Humphries RM, Yang S, Kim S, Muthusamy VR, Russell D, et. al. Duodenoscope-Related<br />Outbreak of a Carbapenem-Resistant Klebsiella pneumoniae Identified Using Advanced<br />Molecular Diagnostics. Clin Infect Dis. 2017 Oct 1;65(7):1159-1166.</p><p>5. Kumarage J, Khonyongwa K, Khan A, Desai N, Hoffman P, Taori SK. Transmission of multi-drug<br />resistant Pseudomonas aeruginosa between two flexible ureteroscopes and an outbreak of<br />urinary tract infection: the fragility of endoscope decontamination. J Hosp Infect. 2019<br />May;102(1):89-94.</p><p>6. Rahman MR, Perisetti A, Coman R, Bansal P, Chhabra R, Goyal H. Duodenoscope-Associated<br />Infections: Update on an Emerging Problem. Dig Dis Sci. 2019 Jun;64(6):1409-1418.</p><p><i>Heater-Cooler Devices</i></p><p>1. CDC. Contaminated Heater-Cooler Devices: Health Alert. Available at:<br /><a href=\\\"https://www.cdc.gov/hai/outbreaks/heater-cooler.html\\\">https://www.cdc.gov/hai/outbreaks/heater-cooler.html</a> <br /> </p><p>2. Lyman MM, Grigg C, Kinsey CB, et. al. Invasive Nontuberculous Mycobacterial Infections among<br />Cardiothoracic Surgical Patients Exposed to Heater–Cooler Devices. Emerg Infect Dis. 2017<br />May; 23(5): 796–805.</p><p>3. Perkins KM, Lawsin A, Hasan NA, et al. Notes from the Field. Mycobacterium chimaera<br />Contamination of Heater-Cooler Devices Used in Cardiac Surgery — United States. MMWR<br />Morb Mortal Wkly Rep 2016;65:1117–1118. </p><p>4. van Ingen J, Kohl TA, Kranzer K, Hasse B, Keller PM, et. al. Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study. Lancet Infect Dis. 2017 Oct;17(10):1033-1041. </p><p><i>Medication/Product </i></p><p>1. Dolan SA, Littlehorn C, Glodé MP, Dowell E, Xavier K, et. al. Association of Bacillus cereus infection with contaminated alcohol prep pads. Infect Control Hosp Epidemiol. 2012 Jul;33(7):666-71. </p><p>2. Kainer MA, Reagan DR, Nguyen DB, et. al. Fungal Infections Associated with Contaminated Methylprednisolone in Tennessee. N Engl J Med. 2012 Dec 6; 367(23): 2194–2203. </p><p>3. West K, Janelle S, Schutz K, Hamilton S, Mayo K, et. al. Outbreak of Serratia marcescens bacteremia in pediatric patients epidemiologically linked to pre-filled heparin flushes. Infect Control Hosp Epidemiol. 2019 Jul 25:1-2. </p><p>4. Hudson MJ, Park SC, Mathers A, Parikh H, Glowicz J, Dar D, Nabili M, LiPuma JJ, Bumford A, Pettengill MA, Sterner Jr MR. Outbreak of Burkholderia stabilis infections associated with contaminated nonsterile, multiuse ultrasound gel—10 states, May–September 2021. Morbidity and Mortality Weekly Report. 2022 Dec 12;71(48):1517. </p><p>5. CDC. Outbreak of Extensively Drug-resistant Psuedomonas aeruginosa Associated with Artificial Tears. Available at: <a href=\\\"https://www.cdc.gov/hai/outbreaks/crpa-artificial-tears.html\\\">https://www.cdc.gov/hai/outbreaks/crpa-artificial-tears.html</a>  </p><p>6. Schwartz NG, Hernandez-Romieu AC, Annambhotla P, Filardo TD, Althomsons SP, Free RJ, Li R, Wilson WW, Deutsch-Feldman M, Drees M, Hanlin E. Nationwide tuberculosis outbreak in the USA linked to a bone graft product: an outbreak report. The Lancet Infectious Diseases. 2022 Nov 1;22(11):1617-25. </p><p>7. Hartnett KP, Powell KM, Rankin D, Gable P, Kim JJ, Spoto S, Breaker E, Hunter R, Dotson N, McAllister G, Stevens V. Investigation of Bacterial Infections Among Patients Treated With Umbilical Cord Blood–Derived Products Marketed as Stem Cell Therapies. JAMA Network Open. 2021 Oct 1;4(10):e2128615.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Chapter References\"}',1,'2024-05-17 19:52:47','2024-06-06 18:29:50','0130b654-f2d7-4be6-9792-39d3f19a8344'),(9831,9831,1,'Infection Control Breach Investigations','infection-control-breach-investigations-2','chapters/infection-control-breach-investigations-2',NULL,1,'2024-05-17 19:52:48','2024-05-17 19:52:48','ae53e7f7-3e03-41b5-9e40-fcc646f0c8e4'),(9832,9832,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','7a7c3bc4-7c93-4d73-9c56-ebc888704068'),(9833,9833,1,NULL,NULL,NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For infection prevention specialists\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for epidemiologists\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','5332245b-8e0e-4f2f-b58f-6739e3288b28'),(9834,9834,1,NULL,NULL,NULL,'{\"a48729ab-e8ea-4b7f-a871-7ece2b6c639a\": \"For health departments & healthcare facilities\", \"e6ff6d22-2545-4632-893e-5feb543677a2\": \"Also useful for associated specialists\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','194b70ce-e0ee-4adf-bad5-a08c8c545f33'),(9835,9835,1,NULL,NULL,NULL,'{\"1e722570-9511-4fa1-8aef-4415e13072e1\": \"<p><a href=\\\"#\\\">Optional: Committee</a></p>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','94e5d3c7-f9cb-49ca-bc44-df9470dacb7d'),(9836,9836,1,NULL,NULL,NULL,'{\"4ef0d8f2-6c32-41b6-8648-80abbba8adaf\": {\"date\": \"2021-09-01 07:00:00\"}, \"ce38096b-1714-4d43-ae46-d75b6150ba1a\": {\"date\": \"2024-01-05 08:00:00\"}}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','55d72cc0-715c-4b24-89fc-b7dcbaf09522'),(9837,9837,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:48','2024-05-17 19:52:48','94fde3bf-d2d8-4c74-b947-3416326df638'),(9839,9839,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:48','2024-05-17 19:52:48','96cac246-bbf5-41e8-a3b1-7de016838e69'),(9840,9840,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Chapter Summary</h2><p>Preparations made ahead of a healthcare-associated infection (HAI) or antimicrobial-resistant (AR) pathogen outbreak lay the groundwork for actions taken during the outbreak response. Activities that prepare public health agencies to respond to outbreaks involving healthcare delivery include developing the capacity to rapidly collect and analyze large amounts of information, take rapid action to stop transmission, and communicate effectively with stakeholders.</p>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','51660b7d-7089-4e61-9198-c1156d596d5b'),(9841,9841,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:48','2024-05-17 19:52:48','54808398-d02b-47c2-a931-95b0411d6c94'),(9842,9842,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Introduction</h3>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','0306a68f-7b2d-4a59-98da-88cd332ea033'),(9843,9843,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What are the general roles and responsibilities of various agencies during an outbreak?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','8a2e5ccd-c5c4-476e-89c6-530e5b1d68de'),(9844,9844,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What individual roles should the outbreak response team consist of, and what are their responsibilities?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','9e12130d-42b6-4a8d-b305-97c183f54050'),(9845,9845,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What equipment, supplies, documents, toolkits, and other resources should a response team have?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','8c14dd47-c2f6-4432-a962-a18aa1469cfd'),(9846,9846,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:48','2024-05-17 19:52:48','62955969-cf0c-4bbc-8cf7-841dd8e2c333'),(9847,9847,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Protocol &amp; Responsibilities</h3>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','08201b14-a3ea-4311-b33e-8788fa84195a'),(9848,9848,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What communication needs should an outbreak response team be prepared for?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','e1cd29d7-bf7f-4ed6-8a4d-296c611a08e2'),(9849,9849,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How should an outbreak response team manage their records?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','b43ece18-773d-4506-a26b-6d36269a34d6'),(9850,9850,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"When should an outbreak response team ask for help, and who can provide it?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','6a9f7f0d-6754-42da-9a1f-635f2cadd448'),(9851,9851,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What is an incident command center?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','641fd8c7-576a-47c3-afd7-22887ab08778'),(9852,9852,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:48','2024-05-17 19:52:48','d9040a02-fd27-488c-a8ac-316616259c30'),(9853,9853,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Additional Topics</h3>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','6cf1aeb9-f082-4341-bac0-9a3ce3567593'),(9854,9854,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"What other legal, ethical, or privacy concerns should be considered?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:48','2024-05-17 19:52:48','9500f070-bbc5-4c1a-b11d-bf631b99bc2d'),(9855,9855,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"How can an outbreak response team plan for recovery and follow up?\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Since states organize their governmental public health systems in diverse ways, the relative roles of local  and state health departments will vary. In states where governance is centralized, responsibility for conducting outbreak investigations rests primarily with state health departments. Conversely, in jurisdictions where governance is decentralized (“home rule” states), this responsibility may rest primarily with the local health department.</p>\"}',1,'2024-05-17 19:52:49','2024-05-17 19:52:49','c57e6f32-7dec-4e43-a1ec-9aada558b2d9'),(9856,9856,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:49','2024-05-17 19:52:49','1ca47e17-7b33-4230-b2f3-b9cf553baf92'),(9857,9857,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Change Log</h2><p>As advances occur in outbreak protocols, this guidance document will be updated. Previous changes can be tracked below:</p>\"}',1,'2024-05-17 19:52:49','2024-05-17 19:52:49','543a2cd2-b878-45bd-a527-b987a1abd8c7'),(9858,9858,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:49','2024-05-17 19:52:49','c2e78075-2720-42aa-a346-7e5a338ef692'),(9859,9859,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>January 5, 2024</h3><ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:52:49','2024-05-17 19:52:49','f10770b3-ae36-4de1-b87e-99173eb17593'),(9860,9860,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:49','2024-05-17 19:52:49','8bef0c3a-d663-4bb4-b3d2-054046038137'),(9861,9861,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h3>Previous Changes</h3>\"}',1,'2024-05-17 19:52:49','2024-05-17 19:52:49','9bdab530-648e-498d-838c-b54fcee3034b'),(9862,9862,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"December 10, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:52:49','2024-05-17 19:52:49','483f776b-cec3-4837-955c-6ac2d06019a5'),(9863,9863,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"April 23, 2023\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:52:49','2024-05-17 19:52:49','f05788ba-82ee-47b1-a6d6-f76139587896'),(9864,9864,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"September 05, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:52:49','2024-05-17 19:52:49','293367c1-72c8-4cb5-83bc-3445a410a706'),(9865,9865,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"February 19, 2022\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<ul><li><strong>Added</strong> lorem ipsum dolor sit amet, consectetur adipiscing elit. </li><li><strong>Added</strong> etiam vulputate tincidunt vestibulum. </li><li><strong>Removed</strong> nulla semper est sem. </li><li><strong>Updated</strong> in nec sollicitudin nisi, eget viverra lectus. Phasellus at leo varius eros suscipit varius sit amet ut nisi. Cras sit amet ullamcorper erat. Vestibulum pretium luctus justo, at volutpat odio finibus nec. </li><li><strong>Removed</strong> praesent volutpat diam et vestibulum malesuada. Aenean cursus nibh a odio vehicula sodales. Sed pellentesque convallis neque ac tempor.</li></ul>\"}',1,'2024-05-17 19:52:49','2024-05-17 19:52:49','4e123e22-9e74-413d-8425-de3530574f93'),(9866,9866,1,NULL,NULL,NULL,NULL,1,'2024-05-17 19:52:49','2024-05-17 19:52:49','2a4a3fe9-ecfb-4cf7-aa9c-22bbd9e64c84'),(9867,9867,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Chapter References</h2><ol><li>Centers for Disease Control and Prevention (CDC). Public Health Professionals Gateway: HealthDepartment Governance. <a href=\\\"https://www.cdc.gov/publichealthgateway/sitesgovernance/index.html\\\">https://www.cdc.gov/publichealthgateway/sitesgovernance/index.html</a></li><li>Centers for Disease Control and Prevention (CDC). State Based HAI Prevention Activities. <a href=\\\"https://www.cdc.gov/hai/state-based/index.html\\\">https://www.cdc.gov/hai/state-based/index.html</a></li><li>Franklin SM, Crist MB, Perkins KM, Perz JF. Outbreak response capacity assessments and improvements among public health department health care-associated infection programs— United States, 2015-2017. J Public Health Manag Pract. 2020;2022; 28(2):116-125. DOI: 10.1097/PHH.0000000000001148</li><li>Centers for Disease Control and Prevention (CDC). Epidemic Intelligence Service: Urgent Assistance (Epi-Aids). <a href=\\\"https://www.cdc.gov/eis/request-services/epiaids.html\\\">https://www.cdc.gov/eis/request-services/epiaids.html</a></li><li>U.S. Food &amp; Drug Administration. Information Sharing. <a href=\\\"https://www.fda.gov/federal-state-localtribal-and-territorial-officials/communications-outreach/information-sharing\\\">https://www.fda.gov/federal-state-localtribal-and-territorial-officials/communications-outreach/information-sharing</a></li><li>Holt JD, Ghosh SN, Black JR. Legal Considerations. In: Rasmussen SA, Goodman RA, eds. The CDC Field Epidemiology Manual. US Department of Health and Human Services Centers for Disease Control and Prevention (CDC); 2018:chap 13. <a href=\\\"https://www.cdc.gov/eis/field-epimanual/chapters/Legal.html\\\">https://www.cdc.gov/eis/field-epimanual/chapters/Legal.html</a></li><li>California Hospital Association. Emergency Preparedness: Drills and Exercises. <a href=\\\"https://www.calhospitalprepare.org/exercises\\\">https://www.calhospitalprepare.org/exercises</a></li><li>Centers for Disease Control and Prevention (CDC). Healthcare-associated infections (HAIs): Infection Control Assessment Tools. <a href=\\\"https://www.cdc.gov/hai/prevent/infection-controlassessment-tools.html\\\">https://www.cdc.gov/hai/prevent/infection-controlassessment-tools.html</a></li><li>Centers for Disease Control and Prevention (CDC). Quick Observation Tools (QUOTs) for Infection Prevention. <a href=\\\"https://www.cdc.gov/infectioncontrol/tools/quots.html\\\">https://www.cdc.gov/infectioncontrol/tools/quots.html</a></li><li>Heymann DL, ed. Control of Communicable Diseases Manual. 20th ed. APHA Press; 2015.</li><li>Centers for Medicare and Medicaid Services (CMS). Emergency Preparedness Rule. <a href=\\\"https://www.cms.gov/Medicare/Provider-Enrollment-andCertification/SurveyCertEmergPrep/Emergency-Prep-Rule.html\\\">https://www.cms.gov/Medicare/Provider-Enrollment-andCertification/SurveyCertEmergPrep/Emergency-Prep-Rule.html</a></li><li>Christensen BE, Fagan RP. Healthcare Settings. In: Rasmussen SA, Goodman RA, eds. The CDC Field Epidemiology Manual. US Department of Health and Human Services Centers for Disease Control and Prevention (CDC); 2018:chap 18. <a href=\\\"https://www.cdc.gov/eis/field-epimanual/chapters/Healthcare-Settings.html\\\">https://www.cdc.gov/eis/field-epimanual/chapters/Healthcare-Settings.html</a></li><li>Centers for Disease Control and Prevention (CDC). Outpatient Settings Policy Options for Improving Infection Prevention. October 2015. <a href=\\\"https://www.cdc.gov/hai/pdfs/prevent/Outpatient-Settings-Policy-Options.pdf\\\">https://www.cdc.gov/hai/pdfs/prevent/Outpatient-Settings-Policy-Options.pdf</a></li><li>US Department of Health &amp; Human Services(HHS). Public Health. 45 CFR 164.512(b). <a href=\\\"https://www.hhs.gov/hipaa/for-professionals/special-topics/public-health/index.html\\\">https://www.hhs.gov/hipaa/for-professionals/special-topics/public-health/index.html</a> </li><li>US Department of Health &amp; Human Services(HHS). Summary of the HIPAA Privacy Rule. https://www.hhs.gov/hipaa/for-professionals/privacy/laws-regulations/index.html</li></ol>\"}',1,'2024-05-17 19:52:49','2024-05-17 19:52:49','58cc0300-5d85-4ad1-9daf-76fdf58283a7'),(9869,9869,1,'Medical Product Investigations','medical-product-investigations','chapters/medical-product-investigations',NULL,1,'2024-05-17 19:53:20','2024-05-17 19:53:20','13fe089a-155e-4063-a3e9-51a7d70603cd'),(9870,9870,1,'8-Jennifer Jones, 2023 McKnight Prize for Healthcare Outbreak Heroes Recipient','jennifer-jones-2023-mcknight-prize-for-healthcare-outbreak-heroes-recipient-2','news/jennifer-jones-2023-mcknight-prize-for-healthcare-outbreak-heroes-recipient-2','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Jennifer Jones, Senior Infection Preventionist at Helen DeVos Children’s Hospital, part of Corewell Health in Grand Rapids, Michigan is the recipient of the 2023 McKnight Prize for Healthcare Outbreak Heroes award for her outstanding response to a Methicillin-resistant Staphylococcus aureus (MRSA) outbreak in a Neonatal Intensive Care Unit.</p><figure class=\\\"image\\\"><img src=\\\"{asset:1557:url||http://staging.corha.astriatawiki.com/assets/images/305fe57496acb9a1db30e7e0795e2bce.jpg}\\\" alt=\\\"Jennifer Jones Headshot\\\" width=\\\"200\\\" height=\\\"300\\\" /></figure><p>Jennifer Jones, Senior Infection Preventionist</p><p>The Evelyn and Thomas McKnight Family Fund for Patient Safety and the CDC Foundation created the McKnight Healthcare Outbreak Heroes Prize to encourage and reward those who protect patients from harm related to healthcare outbreaks. We’re happy to introduce Jennifer Jones as the 2023 recipient of this prestigious award!</p><p>Epidemic Keratoconjunctivitis</p><p><br />In the Spring of 2022, the Helen DeVos Children’s Hospital’s Infection Prevention team, led by Jennifer, Senior Infection Preventionist, was monitoring hospital-acquired MRSA cases in their Neonatal Intensive Care Unit (NICU). The team identified an outbreak after observing a sudden uptick in MRSA bacteremia cases in a short period of time, prompting an investigation. The infection prevention team utilized their Outbreak Investigation Policy, referenced CDC &amp; APIC resources, and implemented mitigation strategies. Examples of these strategies included mandatory Call-to-Action sessions for all team members who enter the NICU, weekly MRSA screening of all admitted NICU babies, development of a decolonization protocol, and installation of additional hand sanitizer dispensers. Jennifer exemplified outstanding leadership, initiative, and personal commitment as part of a successful effort to protect newborns throughout this outbreak response. CORHA spoke with her about her lessons learned and keys to success.</p><p><br />Jennifer recognized that during this outbreak, good communication was essential for all stakeholders: parents, staff, leadership, the health department, and CDC. She organized weekly meetings to provide updates during the investigation that could be shared among their teams. Jennifer emphasized that navigating these conversations with partners during an HAI/AR outbreak response is always tough; however, when you provide data to support your rationale and response, it makes the conversations easier.</p><p><br />A success Jennifer shares is that her staff felt comfortable going to leadership and the infection prevention team with suggestions. For example, during their Call-to-Action sessions, staff felt empowered to notify the infection prevention team that gloves in all sizes were not easily accessible to provide care. Jennifer’s team went onsite with facility and bedside team members to see where they could install a place to house small, medium, and large gloves for staff use. This is just one example of open communication from over 40 suggestions that were provided to Jennifer’s team.<br />Sharing key messages with everyone who might enter the NICU space was a challenging and essential part of the outbreak response. Jennifer’s team rounded in the NICU frequently to conduct knowledge surveys (and, of course, hand out candy). This helped them evaluate whether their messaging was reaching the care team and provide real-time observations and feedback. The following is a key insight Jennifer gained while leading the outbreak response:</p><blockquote><p>Get out there and observe what is truly happening and partner with the care team so it doesn’t seem punitive. Walk alongside them in all phases of an outbreak scenario so it remains a partnership between the care team and infection prevention team.</p></blockquote><p class=\\\"quote-author\\\">-Jennifer Jones</p><p>We applaud Jennifer for her leadership, dedication and initiative to ensure a well-coordinated and successful outbreak response.</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Example Author\"}',1,'2024-05-17 21:22:27','2024-05-17 21:22:27','60570d9a-95f1-40aa-b5be-f0c331ccba19'),(9871,9871,1,NULL,NULL,NULL,NULL,1,'2024-05-17 21:22:28','2024-05-17 21:22:28','8e80e7e1-f2cd-4c43-a54d-ca9d62315e9b'),(9872,9872,1,'Fundamental Concepts','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:25:08','2024-05-21 03:48:08','8319c82f-8687-42ef-b18a-8c00f1be2d77'),(9874,9874,1,'Planning & Preparation','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:25:39','2024-05-21 03:49:06','b1986905-bfee-4df1-b48b-6e9517ab7b37'),(9875,9875,1,'Detection & Reporting','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:25:55','2024-05-21 03:50:37','1ff586d0-e924-4631-b04e-a0daaa3f7d28'),(9876,9876,1,'Investigation & Control','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:26:14','2024-05-21 03:52:05','c069d3fb-a1c6-4f10-9b3a-411b70182bee'),(9877,9877,1,'Laboratory Best Practices','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:26:26','2024-05-21 03:52:33','ff05a420-cd07-4e8d-80e2-e9f640bbdd2d'),(9878,9878,1,'Notification & Communication','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:26:37','2024-05-21 03:53:43','dd974360-cf10-4d3d-8b37-51a597143fd8'),(9879,9879,1,'Breach Investigations','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:26:49','2024-05-21 03:54:15','b6d8be49-113e-4dc9-8b47-9d9d20b95220'),(9882,9882,1,'C. Diff','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:33:25','2024-05-31 20:24:56','04c2def6-4374-4aca-8e0a-22c2e8014b8c'),(9887,9887,1,NULL,NULL,NULL,'{\"3a9f67a1-7f13-4f08-a637-c121dbe45ba6\": \"Clostridioides difficile\", \"f11fd59c-9f12-4695-9937-141a5d15f116\": false}',1,'2024-05-17 21:35:32','2024-05-17 21:35:32','6c7690a5-6cee-4741-af6a-83f589e1b22d'),(9888,9888,1,'COVID-19','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:36:11','2024-05-31 20:27:53','4e150ed4-aa41-4775-92fa-b774ff5234b4'),(9889,9889,1,'CRE',NULL,NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:36:31','2024-05-29 20:27:23','ebe6c11b-0292-429d-8512-2f58ff2586e9'),(9894,9894,1,NULL,NULL,NULL,'{\"3a9f67a1-7f13-4f08-a637-c121dbe45ba6\": \"Carbapenem-Resistant Enterobacterales\", \"f11fd59c-9f12-4695-9937-141a5d15f116\": false}',1,'2024-05-17 21:36:51','2024-05-17 21:36:51','d8ae2f47-53e9-4c61-be6e-b2d48c0482c3'),(9895,9895,1,'Ebola','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:37:10','2024-05-31 20:40:04','07742543-bea7-45c2-8b83-e0003d6b90ae'),(9896,9896,1,'EKC','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:37:27','2024-05-31 20:37:15','a10238c3-a0d4-4c96-8d3a-02be5436dfd7'),(9901,9901,1,NULL,NULL,NULL,'{\"3a9f67a1-7f13-4f08-a637-c121dbe45ba6\": \"Epidemic Keratoconjunctivitis\", \"f11fd59c-9f12-4695-9937-141a5d15f116\": false}',1,'2024-05-17 21:37:56','2024-05-17 21:37:56','3070bb52-9de4-4f2a-91a2-ee7997f46c9c'),(9902,9902,1,'GAS',NULL,NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:38:09','2024-05-29 20:27:26','6d558315-9e69-43ff-b0ea-6ef5d8deed09'),(9906,9906,1,NULL,NULL,NULL,'{\"3a9f67a1-7f13-4f08-a637-c121dbe45ba6\": \"Group A Streptococcus\", \"f11fd59c-9f12-4695-9937-141a5d15f116\": false}',1,'2024-05-17 21:38:40','2024-05-17 21:38:40','fd1856e3-37c6-47fa-b7ba-5f125a5c16ca'),(9907,9907,1,'Influenza',NULL,NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:38:53','2024-05-29 20:27:28','f88962a4-dcc6-460c-92fd-39a968673f99'),(9908,9908,1,'Legionella','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:39:12','2024-05-31 20:37:55','6ce498b5-6d4a-454f-af1f-3ef65bf77812'),(9909,9909,1,'Measles','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:39:29','2024-05-31 20:41:03','ad63ea8d-f2c2-4056-901b-5cb92da5dee7'),(9910,9910,1,'Mpox','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:39:49','2024-05-31 20:38:42','4e19313f-7acc-4057-97e3-be4ffc90377f'),(9911,9911,1,'Norovirus',NULL,NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:40:07','2024-05-29 20:27:33','84f70cec-2d8b-42f6-896b-23f98d47ce79'),(9912,9912,1,'NTM','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:40:25','2024-05-31 20:40:40','6518ad2c-f138-4e7a-b79c-095ad1aa849b'),(9917,9917,1,NULL,NULL,NULL,'{\"3a9f67a1-7f13-4f08-a637-c121dbe45ba6\": \"Nontuberculous Mycobacteria\", \"f11fd59c-9f12-4695-9937-141a5d15f116\": false}',1,'2024-05-17 21:40:46','2024-05-17 21:40:46','b2604340-72cb-4574-9a5b-15ee318cc5a1'),(9920,9920,1,'Viral Hepatitis','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:43:07','2024-05-31 20:39:03','8b5c505c-0529-4b1e-9bd9-ab29f5f9a61b'),(9921,9921,1,'Investigation Tracking System',NULL,NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:45:27','2024-05-29 22:25:14','2900e82f-0005-4324-8e3a-f95f500ecec9'),(9925,9925,1,NULL,NULL,NULL,'{\"3a9f67a1-7f13-4f08-a637-c121dbe45ba6\": \"Add a blurb to describe what the tool does and how it helps\", \"f11fd59c-9f12-4695-9937-141a5d15f116\": false}',1,'2024-05-17 21:45:46','2024-05-17 21:45:46','dd39b15a-f27a-4fe9-9354-6005f1ceaa36'),(9926,9926,1,'Standard Variables List','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:46:09','2024-07-30 18:46:12','3cf18834-1fe7-4852-a06a-d4f8176ce941'),(9927,9927,1,'Line List & Data Collection Tool',NULL,NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:46:26','2024-05-29 22:25:17','a13858b4-e120-47be-afbd-1e531dc58b5b'),(9928,9928,1,'Placeholder Link for Future',NULL,NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-17 21:47:03','2024-05-29 22:25:21','7c8295a1-2b2b-4bbf-b6a3-1467a697f29d'),(9932,9932,1,NULL,NULL,NULL,'{\"3a9f67a1-7f13-4f08-a637-c121dbe45ba6\": \"Describe who made the tool and what it does\", \"f11fd59c-9f12-4695-9937-141a5d15f116\": false}',1,'2024-05-17 21:48:06','2024-05-17 21:48:06','e37a1f94-3359-4889-9bad-b19d33cd811a'),(9936,9936,1,NULL,'__temp_viljgiwijznqenytuhvjtbyivbpruqhmwods',NULL,'{\"3a9f67a1-7f13-4f08-a637-c121dbe45ba6\": \"Add a blurb to describe what the tool does and how it helps\", \"f11fd59c-9f12-4695-9937-141a5d15f116\": false}',1,'2024-05-17 21:49:16','2024-07-30 18:35:28','d138151f-f0c4-476c-9dc3-0e158e3d15c2'),(9940,9940,1,NULL,NULL,NULL,'{\"3a9f67a1-7f13-4f08-a637-c121dbe45ba6\": \"Add a blurb to describe what the tool does and how it helps\", \"f11fd59c-9f12-4695-9937-141a5d15f116\": false}',1,'2024-05-17 21:49:29','2024-05-17 21:49:29','68bf036e-54c4-4cff-99b7-c17c0754edf3'),(9941,9941,1,'EKC','ekc','diseases-pathogens/ekc',NULL,1,'2024-05-18 20:32:08','2024-05-18 20:32:08','3106a564-a17f-4570-8ee1-8eafea8e0944'),(9942,9942,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called Epidemic Keratoconjunctivitis uptdate Test</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"EKC Resources\"}',1,'2024-05-18 20:32:08','2024-05-18 20:32:08','e039e194-bd63-4deb-bd29-df06b40c6bec'),(9943,9943,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2022-10-01 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2021-02-01 08:00:00\"}}',1,'2024-05-18 20:32:08','2024-05-18 20:32:08','7b41f0c1-7d9a-426f-98d3-9709458952dc'),(9944,9944,1,NULL,NULL,NULL,NULL,1,'2024-05-18 20:32:08','2024-05-18 20:32:08','0f45a1b7-b3bd-4002-9149-1789e7e936e1'),(9945,9945,1,NULL,NULL,NULL,NULL,1,'2024-05-18 20:32:08','2024-05-18 20:32:08','89af525a-c6d4-4155-95c4-99a681255f3e'),(9946,9946,1,NULL,NULL,NULL,NULL,1,'2024-05-18 20:32:08','2024-05-18 20:32:08','13b9282e-75f1-4088-ab3a-40a46a5c1dc2'),(9947,9947,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Line List: Sample Documentation Template\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-18 20:32:08','2024-05-18 20:32:08','061b5c8c-d17a-4a5f-bc4f-5dd7c70c46ac'),(9948,9948,1,NULL,NULL,NULL,NULL,1,'2024-05-18 20:32:08','2024-05-18 20:32:08','80fca559-a080-4e6a-a11e-9c3dbe2ec8ed'),(9949,9949,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Outbreak Patient Letter: Sample Communications\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-18 20:32:08','2024-05-18 20:32:08','1c216e94-a832-4b27-8c79-c89efa68af9e'),(9950,9950,1,NULL,NULL,NULL,NULL,1,'2024-05-18 20:32:08','2024-05-18 20:32:08','563b1791-c133-4be9-a327-3a17397bed96'),(9951,9951,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-18 20:32:08','2024-05-18 20:32:08','89c77c6c-62bd-4d8b-986a-615d3efdeab1'),(9952,9952,1,NULL,NULL,NULL,NULL,1,'2024-05-18 20:32:08','2024-05-18 20:32:08','6c294030-f55d-4486-a57d-7b28ceeeca23'),(9953,9953,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Adenovirus-Associated EKC Outbreaks: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-18 20:32:08','2024-05-18 20:32:08','032964fd-161c-4a61-9041-b1e96854deb3'),(9954,9954,1,NULL,NULL,NULL,NULL,1,'2024-05-18 20:32:08','2024-05-18 20:32:08','ca639913-1920-49fb-8725-cc2a79687ca6'),(9955,9955,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Outbreak of EKC Caused by Human Adenovirus Type D53 in an Eye Care Clinic: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-18 20:32:08','2024-05-18 20:32:08','973f31ae-8a50-404f-9103-94e790de5a42'),(9956,9956,1,NULL,NULL,NULL,NULL,1,'2024-05-18 20:32:08','2024-05-18 20:32:08','c1ed8756-7d24-4a00-b6c9-83cf9127f581'),(9957,9957,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | EKC Outbreak Associated with Human Adenovirus Type 8 : Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-11-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-18 20:32:08','2024-05-18 20:32:08','b895512c-4881-438d-ad0e-fa350e0e1380'),(9958,9958,1,NULL,NULL,NULL,NULL,1,'2024-05-18 20:32:08','2024-05-18 20:32:08','d79e12d8-97bd-4580-aa2b-04911fc36954'),(9959,9959,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Principles & Practices\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Get comprehensive guidance to build or improve practices related to detection, reporting, investigation, or control of any HAI or AR outbreak.\"}',1,'2024-05-18 20:32:08','2024-05-18 20:32:08','0ccfabbc-e32b-4ed1-b346-0c6c16bad8b7'),(9967,9967,1,NULL,NULL,NULL,NULL,1,'2024-05-19 20:57:26','2024-05-19 20:57:26','7eceb699-2498-46e6-8ab6-3fcd9e31e483'),(9984,9984,1,'EKC','ekc','diseases-pathogens/ekc',NULL,1,'2024-05-19 21:00:08','2024-05-19 21:00:08','cea2227a-e17d-45be-b81e-902e8948d81b'),(9985,9985,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called Epidemic Keratoconjunctivitis uptdate Test</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"EKC Resources\"}',1,'2024-05-19 21:00:08','2024-05-19 21:00:08','46531d92-6dc3-40b8-bb92-ddd347efff4d'),(9986,9986,1,NULL,NULL,NULL,NULL,1,'2024-05-19 21:00:08','2024-05-19 21:00:08','26033461-9701-46fc-b9e2-b402ddb01655'),(9987,9987,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Line List: Sample Documentation Template\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-19 21:00:08','2024-05-19 21:00:08','8c9b23ea-5394-4958-bf23-d8fa7d3a47ce'),(9988,9988,1,NULL,NULL,NULL,NULL,1,'2024-05-19 21:00:08','2024-05-19 21:00:08','bc1ba7ba-5488-406d-adae-af012d33f3d1'),(9989,9989,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Outbreak Patient Letter: Sample Communications\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-19 21:00:08','2024-05-19 21:00:08','76ff8d65-82d7-4be3-ad79-882586ffaa0e'),(9990,9990,1,NULL,NULL,NULL,NULL,1,'2024-05-19 21:00:08','2024-05-19 21:00:08','115af51d-413c-4b2e-a005-95a2491b9dab'),(9991,9991,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-19 21:00:08','2024-05-19 21:00:08','e0ac12f4-13a2-4472-a55d-4c91674fc372'),(9992,9992,1,NULL,NULL,NULL,NULL,1,'2024-05-19 21:00:08','2024-05-19 21:00:08','0c0ff299-3c73-4076-a4e9-d59b2edf8f99'),(9993,9993,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Adenovirus-Associated EKC Outbreaks: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-19 21:00:08','2024-05-19 21:00:08','c310ba73-b9ae-4b7a-aa52-f097fb95bc73'),(9994,9994,1,NULL,NULL,NULL,NULL,1,'2024-05-19 21:00:08','2024-05-19 21:00:08','2ad6133b-2ba3-4a0f-b721-85d75213bea1'),(9995,9995,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Outbreak of EKC Caused by Human Adenovirus Type D53 in an Eye Care Clinic: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-19 21:00:09','2024-05-19 21:00:09','d00872ef-ab46-44f6-b881-48aea089659b'),(9996,9996,1,NULL,NULL,NULL,NULL,1,'2024-05-19 21:00:09','2024-05-19 21:00:09','07bf7d38-75f0-4b10-bc05-96304171f71d'),(9997,9997,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | EKC Outbreak Associated with Human Adenovirus Type 8 : Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-11-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-19 21:00:09','2024-05-19 21:00:09','8f73cda2-78a2-4724-bc3d-524e1e25e687'),(9998,9998,1,NULL,NULL,NULL,NULL,1,'2024-05-19 21:00:09','2024-05-19 21:00:09','3f4b837c-0252-4a8c-adaa-d58820c6cbc0'),(9999,9999,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Principles & Practices\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Get comprehensive guidance to build or improve practices related to detection, reporting, investigation, or control of any HAI or AR outbreak.\"}',1,'2024-05-19 21:00:09','2024-05-19 21:00:09','3c9840ab-1ee1-4681-975a-4b59e8cf4eca'),(10000,10000,1,'5-Jennifer Jones, 2023 McKnight Prize for Healthcare Outbreak Heroes Recipient','jennifer-jones-2023-mcknight-prize-for-healthcare-outbreak-heroes-recipient','news/jennifer-jones-2023-mcknight-prize-for-healthcare-outbreak-heroes-recipient','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Jennifer Jones, Senior Infection Preventionist at Helen DeVos Children’s Hospital, part of Corewell Health in Grand Rapids, Michigan is the recipient of the 2023 McKnight Prize for Healthcare Outbreak Heroes award for her outstanding response to a Methicillin-resistant Staphylococcus aureus (MRSA) outbreak in a Neonatal Intensive Care Unit.</p><figure class=\\\"image\\\"><img src=\\\"{asset:1557:url||http://staging.corha.astriatawiki.com/assets/images/305fe57496acb9a1db30e7e0795e2bce.jpg}\\\" alt=\\\"Jennifer Jones Headshot\\\" width=\\\"200\\\" height=\\\"300\\\" /></figure><p>Jennifer Jones, Senior Infection Preventionist</p><p>The Evelyn and Thomas McKnight Family Fund for Patient Safety and the CDC Foundation created the McKnight Healthcare Outbreak Heroes Prize to encourage and reward those who protect patients from harm related to healthcare outbreaks. We’re happy to introduce Jennifer Jones as the 2023 recipient of this prestigious award!</p><p><br />In the Spring of 2022, the Helen DeVos Children’s Hospital’s Infection Prevention team, led by Jennifer, Senior Infection Preventionist, was monitoring hospital-acquired MRSA cases in their Neonatal Intensive Care Unit (NICU). The team identified an outbreak after observing a sudden uptick in MRSA bacteremia cases in a short period of time, prompting an investigation. The infection prevention team utilized their Outbreak Investigation Policy, referenced CDC &amp; APIC resources, and implemented mitigation strategies. Examples of these strategies included mandatory Call-to-Action sessions for all team members who enter the NICU, weekly MRSA screening of all admitted NICU babies, development of a decolonization protocol, and installation of additional hand sanitizer dispensers. Jennifer exemplified outstanding leadership, initiative, and personal commitment as part of a successful effort to protect newborns throughout this outbreak response. CORHA spoke with her about her lessons learned and keys to success.</p><p><br />Jennifer recognized that during this outbreak, good communication was essential for all stakeholders: parents, staff, leadership, the health department, and CDC. She organized weekly meetings to provide updates during the investigation that could be shared among their teams. Jennifer emphasized that navigating these conversations with partners during an HAI/AR outbreak response is always tough; however, when you provide data to support your rationale and response, it makes the conversations easier.</p><p><br />A success Jennifer shares is that her staff felt comfortable going to leadership and the infection prevention team with suggestions. For example, during their Call-to-Action sessions, staff felt empowered to notify the infection prevention team that gloves in all sizes were not easily accessible to provide care. Jennifer’s team went onsite with facility and bedside team members to see where they could install a place to house small, medium, and large gloves for staff use. This is just one example of open communication from over 40 suggestions that were provided to Jennifer’s team.</p><p>Sharing key messages with everyone who might enter the NICU space was a challenging and essential part of the outbreak response. Jennifer’s team rounded in the NICU frequently to conduct knowledge surveys (and, of course, hand out candy). This helped them evaluate whether their messaging was reaching the care team and provide real-time observations and feedback. The following is a key insight Jennifer gained while leading the outbreak response:</p><blockquote><p>Get out there and observe what is truly happening and partner with the care team so it doesn’t seem punitive. Walk alongside them in all phases of an outbreak scenario so it remains a partnership between the care team and infection prevention team.</p></blockquote><p class=\\\"quote-author\\\">-Jennifer Jones</p><p>We applaud Jennifer for her leadership, dedication and initiative to ensure a well-coordinated and successful outbreak response.</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Author Name\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The Evelyn and Thomas McKnight Family Fund for Patient Safety and the CDC Foundation created the McKnight Healthcare Outbreak Heroes Prize to encourage and reward those who protect patients from harm related to healthcare outbreaks. We’re happy to introduce Jennifer Jones as the 2023 recipient of this prestigious award!\"}',1,'2024-05-20 05:15:51','2024-05-20 05:15:51','9096f11a-8b9e-4665-98ea-2d469eb68fca'),(10001,10001,1,NULL,NULL,NULL,NULL,1,'2024-05-20 05:15:51','2024-05-20 05:15:51','463cc977-1db6-4b09-91ca-8cb5faa9abf2'),(10002,10002,1,'3 - Planning & Preparation','planning-preparation','chapters/planning-preparation',NULL,1,'2024-05-20 17:39:40','2024-05-20 17:39:40','c0127211-dec2-4725-92cf-e24a00aa1b44'),(10003,10003,1,NULL,'__temp_stwadcgwjzcaisqordfzwxipgcqsalyipnff','__temp_stwadcgwjzcaisqordfzwxipgcqsalyipnff',NULL,1,'2024-05-20 18:20:05','2024-05-20 18:58:10','9506742e-f7ed-4f2a-a804-b0c4fea70244'),(10004,10004,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:25:36','2024-05-20 18:25:36','2aca07b0-0bf0-400a-96c6-08cda7fb0e05'),(10005,10005,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:25:36','2024-05-20 18:25:36','ad3703c2-c9b2-4471-b151-cd530a676c33'),(10006,10006,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:26:30','2024-05-20 18:26:30','0fbcafe1-d88d-4393-8e97-6a096ddee1a0'),(10007,10007,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:26:30','2024-05-20 18:26:30','0c98a0d5-2417-412a-8660-98b18d53974d'),(10008,10008,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:21','2024-05-20 18:27:21','5c91b95b-1e42-448b-a17d-d29c6c924cb5'),(10009,10009,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:21','2024-05-20 18:27:21','d21641cb-b6d9-453e-81aa-a9a1f191c74b'),(10010,10010,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:21','2024-05-20 18:27:21','c7c210a8-ad4d-4b61-ab84-9395f7d5c4fe'),(10011,10011,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:25','2024-05-20 18:27:25','f8df85ba-9aad-490e-aaa0-2382ecd9f43f'),(10012,10012,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:25','2024-05-20 18:27:25','5bf544cf-c294-4a0b-8235-e07c2a12baae'),(10013,10013,1,NULL,NULL,NULL,'{\"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Testing\"}',1,'2024-05-20 18:27:25','2024-05-20 18:27:25','0f4461ac-1048-47e0-a0fc-802fc7af2edf'),(10014,10014,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:26','2024-05-20 18:27:26','0340a02b-b87b-4600-ba9c-9fef2aade6d9'),(10015,10015,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:26','2024-05-20 18:27:26','bbb504d5-a614-4b30-b703-f81ef3bb51d9'),(10016,10016,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>testing </p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Testing\"}',1,'2024-05-20 18:27:26','2024-05-20 18:27:26','bf8ed567-8988-4597-a272-d59331f85e2e'),(10017,10017,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:27','2024-05-20 18:27:27','48e92bd9-0f33-4ba1-9e2d-c4049c730d5b'),(10018,10018,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:27','2024-05-20 18:27:27','07f4c347-6482-4634-aaf4-857bc161ec44'),(10019,10019,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>testing lorem </p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Testing\"}',1,'2024-05-20 18:27:27','2024-05-20 18:27:27','37d26dd8-4249-4248-9eee-30f7f56b1bf0'),(10020,10020,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:28','2024-05-20 18:27:28','eb1f72a9-ffbd-4dbe-81fa-c87b25f8748c'),(10021,10021,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:29','2024-05-20 18:27:29','19cc8c0c-ff9f-4f8c-8937-6d96a769528e'),(10022,10022,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>testing lorem ipso</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Testing\"}',1,'2024-05-20 18:27:29','2024-05-20 18:27:29','654fa746-3433-4b21-94f6-01543f17b029'),(10023,10023,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:29','2024-05-20 18:27:29','37f15d91-957b-452f-8b85-b72ed5e5a263'),(10024,10024,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:29','2024-05-20 18:27:29','0f10198d-ffec-4d9a-89b9-393913994a46'),(10025,10025,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>testing lorem ipsom</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Testing\"}',1,'2024-05-20 18:27:29','2024-05-20 18:27:29','5d2a2a69-353c-4819-9c9d-fe386edeb763'),(10026,10026,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:27:35','2024-05-20 18:27:35','e870a1f9-e2f4-412d-bdb4-461948b0d296'),(10027,10027,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:28:03','2024-05-20 18:28:03','35c360a3-4ab6-47da-b9ef-56ae9c4050bf'),(10028,10028,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:31:08','2024-05-20 18:31:08','74c28348-10ad-4e19-b9c2-1afae3f066d9'),(10029,10029,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:31:39','2024-05-20 18:31:39','8ab43fa4-eaf4-4200-b9b2-322b6c354089'),(10030,10030,1,NULL,NULL,NULL,'{\"d34ad5d6-4524-4c40-8376-ad2cf3772110\": \"narrowWidth\"}',1,'2024-05-20 18:34:23','2024-05-20 18:34:23','7ee29c46-c629-495a-89b2-7f5a39cda1b9'),(10031,10031,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:38:19','2024-05-20 18:38:19','eeeed1b9-6c26-422e-86e8-5adc2099ecbd'),(10032,10032,1,NULL,NULL,NULL,'{\"d34ad5d6-4524-4c40-8376-ad2cf3772110\": \"narrowWidth\"}',1,'2024-05-20 18:40:38','2024-05-20 18:40:38','b23e7b5d-2e35-4c0b-82e8-6aae24df6acd'),(10033,10033,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:40:43','2024-05-20 18:40:43','fff03389-df12-4d18-b8b0-ab60afdfec76'),(10034,10034,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:42:22','2024-05-20 18:42:22','1ab55b79-8dd3-4746-95b1-e26c535ed0db'),(10035,10035,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:42:22','2024-05-20 18:42:22','b27a519e-8574-4d5a-b4e3-536e821cb193'),(10036,10036,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:42:24','2024-05-20 18:42:24','d5c421e1-8475-4982-9913-a174a9d95ef8'),(10037,10037,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:42:26','2024-05-20 18:42:26','25291aa8-a9ba-4b23-a41a-06b800262d6f'),(10038,10038,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:42:26','2024-05-20 18:42:26','d07b5af4-0a72-4866-ac86-868ec469165f'),(10039,10039,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:44:41','2024-05-20 18:44:41','001e450d-6aaf-4321-b272-56ebde87fcbd'),(10040,10040,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:44:41','2024-05-20 18:44:41','5a6140f6-f35c-4bec-92bc-580f1656adef'),(10041,10041,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:44:41','2024-05-20 18:44:41','449974f9-87cc-4e07-ab09-432fca69fb0b'),(10042,10042,1,'Search','1',NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"topicsDropdown\"}',1,'2024-05-20 18:53:47','2024-05-29 20:15:49','92596acc-d49e-4233-aebb-1740e0f2438c'),(10043,10043,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:55:41','2024-05-20 18:55:41','97f708b0-1cb7-4835-b1f0-016d63ff624c'),(10044,10044,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:55:41','2024-05-20 18:55:41','2d5ef6f5-6a92-40e2-b8f6-19e5c10f7354'),(10045,10045,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:55:41','2024-05-20 18:55:41','cb66cb23-add7-47f9-a24b-0d9cc1b67028'),(10046,10046,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:55:41','2024-05-20 18:55:41','6cc69eb4-a9c8-4521-b06f-29e95a238cd5'),(10047,10047,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:58:10','2024-05-20 18:58:10','1fa7a791-8835-4dee-a43c-d29793c39911'),(10048,10048,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:58:10','2024-05-20 18:58:10','1bfc8c29-a52b-49f9-a1e7-c1efe689913d'),(10049,10049,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:58:10','2024-05-20 18:58:10','9abd6c4a-4f15-4c90-b0f1-56cc9e783df7'),(10051,10051,1,NULL,NULL,NULL,NULL,1,'2024-05-20 18:58:10','2024-05-20 18:58:10','4e441e36-faca-4379-8551-e63efa1c4089'),(10065,10065,1,'Infection Control Breach Investigations','infection-control-breach-investigations','chapters/infection-control-breach-investigations',NULL,1,'2024-05-20 19:13:01','2024-05-20 19:13:01','8aacdc6b-578e-4dbe-a153-935f3c22ec93'),(10066,10066,1,NULL,NULL,NULL,NULL,1,'2024-05-20 19:13:01','2024-05-20 19:13:01','957c21b9-d8e3-4b40-9d46-368da548e6d6'),(10084,10084,1,'Scabies 3','scabies-4','diseases-pathogens/scabies-4',NULL,1,'2024-05-20 19:14:09','2024-05-20 19:14:09','8d672a2c-18e6-4b82-b525-b884cd8fda6c'),(10085,10085,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called sarcoptes scabiei or sarcoptic mange</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Scabies Resources\"}',1,'2024-05-20 19:14:09','2024-05-20 19:14:09','c9de3189-fda2-45eb-bc05-fd5fbbd4064e'),(10086,10086,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Parasite\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-07 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-01 07:00:00\"}}',1,'2024-05-20 19:14:09','2024-05-20 19:14:09','c493f468-acba-4881-8f7c-5bffbf8405a8'),(10087,10087,1,NULL,NULL,NULL,NULL,1,'2024-05-20 19:14:09','2024-05-20 19:14:09','2ecf2194-d76b-42d4-8756-f39854ba5a87'),(10089,10089,1,NULL,NULL,NULL,NULL,1,'2024-05-20 19:14:09','2024-05-20 19:14:09','ac2c3324-feed-4453-b1a3-2536e3ce44d6'),(10090,10090,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Scabies: How to disinfect Sourfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://my-craft-project.ddev.site/diseases-pathogens/scabies\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-20 19:14:09','2024-05-20 19:14:09','a719e196-890f-499b-b8c7-e1f424b784ff'),(10091,10091,1,NULL,NULL,NULL,NULL,1,'2024-05-20 19:14:09','2024-05-20 19:14:09','13112695-66f7-475c-812d-d77713499731'),(10097,10097,1,'Scabies 3','scabies-4','diseases-pathogens/scabies-4',NULL,1,'2024-05-20 19:14:55','2024-05-20 19:14:55','85ee2d14-a1ae-4d17-ab58-c1e5744770bd'),(10098,10098,1,NULL,NULL,NULL,NULL,1,'2024-05-20 19:14:55','2024-05-20 19:14:55','feae5cd5-264b-4fe3-bc77-a7fd6b6f19e2'),(10100,10100,1,NULL,NULL,NULL,NULL,1,'2024-05-20 19:14:55','2024-05-20 19:14:55','ea55fa0f-72b2-4466-ae22-96fb4beca533'),(10101,10101,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Scabies: How to disinfect Sourfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://my-craft-project.ddev.site/diseases-pathogens/scabies\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-20 19:14:55','2024-05-20 19:14:55','8c6c046a-579a-4712-b8fd-94d45599af64'),(10107,10107,1,'Scabies 3','scabies-4','diseases-pathogens/scabies-4',NULL,1,'2024-05-20 19:16:23','2024-05-20 19:16:23','0e6c9b8b-6655-4eea-bb5c-4bfeba995faf'),(10108,10108,1,NULL,NULL,NULL,NULL,1,'2024-05-20 19:16:23','2024-05-20 19:16:23','802f7f48-d2ce-4c97-8a98-9f8fcf6b964b'),(10110,10110,1,NULL,NULL,NULL,NULL,1,'2024-05-20 19:16:23','2024-05-20 19:16:23','1f96bab6-20b9-4c5e-8b3a-584e92bbcd89'),(10111,10111,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Scabies: How to disinfect Sourfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://my-craft-project.ddev.site/diseases-pathogens/scabies\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-20 19:16:23','2024-05-20 19:16:23','fe516b9f-0656-4980-9ab6-ccfa21abeea3'),(10121,10121,1,'Scabies 3','scabies-4','diseases-pathogens/scabies-4',NULL,1,'2024-05-20 20:16:11','2024-05-20 20:16:11','a3d86f76-f88d-4531-b6ee-088ed6e962c4'),(10122,10122,1,NULL,NULL,NULL,NULL,1,'2024-05-20 20:16:11','2024-05-20 20:16:11','4eb74cf0-ca19-441c-bad6-8aeca02bac8b'),(10124,10124,1,NULL,NULL,NULL,NULL,1,'2024-05-20 20:16:12','2024-05-20 20:16:12','1c299469-2fcf-440c-a63c-f00a983a96dd'),(10125,10125,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Scabies: How to disinfect Sourfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://my-craft-project.ddev.site/diseases-pathogens/scabies\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-20 20:16:12','2024-05-20 20:16:12','3ac47c6c-4324-4f03-bb4c-12055384d132'),(10126,10126,1,'Scabies 3','scabies-4','diseases-pathogens/scabies-4',NULL,1,'2024-05-20 20:17:10','2024-05-20 20:17:10','d13862da-8028-4137-a22f-355b816affa2'),(10127,10127,1,NULL,NULL,NULL,NULL,1,'2024-05-20 20:17:10','2024-05-20 20:17:10','8937186b-c3c2-40b8-a9cd-9a1e4692b5ff'),(10128,10128,1,NULL,NULL,NULL,NULL,1,'2024-05-20 20:17:10','2024-05-20 20:17:10','c7ca816b-91e5-4c7f-9cb5-4a856043297f'),(10129,10129,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Scabies: How to disinfect Sourfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://my-craft-project.ddev.site/diseases-pathogens/scabies\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": false}',1,'2024-05-20 20:17:10','2024-06-06 18:37:43','e0f5d79c-3e51-4e44-8037-35fa34bee776'),(10149,10149,1,'3 - Planning & Preparation','planning-preparation','chapters/planning-preparation',NULL,1,'2024-05-21 18:28:26','2024-05-21 18:28:26','7486bda5-43e4-42ff-99e5-5b78e2893a83'),(10150,10150,1,'3 - Planning & Preparation','planning-preparation','chapters/planning-preparation',NULL,1,'2024-05-21 18:30:09','2024-05-21 18:30:09','1c3ac4b8-db09-421b-824d-9b14eee14153'),(10153,10153,1,'3 - Planning & Preparation','planning-preparation','chapters/planning-preparation',NULL,1,'2024-05-21 18:30:38','2024-05-21 18:30:38','3260e364-e6bf-40d8-af1d-30790ae0978b'),(10154,10154,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Planning & Preparation\"}',1,'2024-05-21 18:30:38','2024-05-21 18:30:38','1efa17fa-34a7-49a5-b907-e87659e97196'),(10159,10159,1,'4 - Outbreak Detection & Reporting','outbreak-detection-reporting','chapters/outbreak-detection-reporting',NULL,1,'2024-05-21 21:07:01','2024-05-21 21:07:01','ebb311d3-6fd7-419b-a2f2-320b00a4eab4'),(10160,10160,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Outbreak Detection & Reporting\"}',1,'2024-05-21 21:07:02','2024-05-21 21:07:02','f2609331-a7d5-47f8-8875-9c36d09fbea5'),(10165,10165,1,'Infection Control Breach Investigations','infection-control-breach-investigations','chapters/infection-control-breach-investigations',NULL,1,'2024-05-21 21:08:33','2024-05-21 21:08:33','0bd80a90-1577-4354-af29-9ca2890b26a6'),(10166,10166,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\"}',1,'2024-05-21 21:08:34','2024-05-21 21:08:34','6fef4a9f-07ec-485d-a36f-b2d8881d561f'),(10169,10169,1,'8 - Notification & Communication','notification-communication','chapters/notification-communication',NULL,1,'2024-05-21 21:08:47','2024-05-21 21:08:47','e1ac4d77-bd0c-4242-bbf3-e5d68610c58b'),(10170,10170,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Notification & Communication\"}',1,'2024-05-21 21:08:47','2024-05-21 21:08:47','b8387c45-63d0-4bb3-876a-cc65d4c8b324'),(10171,10171,1,'6 - Laboratory Best Practices','laboratory-best-practices','chapters/laboratory-best-practices',NULL,1,'2024-05-21 21:08:57','2024-05-21 21:08:57','c05536e2-675e-48ec-b945-cc03d79e5db0'),(10172,10172,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Laboratory Best Practices\"}',1,'2024-05-21 21:08:57','2024-05-21 21:08:57','50c18cb8-be82-4cae-b38e-1df036b8d725'),(10175,10175,1,'Medical Product Investigations','medical-product-investigations','chapters/medical-product-investigations',NULL,1,'2024-05-21 21:09:15','2024-05-21 21:09:15','26d2cf0d-ac67-42c2-98bf-b43e20d13e09'),(10176,10176,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Medical Product Investigations\"}',1,'2024-05-21 21:09:15','2024-05-21 21:09:15','2eb43ea1-a32d-47a0-b3e9-806e80104810'),(10186,10186,1,'Home','home','__home__',NULL,1,'2024-05-21 21:25:04','2024-05-21 21:25:04','60720642-4eb0-43a9-bef9-f8cd97e2a5c6'),(10187,10187,1,NULL,NULL,NULL,NULL,1,'2024-05-21 21:25:04','2024-05-21 21:25:04','6a98e1c8-0599-45b3-a7de-ac7632aa525b'),(10188,10188,1,NULL,NULL,NULL,'{\"1e3155d2-9642-4c68-b567-fdda30b7fb25\": \"Corha Prepared\", \"45e4f84e-551e-4998-b335-f05f330da2a9\": \"clipboard_lightblue_nobg.svg\", \"660f5a61-4887-42eb-837a-3711e4bdf1b9\": \"http://#\", \"d1b33c95-3bfe-4318-8423-c00ceb64d2db\": \"Item Title Goes Here, Which Can Accommodate Long Text\", \"fdb7cf96-b73b-4901-8556-18b2b34c6e0d\": \"One-sentence optional summary discussing what this tool does\"}',1,'2024-05-21 21:25:04','2024-05-21 21:25:04','25e37e5d-b27b-4dda-94b7-e250e13342da'),(10189,10189,1,NULL,NULL,NULL,'{\"1e3155d2-9642-4c68-b567-fdda30b7fb25\": \"Corha Prepared\", \"45e4f84e-551e-4998-b335-f05f330da2a9\": \"compbubble_lightblue_nobg.svg\", \"660f5a61-4887-42eb-837a-3711e4bdf1b9\": \"http://#\", \"d1b33c95-3bfe-4318-8423-c00ceb64d2db\": \"Item Title Goes Here, Which Can Accommodate Long Text\", \"fdb7cf96-b73b-4901-8556-18b2b34c6e0d\": \"One-sentence optional summary discussing what this tool does\"}',1,'2024-05-21 21:25:04','2024-05-21 21:25:04','011af732-ecbe-4800-b500-6806a924584c'),(10190,10190,1,NULL,NULL,NULL,'{\"1e3155d2-9642-4c68-b567-fdda30b7fb25\": \"Corha Prepared\", \"45e4f84e-551e-4998-b335-f05f330da2a9\": \"document_lightblue_nobg.svg\", \"660f5a61-4887-42eb-837a-3711e4bdf1b9\": \"http://#\", \"d1b33c95-3bfe-4318-8423-c00ceb64d2db\": \"Item Title Goes Here, Which Can Accommodate Long Text\", \"fdb7cf96-b73b-4901-8556-18b2b34c6e0d\": \"One-sentence optional summary discussing what this tool does\"}',1,'2024-05-21 21:25:04','2024-05-21 21:25:04','3d8286fa-cce2-4b79-ae8b-23d9e9f82966'),(10191,10191,1,NULL,NULL,NULL,'{\"1e3155d2-9642-4c68-b567-fdda30b7fb25\": \"Corha Prepared\", \"45e4f84e-551e-4998-b335-f05f330da2a9\": \"documents_lightblue_nobg.svg\", \"660f5a61-4887-42eb-837a-3711e4bdf1b9\": \"http://#\", \"d1b33c95-3bfe-4318-8423-c00ceb64d2db\": \"Item Title Goes Here, Which Can Accommodate Long Text\", \"fdb7cf96-b73b-4901-8556-18b2b34c6e0d\": \"One-sentence optional summary discussing what this tool does\"}',1,'2024-05-21 21:25:04','2024-05-21 21:25:04','baf633be-572c-49ae-a553-2a60edcaa818'),(10192,10192,1,NULL,NULL,NULL,'{\"1e3155d2-9642-4c68-b567-fdda30b7fb25\": \"Corha Prepared\", \"45e4f84e-551e-4998-b335-f05f330da2a9\": \"clipboard_lightblue_nobg.svg\", \"660f5a61-4887-42eb-837a-3711e4bdf1b9\": \"http://#\", \"d1b33c95-3bfe-4318-8423-c00ceb64d2db\": \"Item Title Goes Here, Which Can Accommodate Long Text\", \"fdb7cf96-b73b-4901-8556-18b2b34c6e0d\": \"One-sentence optional summary discussing what this tool does\"}',1,'2024-05-21 21:25:04','2024-05-21 21:25:04','bab095fd-37d6-41ee-918a-1fdcf8b86073'),(10209,10209,1,'EKC','ekc','diseases-pathogens/ekc',NULL,1,'2024-05-21 21:45:41','2024-05-21 21:45:41','5c20434f-e5be-4101-823d-c33e86135afe'),(10210,10210,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called Epidemic Keratoconjunctivitis update Test</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"EKC Resources\"}',1,'2024-05-21 21:45:41','2024-05-21 21:45:41','17dd0199-0b2c-462f-91e3-0f16503065c3'),(10211,10211,1,NULL,NULL,NULL,NULL,1,'2024-05-21 21:45:41','2024-05-21 21:45:41','c51a920f-7b6b-488b-b2ca-23cee5de8245'),(10212,10212,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Line List: Sample Documentation Template\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-21 21:45:41','2024-05-21 21:45:41','ec75e431-dc86-4305-a411-3c1de671501b'),(10213,10213,1,NULL,NULL,NULL,NULL,1,'2024-05-21 21:45:41','2024-05-21 21:45:41','891c5f3a-8dbf-4127-ba3a-4a4885d916c7'),(10214,10214,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Outbreak Patient Letter: Sample Communications\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-21 21:45:41','2024-05-21 21:45:41','51d2bee1-0a55-4385-af6b-f9be33f02e4c'),(10215,10215,1,NULL,NULL,NULL,NULL,1,'2024-05-21 21:45:41','2024-05-21 21:45:41','c804dac7-d6e0-46b4-b209-1bd2509d51a0'),(10216,10216,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-21 21:45:41','2024-05-21 21:45:41','63dcc66e-f4c3-4ef6-b08b-fe7186bc8637'),(10217,10217,1,NULL,NULL,NULL,NULL,1,'2024-05-21 21:45:41','2024-05-21 21:45:41','bc1d3e39-a1fc-47ea-a8bb-2a1725d472a2'),(10218,10218,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Adenovirus-Associated EKC Outbreaks: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-21 21:45:41','2024-05-21 21:45:41','0d8f8d83-de74-435e-b9f8-72aa7784fef0'),(10219,10219,1,NULL,NULL,NULL,NULL,1,'2024-05-21 21:45:42','2024-05-21 21:45:42','dee4d200-2099-43f0-bd2a-4a88e36afe95'),(10220,10220,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Outbreak of EKC Caused by Human Adenovirus Type D53 in an Eye Care Clinic: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-21 21:45:42','2024-05-21 21:45:42','501da279-93ce-4a2d-9cd2-d3ad23fd96bf'),(10221,10221,1,NULL,NULL,NULL,NULL,1,'2024-05-21 21:45:42','2024-05-21 21:45:42','b7f7a616-a400-4c51-915b-693901e967de'),(10222,10222,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | EKC Outbreak Associated with Human Adenovirus Type 8 : Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-11-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-21 21:45:42','2024-05-21 21:45:42','149b1038-dd21-4752-b0e3-ad37fb53d129'),(10223,10223,1,NULL,NULL,NULL,NULL,1,'2024-05-21 21:45:42','2024-05-21 21:45:42','c3cfbb36-1c10-46b2-9998-528f8d338168'),(10224,10224,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Principles & Practices\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Get comprehensive guidance to build or improve practices related to detection, reporting, investigation, or control of any HAI or AR outbreak.\"}',1,'2024-05-21 21:45:42','2024-05-21 21:45:42','7ed4130e-e43f-4af1-ae45-d1f8a4ef771c'),(10226,10226,1,'5-Jennifer Jones, 2023 McKnight Prize for Healthcare Outbreak Heroes Recipient','jennifer-jones-2023-mcknight-prize-for-healthcare-outbreak-heroes-recipient','news/jennifer-jones-2023-mcknight-prize-for-healthcare-outbreak-heroes-recipient','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Jennifer Jones, Senior Infection Preventionist at Helen DeVos Children’s Hospital, part of Corewell Health in Grand Rapids, Michigan is the recipient of the 2023 McKnight Prize for Healthcare Outbreak Heroes award for her outstanding response to a Methicillin-resistant Staphylococcus aureus (MRSA) outbreak in a Neonatal Intensive Care Unit.</p><figure class=\\\"image\\\"><img src=\\\"{asset:1557:url||http://staging.corha.astriatawiki.com/assets/images/305fe57496acb9a1db30e7e0795e2bce.jpg}\\\" alt=\\\"Jennifer Jones Headshot\\\" width=\\\"200\\\" height=\\\"300\\\" /></figure><p class=\\\"main content photo-caption\\\">Jennifer Jones, Senior Infection Preventionist</p><p>The Evelyn and Thomas McKnight Family Fund for Patient Safety and the CDC Foundation created the McKnight Healthcare Outbreak Heroes Prize to encourage and reward those who protect patients from harm related to healthcare outbreaks. We’re happy to introduce Jennifer Jones as the 2023 recipient of this prestigious award!</p><p><br />In the Spring of 2022, the Helen DeVos Children’s Hospital’s Infection Prevention team, led by Jennifer, Senior Infection Preventionist, was monitoring hospital-acquired MRSA cases in their Neonatal Intensive Care Unit (NICU). The team identified an outbreak after observing a sudden uptick in MRSA bacteremia cases in a short period of time, prompting an investigation. The infection prevention team utilized their Outbreak Investigation Policy, referenced CDC &amp; APIC resources, and implemented mitigation strategies. Examples of these strategies included mandatory Call-to-Action sessions for all team members who enter the NICU, weekly MRSA screening of all admitted NICU babies, development of a decolonization protocol, and installation of additional hand sanitizer dispensers. Jennifer exemplified outstanding leadership, initiative, and personal commitment as part of a successful effort to protect newborns throughout this outbreak response. CORHA spoke with her about her lessons learned and keys to success.</p><p><br />Jennifer recognized that during this outbreak, good communication was essential for all stakeholders: parents, staff, leadership, the health department, and CDC. She organized weekly meetings to provide updates during the investigation that could be shared among their teams. Jennifer emphasized that navigating these conversations with partners during an HAI/AR outbreak response is always tough; however, when you provide data to support your rationale and response, it makes the conversations easier.</p><p><br />A success Jennifer shares is that her staff felt comfortable going to leadership and the infection prevention team with suggestions. For example, during their Call-to-Action sessions, staff felt empowered to notify the infection prevention team that gloves in all sizes were not easily accessible to provide care. Jennifer’s team went onsite with facility and bedside team members to see where they could install a place to house small, medium, and large gloves for staff use. This is just one example of open communication from over 40 suggestions that were provided to Jennifer’s team.</p><p>Sharing key messages with everyone who might enter the NICU space was a challenging and essential part of the outbreak response. Jennifer’s team rounded in the NICU frequently to conduct knowledge surveys (and, of course, hand out candy). This helped them evaluate whether their messaging was reaching the care team and provide real-time observations and feedback. The following is a key insight Jennifer gained while leading the outbreak response:</p><blockquote><p>Get out there and observe what is truly happening and partner with the care team so it doesn’t seem punitive. Walk alongside them in all phases of an outbreak scenario so it remains a partnership between the care team and infection prevention team.</p></blockquote><p class=\\\"quote-author\\\">-Jennifer Jones</p><p>We applaud Jennifer for her leadership, dedication and initiative to ensure a well-coordinated and successful outbreak response.</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Author Name\", \"b36780e0-cb72-4402-8bda-d3fd3a8925b0\": \"The Evelyn and Thomas McKnight Family Fund for Patient Safety and the CDC Foundation created the McKnight Healthcare Outbreak Heroes Prize to encourage and reward those who protect patients from harm related to healthcare outbreaks. We’re happy to introduce Jennifer Jones as the 2023 recipient of this prestigious award!\"}',1,'2024-05-21 21:57:18','2024-05-21 21:57:18','38f9705c-8ceb-4016-9967-03cae3fa7d8b'),(10227,10227,1,'Epidemic Keratoconjunctivitis','ekc','diseases-pathogens/ekc',NULL,1,'2024-05-22 02:49:34','2024-07-29 19:47:05','256177c0-309c-4eb0-83c7-d22e73e52092'),(10228,10228,1,NULL,'__temp_syqlioqvmfwwkdyozssjibxyoksivaimtuxn',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as EKC, severe viral conjunctivitis, or pink eye</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Epidemic Keratoconjunctivitis\"}',1,'2024-05-22 02:49:34','2024-07-29 19:47:05','7c3bc0fd-2741-496c-8f54-f7fc6c99d4ba'),(10229,10229,1,NULL,'__temp_gnqxifcfdtguttuniqunqojmswdaihfavyed',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-07-29 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2021-02-01 08:00:00\"}}',1,'2024-05-22 02:49:34','2024-07-29 19:48:12','9888996f-2803-4ed5-99e0-4611a98ac49b'),(10230,10230,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:34','2024-05-22 02:49:34','1f1c0ab9-6e86-4c0e-ac4b-642c1e5b3a52'),(10231,10231,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>EKC is a highly contagious viral conjunctivitis (\\\"pink eye\\\") that can result in reduced vision. EKC is typically caused by adenoviruses. Transmission can occur in healthcare settings via contact with contaminated hands, surfaces, equipment, or medical products. Outbreaks are often associated with eye care settings, with investigations of clinic transmission often pointing to contamination of multi-use drops and tonometer devices. Clustered EKC infections should be reported to the appropriate state or local health department.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About EKC\"}',1,'2024-05-22 02:49:34','2024-05-22 02:49:34','dd86d550-711d-445e-ba5d-d140d1e5ad1b'),(10232,10232,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:34','2024-05-22 02:49:34','d33630b1-8e6c-404c-9cd2-6da560f52929'),(10233,10233,1,NULL,'__temp_sseqicjaqacbrgitdiqarfslhndqaftaxqcp',NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key measures to prevent and control EKC transmission in healthcare settings include: </p><ul><li>Strict adherence to hand hygiene,</li><li>Use of disposable gloves for contact with eye secretions,</li><li>Effective environmental cleaning and disinfection of surfaces and equipment,</li><li>Using single use equipment and eye drops,</li><li>Cohorting of suspected conjunctivitis patients, and </li><li>Work restrictions for symptomatic healthcare personnel.</li></ul>\"}',1,'2024-05-22 02:49:34','2024-07-29 19:47:06','cf62e002-6a76-47af-8c79-2cd413f26608'),(10234,10234,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:34','2024-05-22 02:49:34','3b4cfe6b-9e4a-4a4b-99f3-dbcba270e7cb'),(10235,10235,1,NULL,'__temp_axxbiufulhlhgjcxhxdyksgsnxreewobaywa',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Epidemic Keratoconjunctivitis\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/conjunctivitis/hcp/infection-control-ekc/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides cleaning and disinfection guidance for opthalmologic healthcare settings.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-22 02:49:34','2024-07-29 19:47:06','cdd194bd-ca0a-4c3b-b96a-ef477f16dfd2'),(10236,10236,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:34','2024-05-22 02:49:34','225ececa-e3ad-46b4-8272-5754f3b44030'),(10237,10237,1,NULL,'__temp_exgohiqdmyewgvuucwzrodipwluabuazjezf',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Line List\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/wp-content/uploads/2019/03/Sample-EKC-Line-List.xlsx\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This is a ready-to-use template to document epidemic keratoconjunctivitis (EKC) outbreak information.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-22 02:49:34','2024-07-29 19:47:06','0a5109bc-c046-45c7-aec8-e9f54379eb83'),(10238,10238,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:34','2024-05-22 02:49:34','d70055b2-9290-44b2-b519-31be4b7a21c5'),(10239,10239,1,NULL,'__temp_huosfuidmqiipycwnpphzdgpucpccorrnhqc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This is a ready-to-use template to document epidemic keratoconjunctivitis (EKC) outbreak information.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-22 02:49:34','2024-06-13 13:46:38','d9d596dc-7b04-4d2d-b8d6-a1029937e61d'),(10240,10240,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:34','2024-05-22 02:49:34','ab7561ed-5f23-46ad-88dd-3a8cfb3a000c'),(10241,10241,1,NULL,'__temp_lvdujnegnjelanflaysjgkhpwxiovnjyhyvb',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Sample Epidemic Keratoconjunctivitis (EKC) Outbreak Patient Letter\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/wp-content/uploads/2019/03/Sample-EKC-Patient-Letter.doc\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This resource provides sample language for healthcare facilities communicating with patients on epidemic keratoconjunctivitis (EKC) outbreaks.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-22 02:49:34','2024-07-29 19:47:06','9bbe3cb6-658c-489f-b307-643a10b110cc'),(10242,10242,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:34','2024-05-22 02:49:34','c811c496-172e-416e-ad61-121b575161f3'),(10243,10243,1,NULL,'__temp_wmsbktpozkcuekkhojrqiawwygtxtejasytv',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Adenovirus-Associated Epidemic Keratoconjunctivitis Outbreaks — Four States, 2008–2010\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2013-08-16 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6232a1.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CDC MMWR summarizes EKC investigations across four states and recommends outbreak control measures.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-22 02:49:34','2024-06-13 13:46:38','14851cf3-2910-4e15-ab23-84b4b12ed4ce'),(10244,10244,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:34','2024-05-22 02:49:34','25c8d6c6-dcf3-4efb-be59-31e4bef5daa9'),(10245,10245,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | EKC Outbreak Associated with Human Adenovirus Type 8 : Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-11-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 02:49:34','2024-05-22 02:49:34','e7355ba5-a3ad-49e5-8148-7b37d89fd2c9'),(10246,10246,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:34','2024-05-22 02:49:34','3eb056fb-c73b-49a0-88c5-bcbcf244fe82'),(10247,10247,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Principles & Practices\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Get comprehensive guidance to build or improve practices related to detection, reporting, investigation, or control of any HAI or AR outbreak.\"}',1,'2024-05-22 02:49:34','2024-05-22 02:49:34','1945db75-67cf-4df8-9e17-35257fb01527'),(10248,10248,1,'EKC','ekc-2','diseases-pathogens/ekc-2',NULL,1,'2024-05-22 02:49:34','2024-05-22 02:49:34','d2ee2a7e-079a-4daf-90d6-3f02682c5d4e'),(10249,10249,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called Epidemic Keratoconjunctivitis update Test</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"EKC Resources\"}',1,'2024-05-22 02:49:34','2024-05-22 02:49:34','fc6e04b9-93c8-4a1b-a313-d84aab21cff5'),(10250,10250,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Virus\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2022-10-01 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2021-02-01 08:00:00\"}}',1,'2024-05-22 02:49:34','2024-05-22 02:49:34','c6fecbd3-8554-423a-a8ac-353f962d35b0'),(10251,10251,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:34','2024-05-22 02:49:34','d00a5d3c-cd90-462a-8eea-ecec3390c278'),(10252,10252,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Epidemic Keratoconjunctivitis (EKC), a contagious, severe form of viral conjunctivitis (“pink eye”) can cause  pain and blurred vision. EKC outbreaks are often associated with eye care settings, with investigations of clinic transmission often pointing to contamination of multi-use drops and tonometer devices. Clustered EKC infections should be reported to the appropriate state or local health department.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About EKC\"}',1,'2024-05-22 02:49:34','2024-05-22 02:49:34','da553a2e-65d2-4a25-8fad-82b98cb2ff2f'),(10253,10253,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:35','2024-05-22 02:49:35','75def56e-7be0-4dfb-82c6-bdc954c106ec'),(10254,10254,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about EKC\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Epidemic Keratoconjunctivitis (EKC), a contagious, severe form of viral conjunctivitis (“pink eye”) can cause  pain and blurred vision. EKC outbreaks are often associated with eye care settings, with investigations of clinic transmission often pointing to contamination of multi-use drops and tonometer devices. Clustered EKC infections should be reported to the appropriate state or local health department.</p>\"}',1,'2024-05-22 02:49:35','2024-05-22 02:49:35','e276a87c-7eb2-4736-b53e-8298df4d6993'),(10255,10255,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:35','2024-05-22 02:49:35','57f2d1a4-fba2-4684-99c7-ce6986f23f26'),(10256,10256,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Line List: Sample Documentation Template\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 02:49:35','2024-05-22 02:49:35','253ddc57-0e42-4824-9f90-4fb7d8cdc8d2'),(10257,10257,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:35','2024-05-22 02:49:35','35d0921f-a038-437e-aa7b-a2fcca669202'),(10258,10258,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Outbreak Patient Letter: Sample Communications\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-22 02:49:35','2024-05-22 02:49:35','ef597001-fc9b-4e39-83d7-9f462b44bda8'),(10259,10259,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:35','2024-05-22 02:49:35','fcb4ea4f-14df-4c3e-bbf6-c73572924750'),(10260,10260,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-22 02:49:35','2024-05-22 02:49:35','a7217843-36d1-4c42-aa04-ae46c00703e1'),(10261,10261,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:35','2024-05-22 02:49:35','e3eff694-a5b8-44c5-95f9-1b0b0427d23c'),(10262,10262,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Adenovirus-Associated EKC Outbreaks: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 02:49:35','2024-05-22 02:49:35','cf990dd0-753f-45a4-b970-c44a948b0d93'),(10263,10263,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:35','2024-05-22 02:49:35','6dad38cb-9a1b-4147-b994-0f9f79262766'),(10264,10264,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Outbreak of EKC Caused by Human Adenovirus Type D53 in an Eye Care Clinic: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 02:49:35','2024-05-22 02:49:35','de89ac87-4588-4cff-804c-155aeee57fc0'),(10265,10265,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:35','2024-05-22 02:49:35','7207a392-7bc0-4ac7-bab5-908634d4f14a'),(10266,10266,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | EKC Outbreak Associated with Human Adenovirus Type 8 : Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-11-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 02:49:35','2024-05-22 02:49:35','7381bcf3-b97e-4b73-bca1-295a3b89e3e7'),(10267,10267,1,NULL,NULL,NULL,NULL,1,'2024-05-22 02:49:35','2024-05-22 02:49:35','3397a382-ed81-45a0-8b91-2f6c80d3bf4d'),(10268,10268,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Principles & Practices\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Get comprehensive guidance to build or improve practices related to detection, reporting, investigation, or control of any HAI or AR outbreak.\"}',1,'2024-05-22 02:49:35','2024-05-22 02:49:35','92eb7525-08fe-4ba7-aefd-41d3cacfbfa6'),(10285,10285,1,'1 - Overview','overview','chapters/overview','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 1}',1,'2024-05-22 03:26:20','2024-05-22 03:26:20','a1974050-b5e3-4047-81ef-65de339ff574'),(10286,10286,1,'2 - Fundamental Concepts','fundamental-concepts','chapters/fundamental-concepts','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 2}',1,'2024-05-22 03:26:53','2024-05-22 03:26:53','5b3f95ff-62b0-4cad-84e8-869b3c266856'),(10287,10287,1,'3 - Planning & Preparation','planning-preparation','chapters/planning-preparation','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 3}',1,'2024-05-22 03:30:11','2024-05-22 03:30:11','eb67fca8-a47f-4a5f-9fc8-6181640f3ead'),(10288,10288,1,'4 - Outbreak Detection & Reporting','outbreak-detection-reporting','chapters/outbreak-detection-reporting','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 4}',1,'2024-05-22 03:30:22','2024-05-22 03:30:22','c9914d4d-c322-46b4-b02e-9f63455838cb'),(10289,10289,1,'5 - Investigation & Control','investigation-control','chapters/investigation-control','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 5}',1,'2024-05-22 03:30:33','2024-05-22 03:30:33','88ee7660-f0ed-4e75-9775-320c0cb252a8'),(10290,10290,1,'6 - Laboratory Best Practices','laboratory-best-practices','chapters/laboratory-best-practices','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 6}',1,'2024-05-22 03:30:43','2024-05-22 03:30:43','441c6eba-81dd-4298-8342-b2df22c4f92a'),(10291,10291,1,'8 - Notification & Communication','notification-communication','chapters/notification-communication','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 8}',1,'2024-05-22 03:30:53','2024-05-22 03:30:53','4a39d1e1-a31c-47c4-b818-a2f2d8a5d477'),(10292,10292,1,'7 - Special Considerations for Multi-Facility & Multi-Jurisdiction Outbreaks','special-considerations-for-multi-facility-multi-jurisdiction-outbreaks','chapters/special-considerations-for-multi-facility-multi-jurisdiction-outbreaks','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 7}',1,'2024-05-22 03:31:04','2024-05-22 03:31:04','e38b39ab-a063-4dca-a74f-390e69104458'),(10293,10293,1,'Infection Control Breach Investigations','infection-control-breach-investigations','chapters/infection-control-breach-investigations','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 9}',1,'2024-05-22 03:31:18','2024-05-22 03:31:18','af6aca9d-1f59-44a1-9f70-ef585c2c61ac'),(10294,10294,1,'Medical Product Investigations','medical-product-investigations','chapters/medical-product-investigations','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 10}',1,'2024-05-22 03:31:39','2024-05-22 03:31:39','eda46c43-1d97-4ee0-bf51-b28c856ab09a'),(10299,10299,1,'Investigation Resources',NULL,NULL,'{\"b16fbf8b-59fc-49b9-bfd8-054caa73163e\": \"complexDropdown\"}',1,'2024-05-22 06:43:37','2024-05-22 06:43:37','06c5f4cd-caca-4780-b542-a0c0d559e819'),(10300,10300,1,NULL,NULL,NULL,NULL,1,'2024-05-22 06:43:37','2024-05-22 06:43:37','631dcbb7-4143-4879-b6bc-ed06decee8b2'),(10310,10310,1,'Scabies','scabies','diseases-pathogens/scabies',NULL,1,'2024-05-22 07:11:42','2024-05-22 07:11:42','9a286253-1408-4a2b-99f1-4d15f08e1732'),(10311,10311,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called sarcoptes scabiei or sarcoptic mange</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Scabies Resources\"}',1,'2024-05-22 07:11:42','2024-05-22 07:11:42','5f1a9776-b431-4544-8619-211053461da6'),(10312,10312,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Parasite\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-17 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-01 07:00:00\"}}',1,'2024-05-22 07:11:42','2024-05-22 07:11:42','e532c8cd-851d-4ae2-8e8a-cf8c172395e0'),(10313,10313,1,NULL,NULL,NULL,NULL,1,'2024-05-22 07:11:42','2024-05-22 07:11:42','d9e54582-74ba-4c58-802f-44c88b84c41f'),(10314,10314,1,NULL,NULL,NULL,NULL,1,'2024-05-22 07:11:42','2024-05-22 07:11:42','0f9427a4-3302-44e3-a81b-afa81513f783'),(10315,10315,1,NULL,NULL,NULL,NULL,1,'2024-05-22 07:11:42','2024-05-22 07:11:42','1006db82-f2f6-4dca-8f3a-20c111b4b528'),(10316,10316,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Guidelines for Acute and Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://publichealth.lacounty.gov/acd/Diseases/ScabiesToolkit.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 07:11:42','2024-05-22 07:11:42','dd93ca9c-19db-4c66-a889-a867178c91d5'),(10317,10317,1,NULL,NULL,NULL,NULL,1,'2024-05-22 07:11:42','2024-05-22 07:11:42','b56f15a0-3834-4100-b305-b45da522a775'),(10318,10318,1,NULL,NULL,NULL,NULL,1,'2024-05-22 07:11:42','2024-05-22 07:11:42','7cf477c4-b1be-41e9-8f9b-a7dadfe200f8'),(10319,10319,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies in Institutional Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-02-01 08:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 07:11:42','2024-05-22 07:11:42','e51b45f3-d12e-46a9-8103-2b85bdb5854b'),(10320,10320,1,NULL,NULL,NULL,NULL,1,'2024-05-22 07:11:42','2024-05-22 07:11:42','d6b9caf2-0634-4876-8269-8d4fa7e28b0f'),(10321,10321,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Manual\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-04 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 07:11:43','2024-05-22 07:11:43','03aeb288-6882-48b7-b456-3909493eb59e'),(10331,10331,1,'Principles & Practices for  Outbreak Response','principles-practices-for-outbreak-response','principles-practices-for-outbreak-response',NULL,1,'2024-05-22 13:39:11','2024-05-22 13:39:11','5cf156da-c5b3-4fab-8b28-016d4efddf15'),(10332,10332,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>This comprehensive reference equips public health, healthcare, and other stakeholders with the information they need to build, standardize or improve capacities and practices related to HAI/AR outbreak detection, reporting, investigation, and control.</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Principles & Practices for Outbreak Response\"}',1,'2024-05-22 13:39:11','2024-05-22 13:39:11','e09eeb89-5195-4b49-9556-247a2e78061c'),(10333,10333,1,'Scabies','scabies','diseases-pathogens/scabies',NULL,1,'2024-05-22 13:41:44','2024-05-22 13:41:44','5030706a-5ae5-4346-85ed-ea4dbec35e88'),(10334,10334,1,NULL,NULL,NULL,NULL,1,'2024-05-22 13:41:44','2024-05-22 13:41:44','12c700b4-0d2a-4721-aa7e-ace3f58f86dd'),(10335,10335,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Guidelines for Acute and Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://publichealth.lacounty.gov/acd/Diseases/ScabiesToolkit.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 13:41:44','2024-05-22 13:41:44','029161ad-6134-49db-9921-b010deeae0da'),(10336,10336,1,NULL,NULL,NULL,NULL,1,'2024-05-22 13:41:44','2024-05-22 13:41:44','f8124962-6334-4852-84af-e1ce9166345c'),(10337,10337,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies in Institutional Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-02-01 08:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/scabies/php/public-health-strategy/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 13:41:44','2024-05-22 13:41:44','87a7a325-584a-4f09-98c4-bf086b5d4c4d'),(10338,10338,1,NULL,NULL,NULL,NULL,1,'2024-05-22 13:41:44','2024-05-22 13:41:44','89f137c7-b490-4f2d-8670-6bb5057b2bad'),(10339,10339,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Manual\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-04 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.michigan.gov/mdhhs/keep-mi-healthy/communicablediseases/diseasesandimmunization/overview-of-the-division-of-communicable-disease\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 13:41:44','2024-05-22 13:41:44','8aa8a9dc-4f7f-4450-b298-10b709878f89'),(10349,10349,1,'Scabies','scabies','diseases-pathogens/scabies',NULL,1,'2024-05-22 13:42:46','2024-05-22 13:42:46','051bbdeb-a240-451c-9921-d407220c3f43'),(10350,10350,1,NULL,NULL,NULL,NULL,1,'2024-05-22 13:42:46','2024-05-22 13:42:46','45b15df4-3ad3-4409-b7a0-a35ff4db7618'),(10351,10351,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Guidelines for Acute and Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://publichealth.lacounty.gov/acd/Diseases/ScabiesToolkit.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 13:42:46','2024-05-22 13:42:46','69d81f33-7652-41e7-97d7-d5becc0ad105'),(10352,10352,1,NULL,NULL,NULL,NULL,1,'2024-05-22 13:42:46','2024-05-22 13:42:46','184a6467-288e-4774-9ce2-a7dc37b8eceb'),(10353,10353,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Guidance for Detecting, Reporting and Investigating Outbreaks of Scabies\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-04-01 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2024-04-20 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/resources/corha-general-guidance-outbreak-detection-reporting-scabies/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 13:42:46','2024-05-22 13:42:46','8ec3802b-2ca5-4037-908e-aef91a4f99b2'),(10354,10354,1,NULL,NULL,NULL,NULL,1,'2024-05-22 13:42:46','2024-05-22 13:42:46','16e3d285-09ca-44da-ba1a-bbeb7aaae7ef'),(10355,10355,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies in Institutional Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-02-01 08:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/scabies/php/public-health-strategy/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 13:42:46','2024-05-22 13:42:46','91c6ff64-933f-4a04-b385-d0afc8301895'),(10356,10356,1,NULL,NULL,NULL,NULL,1,'2024-05-22 13:42:46','2024-05-22 13:42:46','3094dad8-6dfb-4a2a-9052-f3ff7c74ab28'),(10357,10357,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Manual\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-04 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.michigan.gov/mdhhs/keep-mi-healthy/communicablediseases/diseasesandimmunization/overview-of-the-division-of-communicable-disease\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 13:42:46','2024-05-22 13:42:46','7916675a-03be-4183-920e-ae9c3c19c2af'),(10367,10367,1,'Scabies','scabies','diseases-pathogens/scabies',NULL,1,'2024-05-22 13:43:17','2024-05-22 13:43:17','d89a3138-2275-4af7-ad70-4752b3df4f2b'),(10368,10368,1,NULL,NULL,NULL,NULL,1,'2024-05-22 13:43:17','2024-05-22 13:43:17','2898d26b-378c-4be6-8141-886fa60bd8ca'),(10369,10369,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Guidelines for Acute and Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://publichealth.lacounty.gov/acd/Diseases/ScabiesToolkit.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 13:43:17','2024-05-22 13:43:17','f2664ef4-65f8-4c6c-a5a3-d09f4150b4a0'),(10370,10370,1,NULL,NULL,NULL,NULL,1,'2024-05-22 13:43:17','2024-05-22 13:43:17','f67511fb-282c-4206-bd07-eaf69bd07e5d'),(10371,10371,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Guidance for Detecting, Reporting and Investigating Outbreaks of Scabies\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2017-10-01 07:00:00\"}, \"8d07cb41-da70-4198-9c8d-e5de926d4a0d\": {\"date\": \"2024-04-20 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.corha.org/resources/corha-general-guidance-outbreak-detection-reporting-scabies/\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 13:43:17','2024-05-22 13:43:17','26982ad9-55be-4a57-9657-c7cb97ea31d4'),(10372,10372,1,NULL,NULL,NULL,NULL,1,'2024-05-22 13:43:17','2024-05-22 13:43:17','8661edc0-471c-4ecd-9490-705a4093820c'),(10373,10373,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies in Institutional Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-02-01 08:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/scabies/php/public-health-strategy/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 13:43:17','2024-05-22 13:43:17','c6471dcb-5c11-414b-b55e-19e28ce672b0'),(10374,10374,1,NULL,NULL,NULL,NULL,1,'2024-05-22 13:43:17','2024-05-22 13:43:17','dd788bfb-37c9-42ab-8152-3eeaeade6823'),(10375,10375,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Manual\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-04 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.michigan.gov/mdhhs/keep-mi-healthy/communicablediseases/diseasesandimmunization/overview-of-the-division-of-communicable-disease\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 13:43:17','2024-05-22 13:43:17','cd33e865-f929-4adb-b336-4eb3e0a68585'),(10379,10379,1,'7 - Special Considerations for Multi-Facility & Multi-Jurisdiction Outbreaks','special-considerations-for-multi-facility-multi-jurisdiction-outbreaks','chapters/special-considerations-for-multi-facility-multi-jurisdiction-outbreaks','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 7}',1,'2024-05-22 15:53:50','2024-05-22 15:53:50','450d8ae1-a7e2-4b37-b895-ecb7aa764ecb'),(10380,10380,1,NULL,NULL,NULL,NULL,1,'2024-05-22 15:53:50','2024-05-22 15:53:50','32284f1c-a23f-4d80-a78c-875ceb0f34d7'),(10381,10381,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<h2>Chapter Summary</h2><p>Preparations made ahead of a healthcare-associated infection (HAI) or antimicrobial-resistant (AR) pathogen outbreak lay the groundwork for actions taken during the outbreak response. Activities that prepare public health agencies to respond to outbreaks involving healthcare delivery include developing the capacity to rapidly collect and analyze large amounts of information, take rapid action to stop transmission, and communicate effectively with stakeholders.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Special Considerations for Multi-Facility & Multi-Jurisdiction Outbreaks\"}',1,'2024-05-22 15:53:50','2024-05-22 15:53:50','717aa509-e9a7-4985-97ba-b89d58720c6a'),(10384,10384,1,'Infection Control Breach Investigations','infection-control-breach-investigations','chapters/infection-control-breach-investigations','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 9}',1,'2024-05-22 15:54:14','2024-05-22 15:54:14','bf3b9480-5ff4-4e1b-97db-de33cf67c7c9'),(10385,10385,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Infection Control Breach Investigations\"}',1,'2024-05-22 15:54:14','2024-05-22 15:54:14','91b1d981-f79c-4476-a96c-1e0bcfff1587'),(10386,10386,1,'EKC','ekc','diseases-pathogens/ekc',NULL,1,'2024-05-22 17:21:57','2024-05-22 17:21:57','3672111b-04b2-46b2-bb0f-b066f0b77972'),(10387,10387,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:21:57','2024-05-22 17:21:57','58d6f38d-5ce9-4269-a735-006c8c49f4cc'),(10388,10388,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Line List: Sample Documentation Template\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": false}',1,'2024-05-22 17:21:57','2024-06-06 18:37:43','9a635f48-2fd4-434e-8dfb-28d05c9ec8fe'),(10389,10389,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:21:57','2024-05-22 17:21:57','8a3da1ea-0620-46b9-a4e9-06b25eefb983'),(10390,10390,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Outbreak Patient Letter: Sample Communications\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": false}',1,'2024-05-22 17:21:57','2024-06-06 18:37:43','3cec7556-70b8-4548-a161-fc2a989c2695'),(10391,10391,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:21:57','2024-05-22 17:21:57','ee82726f-cb5a-491d-a6a1-cd11df2580ec'),(10392,10392,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": false}',1,'2024-05-22 17:21:57','2024-06-06 18:37:43','52ca16a4-14ab-4ce8-9d73-5288d394c486'),(10393,10393,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:21:57','2024-05-22 17:21:57','181ad5fc-b15a-4b8f-aa48-daea44f831a3'),(10394,10394,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Adenovirus-Associated EKC Outbreaks: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": false}',1,'2024-05-22 17:21:57','2024-06-06 18:37:43','6b5dd875-6633-4332-8b74-9d0958253f41'),(10395,10395,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:21:57','2024-05-22 17:21:57','25fcabdb-00cf-41c5-8ee8-c3ed367a8909'),(10396,10396,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Outbreak of EKC Caused by Human Adenovirus Type D53 in an Eye Care Clinic: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": false}',1,'2024-05-22 17:21:57','2024-06-06 18:37:43','e3238f02-a737-43d7-894a-b4d92236e580'),(10397,10397,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:21:57','2024-05-22 17:21:57','fe743e68-fba2-404c-9b1e-428d7e94f24c'),(10398,10398,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | EKC Outbreak Associated with Human Adenovirus Type 8 : Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-11-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": false}',1,'2024-05-22 17:21:58','2024-06-06 18:37:43','f34e7ad5-d8c4-41f6-8a1b-cf47aac3ffa5'),(10399,10399,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:21:58','2024-05-22 17:21:58','7a3c1cff-02db-41fb-b84b-a716e4653b2d'),(10400,10400,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Principles & Practices\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Get comprehensive guidance to build or improve practices related to detection, reporting, investigation, or control of any HAI or AR outbreak.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": false}',1,'2024-05-22 17:21:58','2024-06-06 18:37:43','b822b77c-ad36-4a5d-ae55-fde00368d42a'),(10435,10435,1,'EKC','ekc','diseases-pathogens/ekc',NULL,1,'2024-05-22 17:27:46','2024-05-22 17:27:46','5cbd7d7a-f356-458c-821a-f07f85c5b92b'),(10436,10436,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:27:46','2024-05-22 17:27:46','07fa0328-1524-43c4-b540-1c4ee02916a5'),(10437,10437,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about EKC\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Epidemic Keratoconjunctivitis (EKC), a contagious, severe form of viral conjunctivitis (“pink eye”) can cause  pain and blurred vision. EKC outbreaks are often associated with eye care settings, with investigations of clinic transmission often pointing to contamination of multi-use drops and tonometer devices. Clustered EKC infections should be reported to the appropriate state or local health department.</p>\"}',1,'2024-05-22 17:27:46','2024-05-22 17:27:46','21b88293-a4f6-41ef-82a3-cd41037cdecd'),(10438,10438,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:27:46','2024-05-22 17:27:46','1294b8cb-1581-4fc7-875c-2f5963d15d8a'),(10439,10439,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Line List: Sample Documentation Template\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:27:46','2024-05-22 17:27:46','d0e90f77-f8ed-42fa-8de3-8485fbd6282c'),(10440,10440,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:27:46','2024-05-22 17:27:46','72e6577d-2a75-4f86-9cb1-1312564a08a9'),(10441,10441,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Outbreak Patient Letter: Sample Communications\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-22 17:27:46','2024-05-22 17:27:46','91938b19-2524-4d4d-a40d-5cd03d5f53ec'),(10442,10442,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:27:46','2024-05-22 17:27:46','1df4aab4-fef3-4f2d-9232-4fe96b816324'),(10443,10443,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-22 17:27:46','2024-05-22 17:27:46','744d2474-f73e-459e-8fbc-4a964ebe26df'),(10444,10444,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:27:46','2024-05-22 17:27:46','5538d021-37b1-4e82-b41f-c903e84a3107'),(10445,10445,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Adenovirus-Associated EKC Outbreaks: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:27:46','2024-05-22 17:27:46','3072b0fa-7a05-4d42-b91e-d868be27b5fd'),(10446,10446,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:27:46','2024-05-22 17:27:46','7c986fbb-1878-46aa-94c9-798a24c260f4'),(10447,10447,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Outbreak of EKC Caused by Human Adenovirus Type D53 in an Eye Care Clinic: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:27:46','2024-05-22 17:27:46','a75286ff-ebae-4ef6-bc1f-cadeb2de7e52'),(10448,10448,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:27:46','2024-05-22 17:27:46','cfd968a1-7261-4ab1-906b-913824f6c4c9'),(10449,10449,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | EKC Outbreak Associated with Human Adenovirus Type 8 : Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-11-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:27:46','2024-05-22 17:27:46','996ebcf6-a15f-49c2-b6b3-ca3926b9b7ea'),(10450,10450,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:27:46','2024-05-22 17:27:46','05172c41-e563-408f-9798-defaea3f22a3'),(10451,10451,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Principles & Practices\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Get comprehensive guidance to build or improve practices related to detection, reporting, investigation, or control of any HAI or AR outbreak.\"}',1,'2024-05-22 17:27:46','2024-05-22 17:27:46','39903d26-b93d-451e-ae36-67ad2e695b5e'),(10468,10468,1,'EKC','ekc','diseases-pathogens/ekc',NULL,1,'2024-05-22 17:31:18','2024-05-22 17:31:18','8245acf9-4dd8-4013-b061-2a7c5d628eef'),(10469,10469,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:31:18','2024-05-22 17:31:18','5950cd0a-1dae-4d53-b6c6-078ede6c6100'),(10470,10470,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Line List: Sample Documentation Template\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:31:18','2024-05-22 17:31:18','3a99fd19-beb9-4446-9ae7-f2fba6d0bc4d'),(10471,10471,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:31:18','2024-05-22 17:31:18','5c195c05-39be-47dc-8db1-312496ebed0e'),(10472,10472,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Outbreak Patient Letter: Sample Communications\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-22 17:31:18','2024-05-22 17:31:18','c716eef4-2249-4a79-a7df-b7aa37bd5ae0'),(10473,10473,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:31:18','2024-05-22 17:31:18','ddd898f9-e71e-4a47-84e0-d755ceb3599c'),(10474,10474,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-22 17:31:18','2024-05-22 17:31:18','6d997ccc-53f3-4d31-a74b-3721ab448bbe'),(10475,10475,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:31:18','2024-05-22 17:31:18','58a4d585-01b5-42db-a27b-5bc14f733b32'),(10476,10476,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Adenovirus-Associated EKC Outbreaks: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:31:18','2024-05-22 17:31:18','7f66a6f8-086b-41fd-a203-de57f1b9351b'),(10477,10477,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:31:18','2024-05-22 17:31:18','beb5719f-8733-4aa5-b679-e0e886a468f0'),(10478,10478,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Outbreak of EKC Caused by Human Adenovirus Type D53 in an Eye Care Clinic: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:31:18','2024-05-22 17:31:18','d8a2786b-2fca-4600-ac24-d742b401306e'),(10479,10479,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:31:18','2024-05-22 17:31:18','41badbd6-3360-4a9c-9a3a-13db3d5bce87'),(10480,10480,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | EKC Outbreak Associated with Human Adenovirus Type 8 : Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-11-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:31:18','2024-05-22 17:31:18','286f31a9-1386-4f6d-8baf-75e70d8b1b81'),(10481,10481,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:31:18','2024-05-22 17:31:18','b3d9a1b9-77fe-4e74-83cd-754fc2473a6a'),(10482,10482,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Principles & Practices\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Get comprehensive guidance to build or improve practices related to detection, reporting, investigation, or control of any HAI or AR outbreak.\"}',1,'2024-05-22 17:31:18','2024-05-22 17:31:18','e864c434-26bc-42a8-a28a-b03b26a8c9fa'),(10498,10498,1,'EKC','ekc','diseases-pathogens/ekc',NULL,1,'2024-05-22 17:40:35','2024-05-22 17:40:35','77ad1e93-9f94-4bc9-8f20-c50b8eaad384'),(10499,10499,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:40:35','2024-05-22 17:40:35','e9e16e6c-4558-4b19-9cb0-bcc46a8ed7e8'),(10500,10500,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Line List: Sample Documentation Template\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:40:35','2024-05-22 17:40:35','18e9fcf8-9f9f-4ec4-a92e-2268d52c44fd'),(10501,10501,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:40:35','2024-05-22 17:40:35','101d31c5-dce1-4e71-9c4b-5c95bf6b694d'),(10502,10502,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"EKC Outbreak Patient Letter: Sample Communications\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-09-02 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-22 17:40:35','2024-05-22 17:40:35','a99e8089-235f-42bd-9c1c-45b2f1217b36'),(10503,10503,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:40:35','2024-05-22 17:40:35','fcb4e5b0-bbc3-491f-b4ca-bff9499ec89b'),(10504,10504,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent EKC: How to Disinfect Surfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2020-04-03 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\"}',1,'2024-05-22 17:40:35','2024-05-22 17:40:35','18a3ad50-88f3-435a-9d65-1b0002268a1c'),(10505,10505,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:40:35','2024-05-22 17:40:35','d0035181-e27a-412f-b688-7b61e7f107d0'),(10506,10506,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Adenovirus-Associated EKC Outbreaks: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:40:35','2024-05-22 17:40:35','84fdec65-660b-4d7b-abe2-428281d815d1'),(10507,10507,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:40:35','2024-05-22 17:40:35','ddaa0993-6634-4ff6-8b67-9680066992ec'),(10508,10508,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | Outbreak of EKC Caused by Human Adenovirus Type D53 in an Eye Care Clinic: Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-06-22 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:40:35','2024-05-22 17:40:35','345578d3-ec58-4ce9-9276-2210ecb666a2'),(10509,10509,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:40:36','2024-05-22 17:40:36','bb58b90d-d272-432d-966f-9e6d35c105e4'),(10510,10510,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"MMWR | EKC Outbreak Associated with Human Adenovirus Type 8 : Preventing EKC Transmission\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2023-11-01 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-22 17:40:36','2024-05-22 17:40:36','47286c4c-975b-4da0-91c8-72d1b28b756c'),(10511,10511,1,NULL,NULL,NULL,NULL,1,'2024-05-22 17:40:36','2024-05-22 17:40:36','bd7374ce-0aee-409c-bd4c-50ecdeacca5c'),(10512,10512,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Principles & Practices\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-12 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://#\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"Get comprehensive guidance to build or improve practices related to detection, reporting, investigation, or control of any HAI or AR outbreak.\"}',1,'2024-05-22 17:40:36','2024-05-22 17:40:36','224fc26b-4c84-4d27-ac13-6bebf42d4c74'),(10513,10513,1,NULL,'__temp_rsilzugcwketvfiowtvbaerraaqfpnqxzzvw','chapters/__temp_rsilzugcwketvfiowtvbaerraaqfpnqxzzvw',NULL,1,'2024-05-22 17:50:01','2024-05-22 17:50:01','d4d3d823-7659-4b80-9fc6-eb1ca543d47b'),(10518,10518,1,'1 - Overview','overview','chapters/overview','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 1}',1,'2024-05-22 17:53:37','2024-05-22 17:53:37','7875ecb4-7513-452d-a9b3-e669b6f92812'),(10519,10519,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Overview\"}',1,'2024-05-22 17:53:37','2024-05-22 17:53:37','843f6740-49c9-48e9-8ae9-8f123438a97c'),(10522,10522,1,'1 - Overview','overview','chapters/overview','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 1}',1,'2024-05-22 18:51:14','2024-05-22 18:51:14','5b2d700a-62af-4aba-917f-b9b9ec32915a'),(10524,10524,1,NULL,NULL,NULL,NULL,1,'2024-05-22 21:36:51','2024-05-22 21:36:51','cd14d74a-18aa-4b73-b28a-5cecc7a0eb41'),(10525,10525,1,'About CORHA','about-corha','about-corha',NULL,1,'2024-05-22 21:36:51','2024-05-22 21:36:51','74e40733-447c-48ac-aa36-bb694a195221'),(10526,10526,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Healthcare-associated Infections (HAIs) including antimicrobial-resistant (AR) pathogens cause hundreds of thousands of illnesses and deaths among U.S. patients each year. CORHA is a multidisciplinary collaboration of national associations and federal agencies working together since 2015 to improve methods to detect, investigate, control, and prevent HAI/AR outbreaks.</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"About CORHA\"}',1,'2024-05-22 21:36:51','2024-05-22 21:36:51','0e472e6d-d966-485e-9cf7-1ab0fa295c8a'),(10527,10527,1,NULL,NULL,NULL,NULL,1,'2024-05-22 21:36:51','2024-05-22 21:36:51','be4e640a-555e-41c0-a9e5-aabcfd00f29b'),(10528,10528,1,NULL,NULL,NULL,NULL,1,'2024-05-22 21:36:51','2024-05-22 21:36:51','a6dbff5c-7b98-4647-8775-5a743ac85294'),(10529,10529,1,NULL,NULL,NULL,'{\"d34ad5d6-4524-4c40-8376-ad2cf3772110\": \"halfHalfWidth\"}',1,'2024-05-22 21:36:51','2024-05-22 21:36:51','089bfdb1-c3b6-4023-bd9f-ae3ee3346ad3'),(10530,10530,1,NULL,NULL,NULL,NULL,1,'2024-05-22 21:36:51','2024-05-22 21:36:51','40e11cd5-2cba-44f1-aa89-760c43d1ebae'),(10531,10531,1,NULL,NULL,NULL,NULL,1,'2024-05-22 21:36:51','2024-05-22 21:36:51','4ae4a172-53b9-4541-b2cd-84e09393be64'),(10532,10532,1,'CORHA Strategic Map','corha-strategic-map','corha-strategic-map',NULL,1,'2024-05-22 21:44:30','2024-05-22 21:44:30','b2f0db41-a7f8-47f3-b244-700e1746a386'),(10533,10533,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>CORHA’s Strategic Map identifies the following key priorities as necessary to address its central challenge of building capacity for public health and healthcare to improve outbreak detection,  response and prevention.</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"CORHA Strategic Map\"}',1,'2024-05-22 21:44:30','2024-05-22 21:44:30','9879ad18-aa8e-4a47-952d-c8185a471494'),(10534,10534,1,NULL,NULL,NULL,NULL,1,'2024-05-22 21:44:30','2024-05-22 21:44:30','aa4bd33e-5661-4a29-8a36-d536ade3965a'),(10535,10535,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Swipe to Read Content</p><figure class=\\\"table\\\"><table><thead><tr><th>Support standardized approaches to detection and reporting</th><th>Support consistent and coordinated approaches to investigation &amp; control</th><th>Foster a posture of responsiveness among the practice community</th><th>Strengthen CORHA’s effectiveness and sustainability</th></tr></thead><tbody><tr><td>Standardize outbreak and exposure event definitions &amp; thresholds for reporting</td><td>Describe appropriate levels of response for improved outcomes</td><td>Promote collaboration between public health and healthcare</td><td>Ensure effective council vision and leadership</td></tr><tr><td>Improve the use of surveillance systems to detect outbreaks</td><td>Improve data management for outbreak investigation &amp; tracking</td><td>Promote and disseminate tools and guidance</td><td>Recruit and engage council and workgroup members</td></tr><tr><td>Improve reporting of outbreaks and exposure events to public health</td><td>Foster consistent notifications  and disclosures</td><td>Foster implementation and uptake of CORHA products</td><td>Ensure operational infrastructure and process efficiency</td></tr><tr><td colspan=\\\"2\\\">Develop best practice guidance and identify standards for public health policy and legal authority</td><td>Increase CORHA brand recognition</td><td>Collaborate with member organizations to share and leverage resources</td></tr><tr><td colspan=\\\"2\\\">Define public health, clinical, and commercial laboratory best practices to support outbreak detection &amp; response</td><td>Facilitate and guide the sharing of lessons learned and prevention needs</td><td>Increase and diversify council funding</td></tr><tr><td colspan=\\\"2\\\">Develop a comprehensive repository of tools &amp; guidance</td><td>Define and operationalize CORHA’s role in emerging threats</td><td>Implement succession planning</td></tr><tr><td colspan=\\\"4\\\">Strengthen relationships and communication among stakeholders</td></tr><tr><td colspan=\\\"4\\\">Develop and implement a formal evaluation plan</td></tr></tbody></table></figure>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"CORHA Enhances Capabilities of Public Health and Healthcare to Improve Outbreak Detection, Response, and Prevention\"}',1,'2024-05-22 21:44:30','2024-05-22 21:44:30','d08e1f22-1384-4911-a753-a975b07daa47'),(10536,10536,1,NULL,NULL,NULL,NULL,1,'2024-05-23 14:37:44','2024-05-23 14:37:44','d538c23c-e052-4eda-b679-e84cc4c2eeb3'),(10537,10537,1,NULL,NULL,NULL,NULL,1,'2024-05-23 14:39:02','2024-05-23 14:39:02','c1e18786-0906-4279-8995-ed10172310f8'),(10538,10538,1,NULL,NULL,NULL,NULL,1,'2024-05-23 14:39:48','2024-05-23 14:39:48','204a4a42-fcf4-4a78-b0f6-70be4cf2fffd'),(10539,10539,1,NULL,NULL,NULL,NULL,1,'2024-05-23 14:40:17','2024-05-23 14:40:17','57c39aa1-f1bd-44a2-b451-61c21cc429be'),(10540,10540,1,NULL,NULL,NULL,NULL,1,'2024-05-23 14:40:40','2024-05-23 14:40:40','9e59ae9f-91e8-4d97-8339-37ffe7ed5c01'),(10541,10541,1,NULL,NULL,NULL,NULL,1,'2024-05-23 14:41:05','2024-05-23 14:41:05','51afabc7-d3a6-4ef1-90aa-688e75e05c89'),(10542,10542,1,NULL,NULL,NULL,NULL,1,'2024-05-23 14:41:29','2024-05-23 14:41:29','ff4a07cf-6d82-4c6b-b9be-2e780ff6e66f'),(10545,10545,1,'Home','home','__home__',NULL,1,'2024-05-23 18:16:07','2024-05-23 18:16:07','15782089-020d-461b-bd6d-cc753d6819d5'),(10546,10546,1,NULL,NULL,NULL,'{\"25fd6e6f-c802-418d-87dc-d9f982f900d9\": \"CORHA offers a curated collection of resources to help improve your outbreak response activities, wherever healthcare is delivered.\", \"bbb62ccb-960d-4efb-9245-e85c3ecfe366\": \"Detect, Investigate, & Control Healthcare Outbreaks\"}',1,'2024-05-23 18:16:07','2024-05-23 18:16:07','899a17cd-2c32-492a-b17f-72e36290d73e'),(10551,10551,1,NULL,'__temp_yfexrorbqetjzrpttrhrmibwvvlrthqwjfvh','leadership/__temp_yfexrorbqetjzrpttrhrmibwvvlrthqwjfvh',NULL,1,'2024-05-23 18:27:10','2024-05-23 18:27:10','3023ce2c-5d20-491b-ab28-82e97e25b36a'),(10577,10577,1,NULL,NULL,NULL,NULL,1,'2024-05-23 20:23:48','2024-05-23 20:23:48','4d24c4f5-3980-42ce-a523-68314755265e'),(10580,10580,1,'Infection Control Breach Investigations','infection-control-breach-investigations','chapters/infection-control-breach-investigations','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 9}',1,'2024-05-24 13:56:23','2024-05-24 13:56:23','3e1d993e-7482-4c86-80e3-1ae1d8d93a04'),(10581,10581,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\"}',1,'2024-05-24 13:56:23','2024-05-24 13:56:23','d1270f2d-d473-4891-9e55-ab1631c7cc00'),(10584,10584,1,'Medical Product Investigations','medical-product-investigations','chapters/medical-product-investigations','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 10}',1,'2024-05-24 14:05:59','2024-05-24 14:05:59','7749dd73-311b-4369-b284-d6ce292bb62c'),(10585,10585,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\"}',1,'2024-05-24 14:05:59','2024-05-24 14:05:59','5c4c870b-3949-4501-bdf0-b6c5fa765794'),(10588,10588,1,'Medical Product Investigations','medical-product-investigations','chapters/medical-product-investigations','{\"68c04e47-b499-4e50-88f0-a409394e673e\": 10}',1,'2024-05-24 14:07:40','2024-05-24 14:07:40','3517622a-69d5-4617-aab5-e07e16386fd8'),(10589,10589,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Additional subhead text can go here if needed</i></p>\"}',1,'2024-05-24 14:07:40','2024-05-24 14:07:40','3a94b46e-65ec-4901-a987-40d7e0a09e21'),(10592,10592,1,'About CORHA','about-corha','about-corha',NULL,1,'2024-05-24 14:08:06','2024-05-24 14:08:06','6cec69ad-b492-41e8-957a-c2940b22aa8c'),(10593,10593,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Healthcare-associated Infections (HAIs) including antimicrobial-resistant (AR) pathogens cause hundreds of thousands of illnesses and deaths among U.S. patients each year. CORHA is a multidisciplinary collaboration of national associations and federal agencies working together since 2015 to improve methods to detect, investigate, control, and prevent HAI/AR outbreaks.</p>\"}',1,'2024-05-24 14:08:06','2024-05-24 14:08:06','32a476eb-e568-46e0-b304-dd1f34b3a64a'),(10594,10594,1,'Scabies','scabies','diseases-pathogens/scabies',NULL,1,'2024-05-24 14:09:14','2024-05-24 14:09:14','a92f315e-47ae-473e-b75a-e5e1b1b29696'),(10595,10595,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called sarcoptes scabiei or sarcoptic mange</i></p>\"}',1,'2024-05-24 14:09:14','2024-05-24 14:09:14','77f2f932-0d3c-4155-ae85-d16feeba8946'),(10596,10596,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:09:14','2024-05-24 14:09:14','7b77590a-b80c-42f6-a55d-2369a98105fe'),(10597,10597,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Guidelines for Acute and Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://publichealth.lacounty.gov/acd/Diseases/ScabiesToolkit.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-24 14:09:14','2024-05-24 14:09:14','7749d9dc-ecc7-42a2-82b6-192fc0875ed6'),(10598,10598,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:09:14','2024-05-24 14:09:14','7ba5d36e-5e77-425f-b073-ba07c1f93c43'),(10599,10599,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies in Institutional Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-02-01 08:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/scabies/php/public-health-strategy/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-24 14:09:14','2024-05-24 14:09:14','ca82df7c-107c-41f0-b937-01bfec0ebe2a'),(10600,10600,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:09:14','2024-05-24 14:09:14','6b9df9ab-ab1d-4cee-b8b5-d8c1c7705de6'),(10601,10601,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Manual\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-04 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.michigan.gov/mdhhs/keep-mi-healthy/communicablediseases/diseasesandimmunization/overview-of-the-division-of-communicable-disease\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-24 14:09:14','2024-05-24 14:09:14','095c2a23-3a27-437d-b1b4-605a77d9b93c'),(10610,10610,1,'Scabies','scabies','diseases-pathogens/scabies',NULL,1,'2024-05-24 14:09:49','2024-05-24 14:09:49','a7dbefdd-4865-4c7e-8f52-8087b01fc336'),(10611,10611,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also called sarcoptes scabiei or sarcoptic mange</i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Scabies Resources\"}',1,'2024-05-24 14:09:49','2024-05-24 14:09:49','be982cb3-d0d6-49e1-b0c4-6344b1e0c4f0'),(10612,10612,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:09:49','2024-05-24 14:09:49','6e531aed-b718-43f0-bdb6-9646cd41a150'),(10613,10613,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Guidelines for Acute and Long-Term Care Facilities\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://publichealth.lacounty.gov/acd/Diseases/ScabiesToolkit.htm\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-24 14:09:49','2024-05-24 14:09:49','b16560c8-708b-4ccb-ab7c-ddc0f200400c'),(10614,10614,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:09:49','2024-05-24 14:09:49','45778ef9-7a3d-4945-a3b9-638b9ea760b4'),(10615,10615,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies in Institutional Settings\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-02-01 08:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/scabies/php/public-health-strategy/index.html\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-24 14:09:49','2024-05-24 14:09:49','9d79997e-d6c7-4446-8e1a-e5edf9686c21'),(10616,10616,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:09:49','2024-05-24 14:09:49','13c1bec6-086e-463a-b94e-9f69b91f0442'),(10617,10617,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Scabies Prevention and Control Manual\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-04 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.michigan.gov/mdhhs/keep-mi-healthy/communicablediseases/diseasesandimmunization/overview-of-the-division-of-communicable-disease\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\"}',1,'2024-05-24 14:09:49','2024-05-24 14:09:49','84a32dc7-a862-411a-9fc3-6274caa3ae0c'),(10630,10630,1,'8-Jennifer Jones, 2023 McKnight Prize for Healthcare Outbreak Heroes Recipient','jennifer-jones-2023-mcknight-prize-for-healthcare-outbreak-heroes-recipient-2','news/jennifer-jones-2023-mcknight-prize-for-healthcare-outbreak-heroes-recipient-2','{\"84a051cd-1f3d-42ba-be23-26f3f9856933\": \"<p>Jennifer Jones, Senior Infection Preventionist at Helen DeVos Children’s Hospital, part of Corewell Health in Grand Rapids, Michigan is the recipient of the 2023 McKnight Prize for Healthcare Outbreak Heroes award for her outstanding response to a Methicillin-resistant Staphylococcus aureus (MRSA) outbreak in a Neonatal Intensive Care Unit.</p><figure class=\\\"image\\\"><img src=\\\"{asset:1557:url||http://staging.corha.astriatawiki.com/assets/images/305fe57496acb9a1db30e7e0795e2bce.jpg}\\\" alt=\\\"Jennifer Jones Headshot\\\" width=\\\"200\\\" height=\\\"300\\\" /></figure><p>Jennifer Jones, Senior Infection Preventionist</p><p>The Evelyn and Thomas McKnight Family Fund for Patient Safety and the CDC Foundation created the McKnight Healthcare Outbreak Heroes Prize to encourage and reward those who protect patients from harm related to healthcare outbreaks. We’re happy to introduce Jennifer Jones as the 2023 recipient of this prestigious award!</p><p>Epidemic Keratoconjunctivitis</p><p><br />In the Spring of 2022, the Helen DeVos Children’s Hospital’s Infection Prevention team, led by Jennifer, Senior Infection Preventionist, was monitoring hospital-acquired MRSA cases in their Neonatal Intensive Care Unit (NICU). The team identified an outbreak after observing a sudden uptick in MRSA bacteremia cases in a short period of time, prompting an investigation. The infection prevention team utilized their Outbreak Investigation Policy, referenced CDC &amp; APIC resources, and implemented mitigation strategies. Examples of these strategies included mandatory Call-to-Action sessions for all team members who enter the NICU, weekly MRSA screening of all admitted NICU babies, development of a decolonization protocol, and installation of additional hand sanitizer dispensers. Jennifer exemplified outstanding leadership, initiative, and personal commitment as part of a successful effort to protect newborns throughout this outbreak response. CORHA spoke with her about her lessons learned and keys to success.</p><p><br />Jennifer recognized that during this outbreak, good communication was essential for all stakeholders: parents, staff, leadership, the health department, and CDC. She organized weekly meetings to provide updates during the investigation that could be shared among their teams. Jennifer emphasized that navigating these conversations with partners during an HAI/AR outbreak response is always tough; however, when you provide data to support your rationale and response, it makes the conversations easier.</p><p><br />A success Jennifer shares is that her staff felt comfortable going to leadership and the infection prevention team with suggestions. For example, during their Call-to-Action sessions, staff felt empowered to notify the infection prevention team that gloves in all sizes were not easily accessible to provide care. Jennifer’s team went onsite with facility and bedside team members to see where they could install a place to house small, medium, and large gloves for staff use. This is just one example of open communication from over 40 suggestions that were provided to Jennifer’s team.<br />Sharing key messages with everyone who might enter the NICU space was a challenging and essential part of the outbreak response. Jennifer’s team rounded in the NICU frequently to conduct knowledge surveys (and, of course, hand out candy). This helped them evaluate whether their messaging was reaching the care team and provide real-time observations and feedback. The following is a key insight Jennifer gained while leading the outbreak response:</p><blockquote><p>Get out there and observe what is truly happening and partner with the care team so it doesn’t seem punitive. Walk alongside them in all phases of an outbreak scenario so it remains a partnership between the care team and infection prevention team.</p></blockquote><p class=\\\"quote-author\\\">-Jennifer Jones</p><p>We applaud Jennifer for her leadership, dedication and initiative to ensure a well-coordinated and successful outbreak response.</p>\", \"acf2caae-0773-4eb2-bb10-57a01b19e200\": \"Example Author\"}',1,'2024-05-24 14:17:38','2024-05-24 14:17:38','05d79633-b7b2-4964-87d9-d5262c2cc008'),(10631,10631,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:17:38','2024-05-24 14:17:38','a31fc320-b95a-4386-b69c-b27d04862934'),(10632,10632,1,'Burkholderia Cepacia','scabies-2-2','diseases-pathogens/scabies-2-2',NULL,1,'2024-05-24 14:21:14','2024-05-24 14:21:14','e74a949c-6e54-46c2-8f7b-c8d88e02392d'),(10633,10633,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Burkholderia Cepacia Resources\"}',1,'2024-05-24 14:21:14','2024-05-24 14:21:14','c01375cf-5684-4b2a-9d51-03acd1f51184'),(10634,10634,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:21:14','2024-05-24 14:21:14','5a8573d4-edca-4126-891a-4c0e0a007794'),(10635,10635,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"For infection prevention specialists\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Prevent Scabies: How to disinfect Sourfaces and Equipment\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-01 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"For local health departments, healthcare facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://my-craft-project.ddev.site/diseases-pathogens/scabies\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This summary or excerpt should describe the contents in enough detail that users do not have to guess when such a resource should be used, and by whom.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": false}',1,'2024-05-24 14:21:14','2024-06-06 18:37:44','4c26a155-361f-4ead-8c5f-0c57bddb89c0'),(10638,10638,1,'About CORHA','about-corha','about-corha',NULL,1,'2024-05-24 14:23:38','2024-05-24 14:23:38','57913365-9f75-4a77-a6b9-d447e06ec778'),(10639,10639,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Healthcare-associated Infections (HAIs) including antimicrobial-resistant (AR) pathogens cause hundreds of thousands of illnesses and deaths among U.S. patients each year. CORHA is a multidisciplinary collaboration of national associations and federal agencies working together since 2015 to improve methods to detect, investigate, control, and prevent HAI/AR outbreaks.</p>\"}',1,'2024-05-24 14:23:38','2024-05-24 14:23:38','43b4d6b7-3db6-4623-bbd6-8bdfffda0073'),(10640,10640,1,'Burkholderia Cepacia',NULL,NULL,NULL,1,'2024-05-24 14:23:53','2024-05-24 14:23:53','821d7904-6dcf-4aee-98c9-8092178c6849'),(10643,10643,1,'CORHA Strategic Map','corha-strategic-map','corha-strategic-map',NULL,1,'2024-05-24 14:24:25','2024-05-24 14:24:25','6c732708-984f-4c73-90f8-345d8095c0ae'),(10644,10644,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>CORHA’s Strategic Map identifies the following key priorities as necessary to address its central challenge of building capacity for public health and healthcare to improve outbreak detection,  response and prevention.</p>\"}',1,'2024-05-24 14:24:25','2024-05-24 14:24:25','aefc2e7f-0031-4d67-947e-d117c3c77f55'),(10647,10647,1,'Search','search','search',NULL,1,'2024-05-24 14:24:55','2024-05-24 14:24:55','b1dcf422-2d59-4864-894b-7887261f0940'),(10648,10648,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:24:55','2024-05-24 14:24:55','0a9a82b3-295e-4ae4-a09c-ae6c93455095'),(10649,10649,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:24:55','2024-05-24 14:24:55','cabdae2f-bae6-4a4a-9d69-66f1049c0ddb'),(10652,10652,1,'Contact CORHA','contact-corha','contact-corha',NULL,1,'2024-05-24 14:25:17','2024-05-24 14:25:17','b701fd1a-c458-43c0-8b6c-b148ab13b7fe'),(10653,10653,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Thank you for your interest in CORHA! Please fill out the form below to share with us how you are using these resources, any questions, concerns, or if there are other topics and resources that you would like to see from CORHA.</p>\"}',1,'2024-05-24 14:25:17','2024-05-24 14:25:17','9b4119e8-087f-4f60-b2f4-c783f98c710a'),(10656,10656,1,'Clostridioides difficile','c-diff','diseases-pathogens/c-diff',NULL,1,'2024-05-24 14:25:44','2024-05-24 18:09:03','72a39782-a3f5-4a14-87b9-c5a05c6ecdcb'),(10657,10657,1,'Bylaws & Operating Guidance','bylaws-operating-guidance','bylaws-operating-guidance',NULL,1,'2024-05-24 14:25:50','2024-05-24 14:25:50','831003e8-e9b8-441c-ae7c-730b6c90766e'),(10658,10658,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>As a multidisciplinary association, CORHA is governed by its bylaws and operating protocols. These include a specific organization structure, roles and responsibilities, meeting and voting schedules, workgroup rules, and more.</p>\"}',1,'2024-05-24 14:25:50','2024-05-24 14:25:50','1baee74c-2fb2-441f-b9fc-56e929a4fca1'),(10659,10659,1,NULL,NULL,NULL,'{\"376ff7f0-4fe0-46e9-b8e0-31b3f466aa87\": \"CORHA Bylaws\"}',1,'2024-05-24 14:25:50','2024-05-24 14:25:50','250e11d6-b562-421b-9d76-23988061c648'),(10660,10660,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:25:50','2024-05-24 14:25:50','959657a0-35f2-4c08-97e6-0582e099bc1e'),(10661,10661,1,NULL,NULL,NULL,'{\"376ff7f0-4fe0-46e9-b8e0-31b3f466aa87\": \"Operating Guidance\"}',1,'2024-05-24 14:25:50','2024-05-24 14:25:50','ed8221ce-d8a9-49f8-bde6-0aa63c9138cd'),(10662,10662,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:25:50','2024-05-24 14:25:50','9aafdd0b-3127-4626-8987-e4e7d7f3c4d4'),(10663,10663,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:25:53','2024-05-24 14:25:53','f88812ea-6f64-4df7-a99e-c5da7eab25a0'),(10664,10664,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Bacteria\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 14:25:53','2024-06-03 20:18:47','dcc0134d-6ef9-4360-8fed-967e3e1bc1a7'),(10665,10665,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Ebola\"}',1,'2024-05-24 14:26:01','2024-05-24 14:26:01','8c133d06-4403-490d-ba32-6a734ec0293c'),(10668,10668,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Ebola virus disease</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Ebola\"}',1,'2024-05-24 14:26:16','2024-05-24 14:26:16','3efa801e-0cec-4448-8a45-d5c60eacdd3c'),(10669,10669,1,'Leadership','leadership','leadership',NULL,1,'2024-05-24 14:26:20','2024-05-24 14:26:20','995679d0-5a8d-499f-92cc-6c93184d3431'),(10670,10670,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>The Council is led by a governance committee comprised of a representative from four representatives from The Association of State and Territorial Health Officials (ASTHO), The Council of State and Territorial Epidemiologists (CSTE), The Centers for Disease Control and Prevention (CDC), and the National Association of County and City Health Officials (NACCHO).</p>\"}',1,'2024-05-24 14:26:20','2024-05-24 14:26:20','76f3e4ff-55b2-42e0-b993-ee7b3d26986a'),(10671,10671,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:26:20','2024-05-24 14:26:20','006ca6c0-eb2e-4bb8-aae5-d92de2c3e905'),(10674,10674,1,'CORHA Member Organizations','corha-member-organizations','corha-member-organizations',NULL,1,'2024-05-24 14:26:40','2024-05-24 14:26:40','053f4701-6382-437d-aa86-5320d0ea0f89'),(10675,10675,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>This paragraph should discuss how CORHA represents a variety of organizations, but also has connections with other industry leading groups. The content can discuss how these groups work together on a common goal, and can thank the organizations for their contributions.</p>\"}',1,'2024-05-24 14:26:40','2024-05-24 14:26:40','fbba7cfd-06a4-41fe-9dfc-51d683810c51'),(10676,10676,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:26:41','2024-05-24 14:26:41','231d8105-a25b-4bd2-b5ff-7dd01261fe40'),(10677,10677,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:26:41','2024-05-24 14:26:41','bafa7ee0-5cce-492b-bd5d-a82c748f968f'),(10678,10678,1,'Ebola',NULL,NULL,NULL,1,'2024-05-24 14:27:00','2024-05-24 14:27:00','763f2651-d7e1-4a71-b003-d81757b92f20'),(10679,10679,1,NULL,'__temp_mcpayctrkfgazliqngkcnqsnzbsbazjwvpkk',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>Also referred to as \'C. diff\' or CDI; formerly Clostridium difficile </i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Clostridioides difficile\"}',1,'2024-05-24 14:27:01','2024-06-13 13:47:11','8529b0da-5a59-4487-af11-b9b44adc6441'),(10682,10682,1,'Collaborative Workgroups','collaborative-workgroups','collaborative-workgroups',NULL,1,'2024-05-24 14:27:20','2024-05-24 14:27:20','872d9bdf-dcb2-48a4-b7d1-502085ef427c'),(10683,10683,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>This paragraph should discuss the process by which materials produced by CORHA are created: both the expertise of the contributors and the organizations they represent, and the workgroups that dedicate their time to doing so.</p>\"}',1,'2024-05-24 14:27:20','2024-05-24 14:27:20','86b553b6-76ed-4d1a-9382-f64f596431fd'),(10684,10684,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:27:20','2024-05-24 14:27:20','f9d3dcbe-7c41-4e0d-8fb5-5c8acbca8b56'),(10685,10685,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:27:20','2024-05-24 14:27:20','9505f62e-8867-43d9-89b9-2c7183a346ce'),(10686,10686,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:27:20','2024-05-24 14:27:20','e6cdb958-5dae-4784-9487-790825fd81ae'),(10689,10689,1,'Principles & Practices for  Outbreak Response','principles-practices-for-outbreak-response','principles-practices-for-outbreak-response',NULL,1,'2024-05-24 14:27:58','2024-05-24 14:27:58','47f4dd37-0e67-4e2a-8afe-b828309dc65f'),(10690,10690,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>This comprehensive reference equips public health, healthcare, and other stakeholders with the information they need to build, standardize or improve capacities and practices related to HAI/AR outbreak detection, reporting, investigation, and control.</p>\"}',1,'2024-05-24 14:27:58','2024-05-24 14:27:58','dfd76735-6119-4878-9ceb-8241652b9933'),(10693,10693,1,'Resources for Pathogens & Diseases','resources-for-pathogens-diseases','resources-for-pathogens-diseases',NULL,1,'2024-05-24 14:28:15','2024-05-24 14:28:15','b27561e9-31fd-426d-843c-aa2e02290b09'),(10694,10694,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>In addition to general guidance and tools for all outbreaks, CORHA  has curated a collection of resources from leading institutions for specific outbreaks. To see resources for your facility’s outbreak, select the disease, pathogen, type, or outbreak method below.</p>\"}',1,'2024-05-24 14:28:15','2024-05-24 14:28:15','b39c1393-37c5-496f-8df8-373b7851ead5'),(10695,10695,1,NULL,'__temp_nqehctgmhchdiddznpacpvbzlzimqtcvuagl','__temp_nqehctgmhchdiddznpacpvbzlzimqtcvuagl',NULL,1,'2024-05-24 14:28:21','2024-05-24 14:28:21','83aa711a-157c-424e-896b-add9976f3c84'),(10696,10696,1,'Example of a really long title that\'s over 100 characters and above and beyond and 100 characters more','example-of-a-really-long-title-thats-over-100-characters','example-of-a-really-long-title-thats-over-100-characters',NULL,1,'2024-05-24 14:28:34','2024-05-24 14:29:00','e4a70d7e-b15d-4315-b3a5-a8011d388675'),(10697,10697,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:28:44','2024-05-24 14:28:44','30d5ea2f-3e1f-4c91-9625-8ce22c7fb97a'),(10698,10698,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:29:00','2024-05-24 14:29:00','0c7f9400-58b0-4be0-8730-271a3b526dff'),(10699,10699,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:29:00','2024-05-24 14:29:00','0eb63030-9173-4d3c-bf7f-46e50b96a001'),(10700,10700,1,'Example of a really long title that\'s over 100 characters','example-of-a-really-long-title-thats-over-100-characters','example-of-a-really-long-title-thats-over-100-characters',NULL,1,'2024-05-24 14:29:00','2024-05-24 14:29:00','3661db91-3e63-4d80-a2fc-66607235713d'),(10701,10701,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:29:00','2024-05-24 14:29:00','4557723a-8398-44e2-b890-1f7e9c9f2a83'),(10704,10704,1,'Example of a really long title that\'s over 100 characters and above and beyond and 100 characters more','example-of-a-really-long-title-thats-over-100-characters','example-of-a-really-long-title-thats-over-100-characters',NULL,1,'2024-05-24 14:29:38','2024-05-24 14:29:38','d342a5c5-6e1d-4219-95e6-8bc76623ff46'),(10705,10705,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:29:38','2024-05-24 14:29:38','6eb56860-f939-4a9f-8aff-e437d9d5caad'),(10706,10706,1,'Example of a really long title that\'s over 100 characters and above and beyond and 100 characters more','example-of-a-really-long-title-thats-over-100-characters','example-of-a-really-long-title-thats-over-100-characters',NULL,1,'2024-05-24 14:29:54','2024-05-24 14:29:54','5bd6c2d4-9959-4d68-8447-53810787259c'),(10707,10707,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Override of a really long title that\'s over 100 characters and above and beyond and 100 characters more\"}',1,'2024-05-24 14:29:54','2024-05-24 14:29:54','b3ee38f7-d91e-4806-bc04-a8420e34b048'),(10708,10708,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:30:40','2024-05-24 14:30:40','ef80a088-3af5-41a0-a2b7-e0cf58824dfb'),(10709,10709,1,NULL,NULL,NULL,'{\"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:31:18','2024-05-24 14:31:18','9017b774-cfbf-40f1-aaa6-83a69a89a5eb'),(10710,10710,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health.  The virus can spread person-to-person through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:32:43','2024-05-24 14:32:43','45f26566-7fb9-4583-9665-157550c69ec0'),(10711,10711,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health.  The virus can spread person-to-erson through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:32:49','2024-05-24 14:32:49','d6c793ec-eb7e-4b06-b0b6-d029874e34b5'),(10712,10712,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health.  The virus can spread person-to-person through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:32:51','2024-05-24 14:32:51','7e251404-af36-44a4-9911-c086bf5693e4'),(10713,10713,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health.  The virus can spread person-to-The virus can spreadperson through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:32:58','2024-05-24 14:32:58','075dc79e-ff3c-46fc-b01b-60fb283ede92'),(10714,10714,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public healtThe virus can spreadperson through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:33:08','2024-05-24 14:33:08','036288a2-309e-4591-9efb-613353938152'),(10715,10715,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health. The virus can spreadperson through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:33:09','2024-05-24 14:33:09','4839ae24-71f2-4a5d-80db-e473dcc2ca26'),(10716,10716,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health. The virus can spread person through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:33:14','2024-05-24 14:33:14','0fb215d6-805c-440c-a8d8-d0738e87fdd2'),(10717,10717,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health. The virus can spreadperson through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:33:17','2024-05-24 14:33:17','9e65bd17-1f0b-4b6e-8353-50794da827d5'),(10718,10718,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health. The virus can spread person through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:33:18','2024-05-24 14:33:18','5b6a953f-10a0-4d53-974d-de6e28043831'),(10719,10719,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health person through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:33:28','2024-05-24 14:33:28','86a92a24-f14a-48af-b043-4e6624daf687'),(10720,10720,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health . The virus can spreadperson through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:33:34','2024-05-24 14:33:34','8e6bd09a-8900-4da2-96b9-0152e7812ed3'),(10721,10721,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health . The virus can spread person through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:33:37','2024-05-24 14:33:37','842a4d36-5705-492c-9046-d44b71edeb3f'),(10722,10722,1,NULL,NULL,NULL,'{\"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:33:43','2024-05-24 14:33:43','c27bf3f5-1cc9-470d-8463-a77f852e3032'),(10723,10723,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>. The virus can spread</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:33:46','2024-05-24 14:33:46','9b31431e-4e32-4414-a023-fc4b3fab61d6'),(10724,10724,1,NULL,NULL,NULL,'{\"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:33:48','2024-05-24 14:33:48','900d92e1-acf1-4ae5-a338-c779842d5496'),(10725,10725,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Ebola Virus Disease (EVD) is a rare but severe viral hemorrhagic fever (VHF) caused by the Ebola Virus. Any suspected case(s) of EVD should be promptly reported to public health.  The virus can spread person-to-person through direct contact with blood or bodily fluids of a person who is sick with or has died from EVD. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Preventing transmission of EVD in healthcare settings requires careful application of infection control measures, including but not limited to the effective use of personal protective equipment (PPE).</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"Ebola virus disease\"}',1,'2024-05-24 14:34:04','2024-05-24 14:34:04','5fbaf9ff-fca5-4808-90d1-906759c485a3'),(10726,10726,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:34:24','2024-05-24 14:34:24','25423e8e-3a0c-4c97-8d87-c17b5b44859b'),(10727,10727,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\"}',1,'2024-05-24 14:34:29','2024-05-24 14:34:29','b2fbe4f3-5f2d-4a53-84d9-7920d0bcfff2'),(10728,10728,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:34:47','2024-05-24 14:34:47','d237e748-5813-45fe-a573-ee148a421d13'),(10729,10729,1,NULL,'__temp_zwfclbyqpicvrtkriozuiqlxfgzloorzqvyx',NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p><i>Clostridioides difficile</i> is a type of spore-forming bacteria that can cause life-threatening diarrhea and colitis. C. difficile infection (CDI) is related to antibiotic exposure and is a frequent cause of healthcare-associated infections. CDI can spread from patient to patient and occasionally results in outbreaks among people being cared for in nursing homes and hospitals. </p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About CDI\"}',1,'2024-05-24 14:35:34','2024-07-29 20:04:29','4c9c1072-1e61-43d4-b686-0fd47605e3eb'),(10730,10730,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:36:09','2024-05-24 14:36:09','b69a0341-c8b5-42a7-a194-bd7c5fd79b79'),(10731,10731,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:36:09','2024-05-24 14:36:09','1022d25c-7917-41f8-8cde-56c0e2baa977'),(10732,10732,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:36:46','2024-05-24 14:36:46','80fa668a-f7fb-461e-8460-cf7c43155fda'),(10733,10733,1,NULL,'__temp_dwgqrcejrkxdcgpttgcpadyfsckfcycslotc',NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Clostridioides difficile Infection (CDI): Recommendations for Healthcare Outbreak Response\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"6b9fa6e8-a0d8-49b0-a33f-871f787ec3ba\": \"Health Departments, Healthcare Facilities\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"http://staging.corha.astriatawiki.com/assets/documents/CDI-Recommendations-for-Healthcare-Outbreak-Response.pdf\", \"da987605-91d6-41ef-a67b-639e071b34fe\": \"This CORHA-developed product includes thresholds for investigation and reporting of a possible Clostridioides difficile infection (CDI) outbreak. Additional sections outline important actions and considerations for CDI outbreak investigation and control. This document includes listings of key references and supplemental resources.\", \"f0c02666-8b3e-4971-b7be-fcb0d63d202e\": true}',1,'2024-05-24 14:36:46','2024-06-13 13:47:11','39bc1724-d438-4dd4-9c0e-1147004530a0'),(10734,10734,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:39:22','2024-05-24 14:39:22','64acffd0-4b66-4abb-9be6-c8ad920651b8'),(10735,10735,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:39:25','2024-05-24 14:39:25','bffbac9c-697f-49e0-b2c4-27008b286a79'),(10736,10736,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:39:25','2024-05-24 14:39:25','9d160c9c-3ebe-4f7b-8e62-54157b177d55'),(10737,10737,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:39:32','2024-05-24 14:39:32','1930d536-b5cd-47b9-b41b-6a4fa3ccb394'),(10738,10738,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\"}',1,'2024-05-24 14:39:32','2024-05-24 14:39:32','7fd2c52b-69d6-4dcb-8976-8b5d32ba1e79'),(10739,10739,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:39:36','2024-05-24 14:39:36','e7ae059f-a694-4ed8-bcf8-d6a8e147ee0c'),(10740,10740,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:39:36','2024-05-24 14:39:36','d3c003b5-0651-42c3-8033-0393dade7710'),(10741,10741,1,'Environmental Fungi','environmental-fungi','diseases-pathogens/environmental-fungi',NULL,1,'2024-05-24 14:45:52','2024-05-24 14:46:12','462923c1-b5db-478e-a494-0a2ed7a00c3c'),(10742,10742,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:46:11','2024-05-24 14:46:11','5ea907ec-13ef-42a7-83b8-a212eb968563'),(10743,10743,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:46:11','2024-05-24 14:46:11','73666bea-6c01-4a8b-ad6b-5f199f4a1a37'),(10744,10744,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Environmental Fungi\"}',1,'2024-05-24 14:46:26','2024-05-24 14:46:26','e4338d64-d382-4f13-8911-7e9126d5edbe'),(10745,10745,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Environmental Fungi Resources\"}',1,'2024-05-24 14:46:30','2024-05-24 14:46:30','dbae4b93-4956-4c63-837c-6de852b2302c'),(10746,10746,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>Environmental Fungi</p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Environmental Fungi Resources\"}',1,'2024-05-24 14:46:50','2024-05-24 14:46:50','3c84e104-2d75-45a9-be8d-c76dcb3e8680'),(10747,10747,1,NULL,NULL,NULL,'{\"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Environmental Fungi Resources\"}',1,'2024-05-24 14:46:51','2024-05-24 14:46:51','1abf5688-e964-45c7-93b9-f88fe7cca1fe'),(10748,10748,1,NULL,NULL,NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p>This page addresses pathogenic environmental fungi (including molds) </p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Environmental Fungi Resources\"}',1,'2024-05-24 14:46:59','2024-05-24 14:46:59','b543bad7-3aba-436d-a266-cc082e28cede'),(10749,10749,1,'Fungal mold',NULL,NULL,NULL,1,'2024-05-24 14:47:42','2024-05-24 14:47:42','eacd47c7-14c7-4411-a692-74d7e26ec931'),(10750,10750,1,NULL,'__temp_faiqzxrljuvozxdekdytfkutmgbhkvokbhkk',NULL,'{\"0f72865d-fe3e-4163-918f-27e7c84781c3\": \"<p><i>This page addresses pathogenic environmental fungi (including molds) </i></p>\", \"8e258b49-53ff-4566-8088-a5161e4a62cc\": \"Environmental Fungi\"}',1,'2024-05-24 14:47:43','2024-06-13 13:35:41','03a7dea1-467c-47f9-a3d8-f56d96592308'),(10751,10751,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:37','2024-05-24 14:48:37','0ed78044-3271-4c9a-b3ef-28ef476a1174'),(10752,10752,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:48:37','2024-05-24 14:48:37','63016da8-fbbc-47d2-8a39-df1f2e27d801'),(10753,10753,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:37','2024-05-24 14:48:37','4be7e5a5-ce5b-44a6-aebf-aab1705b1671'),(10754,10754,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:37','2024-05-24 14:48:37','095dea0e-6c28-4dc2-bbe3-5a9dd3bf47e3'),(10755,10755,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:38','2024-05-24 14:48:38','948eb6db-027f-42e7-b634-bfa6d2028a46'),(10756,10756,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:48:38','2024-05-24 14:48:38','41c6f2b9-c868-4fbe-8515-bf276f3562c4'),(10757,10757,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:39','2024-05-24 14:48:39','4f8f2cfa-2445-4b72-a716-8c598275b462'),(10758,10758,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:39','2024-05-24 14:48:39','a0d2f488-4c3d-46d9-ad85-6e62a378a5fd'),(10759,10759,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:41','2024-05-24 14:48:41','995848e9-ccd7-4a0a-856c-59a2c886d7a9'),(10760,10760,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:41','2024-05-24 14:48:41','c8a76a4d-fb55-453f-aab1-15978a385903'),(10761,10761,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:42','2024-05-24 14:48:42','962dbb24-d2e3-4c2c-bd1f-654ceb03fe73'),(10762,10762,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:42','2024-05-24 14:48:42','4cdd5bef-d6ca-484f-8fbc-0d58117eec9c'),(10763,10763,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:43','2024-05-24 14:48:43','36f9ae90-9e00-4de9-b7db-69aa2034e888'),(10764,10764,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:43','2024-05-24 14:48:43','56d32433-8a55-4501-a287-ffc78960a672'),(10765,10765,1,NULL,NULL,NULL,'{\"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 14:48:44','2024-05-24 14:48:44','fd02989a-a307-495b-80e2-4de7a925f896'),(10766,10766,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:44','2024-05-24 14:48:44','bff6f2df-b38c-45a0-b0f0-d02997aff4a7'),(10767,10767,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:44','2024-05-24 14:48:44','8c65e060-7a88-4d84-ad8b-652b8dc46c5d'),(10768,10768,1,NULL,NULL,NULL,'{\"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 14:48:45','2024-05-24 14:48:45','c9278871-02a7-4116-9362-febc72aa57b0'),(10769,10769,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:45','2024-05-24 14:48:45','713f4ca4-0a46-4253-b06a-6ad8304bc2a2'),(10770,10770,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:45','2024-05-24 14:48:45','66b49931-7612-4ffb-a0d1-6709beee3f60'),(10771,10771,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:47','2024-05-24 14:48:47','c1e0340c-4603-44dc-ba77-81dfc2a49c85'),(10772,10772,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:47','2024-05-24 14:48:47','8ef7ec0c-7941-436f-95f0-9876149f996b'),(10773,10773,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:48','2024-05-24 14:48:48','60693f79-a944-4029-bf14-bcf8c722c052'),(10774,10774,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:48','2024-05-24 14:48:48','303da45b-7f70-4f66-b5c2-02fa39763ef4'),(10775,10775,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:49','2024-05-24 14:48:49','00924d67-5929-4d70-93b1-063e329cb00d'),(10776,10776,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:49','2024-05-24 14:48:49','c2975057-dadd-48fb-91ab-a088878b0a3c'),(10777,10777,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:51','2024-05-24 14:48:51','7caca137-85f8-425c-8a8f-923df0f00d09'),(10778,10778,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:51','2024-05-24 14:48:51','bf8c96af-66ad-4882-af98-61a7fb17c6b1'),(10779,10779,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:52','2024-05-24 14:48:52','c3602400-6941-4afe-82eb-216e8fc432f9'),(10780,10780,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:52','2024-05-24 14:48:52','3e18401e-e486-4aca-8e8d-b6b3276c56bf'),(10781,10781,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:53','2024-05-24 14:48:53','74949071-93e4-45b0-bc3c-3fa41fb56afb'),(10782,10782,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:53','2024-05-24 14:48:53','871cf035-22ad-4f5d-8259-2aba30afb549'),(10783,10783,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:54','2024-05-24 14:48:54','acc38bb3-698f-49a0-95d9-aa35fd5acb47'),(10784,10784,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:54','2024-05-24 14:48:54','0a481838-8160-4569-b1f7-a15a0df65718'),(10785,10785,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:55','2024-05-24 14:48:55','d880e0d2-49cd-4283-a282-fcd86088bc3a'),(10786,10786,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:55','2024-05-24 14:48:55','d796020d-121e-41e1-b6d9-67f32d7051f5'),(10787,10787,1,NULL,NULL,NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Fungi\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 14:48:55','2024-05-24 14:48:55','b8e8375f-cd25-4b8c-817e-38209c9bc71e'),(10788,10788,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:56','2024-05-24 14:48:56','b282bc6f-490f-4ba0-acc9-a1df160b1634'),(10789,10789,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:56','2024-05-24 14:48:56','e2bcbc77-5bf8-4520-a2f8-e5e562432019'),(10790,10790,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:57','2024-05-24 14:48:57','3a674657-6c18-4d36-83b8-1d572124caad'),(10791,10791,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:57','2024-05-24 14:48:57','bcfe5d60-33d6-4a3f-a502-c42f6ed1df85'),(10792,10792,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:58','2024-05-24 14:48:58','28151f66-f14f-457c-8e23-9067121ba5a0'),(10793,10793,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:58','2024-05-24 14:48:58','3868b91c-571b-43d0-8cc7-1f0039664a3d'),(10794,10794,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:48:59','2024-05-24 14:48:59','d6cfdd1a-55a6-4765-a99d-2500c975db1c'),(10795,10795,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:48:59','2024-05-24 14:48:59','ac364146-ec7b-433a-ab4c-512e794aa623'),(10796,10796,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:00','2024-05-24 14:49:00','a1dc23ba-0a5a-487d-8d34-37eb012223b1'),(10797,10797,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:00','2024-05-24 14:49:00','35e26eb9-a3bb-4a83-9ed0-c7b135fe5745'),(10798,10798,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:02','2024-05-24 14:49:02','a0c91990-4f16-4212-8f9f-77b1cdd4e8a5'),(10799,10799,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:02','2024-05-24 14:49:02','a2c8561a-5f4b-444f-8805-f157d6d6fc60'),(10800,10800,1,'Fungal mold',NULL,NULL,NULL,1,'2024-05-24 14:49:02','2024-05-24 14:49:02','a86470f1-8b51-4d5c-8296-88355ff78e1f'),(10801,10801,1,NULL,'__temp_miklbvlvefjnuudnpgvbyknggyklashgwgrv',NULL,'{\"0faa63e9-a47b-42c2-95ee-2cfd55201441\": \"Fungi\", \"d057632f-79c8-4652-8fd8-748ac6166ec6\": {\"date\": \"2024-05-24 07:00:00\"}, \"f395977f-9fbd-4439-be7d-6e235b6699ac\": {\"date\": \"2024-05-24 07:00:00\"}}',1,'2024-05-24 14:49:03','2024-06-10 20:03:10','e0c75e92-b0b7-4570-9f83-99443fa3a451'),(10802,10802,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:04','2024-05-24 14:49:04','dac45d5e-b835-4025-bfce-0483af219dda'),(10803,10803,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:04','2024-05-24 14:49:04','b48ed607-e4a1-46e2-b32b-c57c209b14da'),(10804,10804,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:06','2024-05-24 14:49:06','9d07ac3a-ff29-4eb2-ba08-d82fd68d9f2f'),(10805,10805,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:06','2024-05-24 14:49:06','7457b00f-c021-4cd4-a03a-c58958c2713c'),(10806,10806,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:08','2024-05-24 14:49:08','462f7b4b-aabf-4ce2-88d4-8f78f881f78b'),(10807,10807,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:08','2024-05-24 14:49:08','838b06f4-5117-4f31-95b6-391295001084'),(10808,10808,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:10','2024-05-24 14:49:10','7f263176-94d5-4828-a5df-05e50c0982b7'),(10809,10809,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:10','2024-05-24 14:49:10','36c8fdd0-fb73-4b7a-ac99-48120d7be5b9'),(10810,10810,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:11','2024-05-24 14:49:11','6d05abc7-fff6-49d8-94ab-abbfaf396dc5'),(10811,10811,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:11','2024-05-24 14:49:11','be8c4973-6a29-4bb9-87ed-6a2eba561e38'),(10812,10812,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:13','2024-05-24 14:49:13','4882df71-216c-418a-ace6-e91658953578'),(10813,10813,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:13','2024-05-24 14:49:13','c22410a7-c8ef-409c-be0d-9854f6b2351b'),(10814,10814,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:14','2024-05-24 14:49:14','a65d568c-ae2f-464a-bd1a-d0064f944b56'),(10815,10815,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:14','2024-05-24 14:49:14','28cae01b-7a27-423d-8b5e-9bd3cedfed0b'),(10816,10816,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:15','2024-05-24 14:49:15','5c61ac7d-04cb-4a54-ac94-0bd9fbf05784'),(10817,10817,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:15','2024-05-24 14:49:15','8a9707d3-d122-4cc5-b384-289c5c81b2fe'),(10818,10818,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:16','2024-05-24 14:49:16','15cbf746-a5ef-4ea1-9d3e-36931017bd62'),(10819,10819,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:16','2024-05-24 14:49:16','dfc8113b-c8ff-4c38-bba1-0365eeb3a95c'),(10820,10820,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:17','2024-05-24 14:49:17','3740ffdc-37ef-4485-a19a-a63df27dc04d'),(10821,10821,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:17','2024-05-24 14:49:17','6c6fbcd2-8e67-4c8d-ab81-67af4ae5ffe3'),(10822,10822,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:18','2024-05-24 14:49:18','22035359-f93a-4406-802b-25723950e4ee'),(10823,10823,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:18','2024-05-24 14:49:18','436a85c9-afd1-4f5e-8c1c-38d05ef51027'),(10824,10824,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:18','2024-05-24 14:49:18','6343b27b-9f64-48bb-af42-dcd6f77d6ed0'),(10825,10825,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\"}',1,'2024-05-24 14:49:18','2024-05-24 14:49:18','b0f7c7d4-f956-457b-83ff-1ce763c1649d'),(10826,10826,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:19','2024-05-24 14:49:19','c3e53b48-28b7-431e-a670-f273268efe8b'),(10827,10827,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:19','2024-05-24 14:49:19','4cd3aca4-014f-4706-a094-5bb0bebf3c40'),(10828,10828,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:20','2024-05-24 14:49:20','41711d15-50e7-4c80-90b8-a9a09c2a1064'),(10829,10829,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:21','2024-05-24 14:49:21','798105d0-2bad-4334-8075-184d4c71be44'),(10830,10830,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:22','2024-05-24 14:49:22','b7f528ed-fe72-4118-b997-11add80fc1ee'),(10831,10831,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:22','2024-05-24 14:49:22','ea5728d3-2843-4de4-9da2-da26409c5bdb'),(10832,10832,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:23','2024-05-24 14:49:23','6ebc71dc-0de1-4854-a173-6c58bd65785c'),(10833,10833,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:23','2024-05-24 14:49:23','bbeb4e26-b561-4b3a-9a7c-00e198162b9f'),(10834,10834,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:24','2024-05-24 14:49:24','cf94fef6-00a7-4682-bdee-465f11b504d4'),(10835,10835,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:24','2024-05-24 14:49:24','1e02515b-71ae-4f1e-985b-95f39b13b6ea'),(10836,10836,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:25','2024-05-24 14:49:25','4f1e296a-49be-494e-bc43-d86fc8ad4e6b'),(10837,10837,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:25','2024-05-24 14:49:25','98e0f58e-b7f1-47d8-a564-b1e036ffe971'),(10838,10838,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:26','2024-05-24 14:49:26','36fc3bb3-966b-4692-9dd8-f2f517023bf9'),(10839,10839,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:26','2024-05-24 14:49:26','12915aaf-fa35-4f98-b88d-88eb98a28f3c'),(10840,10840,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:27','2024-05-24 14:49:27','03550aa3-d107-4e36-be2b-881004e003c2'),(10841,10841,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:27','2024-05-24 14:49:27','46c50881-d23b-43b3-9cf4-46757e037e0f'),(10842,10842,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:28','2024-05-24 14:49:28','cbab3865-6482-4971-8d36-ff8395808a22'),(10843,10843,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:28','2024-05-24 14:49:28','607b8ea8-34a3-490e-9586-d831eb48fe91'),(10844,10844,1,'World Health Organization','world-health-organization','resource-sources/world-health-organization',NULL,1,'2024-05-24 14:49:28','2024-05-24 14:56:13','34f80084-1e0f-40cf-8660-4d7d76cefbf4'),(10845,10845,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:29','2024-05-24 14:49:29','51706802-7133-42ae-b940-d1cb0b957efc'),(10846,10846,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:29','2024-05-24 14:49:29','316f86aa-a5c8-489a-9124-c6cd25da87dc'),(10847,10847,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:31','2024-05-24 14:49:31','d3b9bfc0-8228-497a-98d0-9344abc4eeed'),(10848,10848,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:31','2024-05-24 14:49:31','9b19d627-3a8d-47ef-8271-5406983ac086'),(10849,10849,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:31','2024-05-24 14:49:31','d5250e9c-ecc1-4b2a-ae84-a789ff1823c0'),(10850,10850,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:32','2024-05-24 14:49:32','2a9ca62b-d3ef-45ad-94cf-0b6652787b9b'),(10851,10851,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:32','2024-05-24 14:49:32','a0fa5caf-4ec8-45eb-97ec-1c0434821285'),(10852,10852,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:33','2024-05-24 14:49:33','ca013d14-9c44-473a-9bd8-db91d5701313'),(10853,10853,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:33','2024-05-24 14:49:33','bcaee4b6-7e68-478a-ac31-e333d84cc4d6'),(10854,10854,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:34','2024-05-24 14:49:34','ae1c7ae2-1094-479f-8748-4c5a15ac5f40'),(10855,10855,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:34','2024-05-24 14:49:34','dbdfe065-125a-4ce1-b65e-b16a54238386'),(10856,10856,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:35','2024-05-24 14:49:35','1f1608fb-ef42-490d-ac31-d368c6f6a0b5'),(10857,10857,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:35','2024-05-24 14:49:35','6dbd289f-705e-4bc5-98e9-8b48be3b2f33'),(10858,10858,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:36','2024-05-24 14:49:36','f979bb53-a22c-4188-8d09-de73575c2224'),(10859,10859,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:36','2024-05-24 14:49:36','b0566749-9820-4b90-bcfa-c5e200180b81'),(10860,10860,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:38','2024-05-24 14:49:38','162bb5a8-1602-4d17-95f1-c3b3c9e9e5d5'),(10861,10861,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:38','2024-05-24 14:49:38','c2cd8650-b0e6-41f6-b181-194c0bcdf2e1'),(10862,10862,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:39','2024-05-24 14:49:39','4dcbc971-4957-4a27-b0bd-6abce0d48f3e'),(10863,10863,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:39','2024-05-24 14:49:39','6c94a835-6f27-4f1b-b72c-7144e63c15d9'),(10864,10864,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:40','2024-05-24 14:49:40','106097a0-6b77-43cd-af8d-ec443250f14c'),(10865,10865,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:40','2024-05-24 14:49:40','305a1a5e-c22a-4a73-9e77-eb55254aded7'),(10866,10866,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:41','2024-05-24 14:49:41','11cbbfd9-16f9-4d3f-90d9-c0455244a079'),(10867,10867,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:41','2024-05-24 14:49:41','60dede89-9361-44a4-a020-e1cbee0b3807'),(10868,10868,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:42','2024-05-24 14:49:42','0239db81-bb8a-4ae3-bb98-44e55959bb84'),(10869,10869,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:42','2024-05-24 14:49:42','8726499b-3301-435d-bd3b-17bfca8eadbb'),(10870,10870,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:43','2024-05-24 14:49:43','35d939fa-ffc6-4254-b3fb-26b5a2ff5183'),(10871,10871,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:43','2024-05-24 14:49:43','bfe46511-85cb-41e7-9b7f-6707111e6c58'),(10872,10872,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:44','2024-05-24 14:49:44','61c001e0-6063-493a-9a70-e8f6482eec4f'),(10873,10873,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:44','2024-05-24 14:49:44','2d02dada-b78f-4713-8d0a-ffe65971d54c'),(10874,10874,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:45','2024-05-24 14:49:45','5a2b53fe-289c-4a7d-a34f-6b39e39091f2'),(10875,10875,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:45','2024-05-24 14:49:45','2e8b2c5d-308e-44fc-865c-8d520b904153'),(10876,10876,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:46','2024-05-24 14:49:46','3d366b59-3a50-4c51-8c52-ad7262e64eac'),(10877,10877,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:46','2024-05-24 14:49:46','902fdb23-a9c1-433c-9efc-2d6fb6187422'),(10878,10878,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:47','2024-05-24 14:49:47','8d5fbbcf-b2a9-4329-84b8-eb04212cf5f7'),(10879,10879,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:47','2024-05-24 14:49:47','7317d669-f922-4191-9e47-826c2a3050a9'),(10880,10880,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:49','2024-05-24 14:49:49','38767023-7ef9-446c-81d3-2749a884c81e'),(10881,10881,1,NULL,NULL,NULL,'{\"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:49:49','2024-05-24 14:49:49','02f44056-3bbc-4485-ba8f-f2108f4a0f9e'),(10882,10882,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:49','2024-05-24 14:49:49','55daaa39-0f7b-4a41-9340-894463602710'),(10883,10883,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:49','2024-05-24 14:49:49','a3447637-63dc-4a6f-a6e6-86d7dc3870da'),(10884,10884,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:50','2024-05-24 14:49:50','de243241-22db-436c-ac37-67a0805a9cbb'),(10885,10885,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:50','2024-05-24 14:49:50','ddcd468f-6648-4a4e-b466-c7e79e96b544'),(10886,10886,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:51','2024-05-24 14:49:51','2dd6982a-0117-4765-b44f-fbfc8d15ac9c'),(10887,10887,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:51','2024-05-24 14:49:51','b1eb705c-509d-4a82-809d-53b9a92755c3'),(10888,10888,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:51','2024-05-24 14:49:51','902832ee-404b-49a1-993b-cc8dc8d3044c'),(10889,10889,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\"}',1,'2024-05-24 14:49:51','2024-05-24 14:49:51','650782c3-b1a4-43d8-bf29-898f531ab91e'),(10890,10890,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:52','2024-05-24 14:49:52','7e931116-8d36-4498-a478-8a7c35e8016e'),(10891,10891,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:52','2024-05-24 14:49:52','52cfc06e-bbce-44f9-aef1-d57be0aa32b0'),(10892,10892,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:53','2024-05-24 14:49:53','9cea571e-d970-4bbb-9ea8-ab115ff113d3'),(10893,10893,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:53','2024-05-24 14:49:53','f5c25578-866d-4905-89f9-04bcb881f7c6'),(10894,10894,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:54','2024-05-24 14:49:54','b9f6ad59-d0f5-4409-b177-26f40474b025'),(10895,10895,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:54','2024-05-24 14:49:54','40ba8cfa-1d89-4bfc-8237-287519523326'),(10896,10896,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:56','2024-05-24 14:49:56','362bdbce-cbab-4a93-97da-d35a88ea488f'),(10897,10897,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:56','2024-05-24 14:49:56','1d6e977b-7bce-4f06-8dbb-4bf8aa73170b'),(10898,10898,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:57','2024-05-24 14:49:57','5c94ffcc-448c-46e2-a4d5-65e70256aabf'),(10899,10899,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:49:57','2024-05-24 14:49:57','4dfb6e34-809a-48a9-8da6-243d10ee4691'),(10900,10900,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:49:58','2024-05-24 14:49:58','7b88fb60-dcac-4aa9-b9c3-928c65b6e89b'),(10901,10901,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:49:58','2024-05-24 14:49:58','cc1fdc0e-6bdf-4e01-a3af-b8c70caeb3a4'),(10902,10902,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:03','2024-05-24 14:50:03','75bfd70a-907a-410b-b1e7-f5fdea57447f'),(10903,10903,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:03','2024-05-24 14:50:03','7cd36f17-a207-435a-8c2e-aa888e248fd4'),(10904,10904,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:04','2024-05-24 14:50:04','5dd64b2e-8917-42bf-91ac-325ee363981f'),(10905,10905,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:04','2024-05-24 14:50:04','d9f5494e-79e1-4da7-901c-42ae2668ce43'),(10906,10906,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:06','2024-05-24 14:50:06','58bf8b10-2a4e-47c3-a72f-1726e15ffe9b'),(10907,10907,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:06','2024-05-24 14:50:06','5c268ced-1825-448b-bca1-71f06f0647b8'),(10908,10908,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:07','2024-05-24 14:50:07','e17adc01-f9c1-46d1-85a4-b5e3796361df'),(10909,10909,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:07','2024-05-24 14:50:07','3d60353e-c3dc-4601-8467-870d5900e57a'),(10910,10910,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:08','2024-05-24 14:50:08','a282eb25-3623-4f99-b10b-916a002a121d'),(10911,10911,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:08','2024-05-24 14:50:08','4687f3cd-0acf-40b3-9101-c0c09ce88c88'),(10912,10912,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:10','2024-05-24 14:50:10','56b466c3-20a9-4db0-a976-8182b76439d7'),(10913,10913,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:10','2024-05-24 14:50:10','e63cfbd6-b64b-45db-acb8-db1264d2960c'),(10914,10914,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:11','2024-05-24 14:50:11','2a0012e1-8b14-440e-8700-64c42b617f36'),(10915,10915,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:11','2024-05-24 14:50:11','c1e2f46b-e600-455d-b5f7-d296328ef8d2'),(10916,10916,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:12','2024-05-24 14:50:12','21bbce3e-a51b-4525-b6eb-62a7e6a9ebd1'),(10917,10917,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:12','2024-05-24 14:50:12','9a8ae391-9a6f-47c8-b091-3b9a66d99184'),(10918,10918,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:14','2024-05-24 14:50:14','cf0041a2-3db8-42d4-85df-9f04ad34bfe5'),(10919,10919,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:14','2024-05-24 14:50:14','4a75f2ac-78b0-4233-be09-984c3570f8a3'),(10920,10920,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:14','2024-05-24 14:50:14','3aa84698-267c-4c79-9e40-b64b72e8703c'),(10921,10921,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:14','2024-05-24 14:50:14','d92cb311-a30c-4a1a-903f-74d021ace9bf'),(10922,10922,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:15','2024-05-24 14:50:15','da1f6bc8-14a5-4382-b365-de3d10a4ca10'),(10923,10923,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:15','2024-05-24 14:50:15','6fb11391-a721-4a8c-96a0-7a17a775c082'),(10924,10924,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:16','2024-05-24 14:50:16','99baf9a2-da5c-43f1-8edc-03651c3cc95a'),(10925,10925,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:16','2024-05-24 14:50:16','53326112-9083-4e83-980e-02dae896f4b1'),(10926,10926,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:17','2024-05-24 14:50:17','1d91705a-0ebf-41db-88b2-6d06625592a8'),(10927,10927,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:17','2024-05-24 14:50:17','556e1678-6b12-4a9a-a86a-1ad452c11711'),(10928,10928,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:18','2024-05-24 14:50:18','ec7de81e-474f-4fc1-bf22-2d09ff946e3e'),(10929,10929,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:19','2024-05-24 14:50:19','c7a37a38-d1a0-4a87-9ac4-38f23d271092'),(10930,10930,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:20','2024-05-24 14:50:20','5d242f56-0cd7-40ad-ac43-ff0627bc6eea'),(10931,10931,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:20','2024-05-24 14:50:20','2adf6426-e314-4562-af46-c3bda4190c93'),(10932,10932,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:21','2024-05-24 14:50:21','d152b13c-6b99-477c-9f28-a615b1b0ebe3'),(10933,10933,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:21','2024-05-24 14:50:21','3003bc79-70e2-4fd7-9d07-f2450ce1d1c3'),(10934,10934,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:22','2024-05-24 14:50:22','7d825a7a-6cdb-45c7-bcdf-2e18b7bf96ce'),(10935,10935,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:22','2024-05-24 14:50:22','d2639699-aa40-4dd4-8d52-8edc1ae45f06'),(10936,10936,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:23','2024-05-24 14:50:23','9688f62e-58a4-43aa-8b70-636f82f2facc'),(10937,10937,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinic\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:23','2024-05-24 14:50:23','d80adff9-62ca-4dd7-bcad-55364f9fbd49'),(10938,10938,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:24','2024-05-24 14:50:24','3e4333a2-9f03-4140-819b-c98ed3ed4e8a'),(10939,10939,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:24','2024-05-24 14:50:24','bc956524-0313-4a3e-970b-2b7d0c9bd927'),(10940,10940,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:24','2024-05-24 14:50:24','62f6be40-818c-4faf-a24f-03b7140397bc'),(10941,10941,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicans\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:24','2024-05-24 14:50:24','06ffbcf8-ba63-45bd-b1f6-bb219d0c8d3f'),(10942,10942,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:25','2024-05-24 14:50:25','1cd41fb0-80ed-4fcf-8aaf-fb323e3fe406'),(10943,10943,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:25','2024-05-24 14:50:25','1472ed70-6066-4104-b881-98bb345a43ad'),(10944,10944,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:25','2024-05-24 14:50:25','eee81450-caa9-48d4-add7-7333b85229c8'),(10945,10945,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicans, pui\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:25','2024-05-24 14:50:25','d871c81f-11c7-4011-b2cc-8b93d87d90ac'),(10946,10946,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:26','2024-05-24 14:50:26','2e10a9cc-02d8-4731-a65d-d771e8a0a553'),(10947,10947,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicans, pu\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:26','2024-05-24 14:50:26','346b3c6d-c258-421a-82df-eb747400fad9'),(10948,10948,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:27','2024-05-24 14:50:27','97e3daa8-25ca-4bc1-aae3-aa1c1c731eb9'),(10949,10949,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:27','2024-05-24 14:50:27','50af001c-d42a-4913-8dec-85f5638487e2'),(10950,10950,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:28','2024-05-24 14:50:28','cab5e5c3-a469-402e-b872-999908643298'),(10951,10951,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:50:28','2024-05-24 14:50:28','99f3eb13-2f09-49a5-b710-19b8a97f25e7'),(10952,10952,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:29','2024-05-24 14:50:29','2e2e936f-2f03-4cae-80cd-8d984977b33d'),(10953,10953,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:29','2024-05-24 14:50:29','fbcd990f-104e-4508-abf0-95242f66ee60'),(10954,10954,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:29','2024-05-24 14:50:29','c2dfd43a-0c51-4a4f-b2ce-cacbb3f24efe'),(10955,10955,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:29','2024-05-24 14:50:29','3cb8955b-6dd8-457a-bb0e-2a466da939ac'),(10956,10956,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicans, pu\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:29','2024-05-24 14:50:29','f267e9f6-8c5a-42f3-ad9f-512b53f370c2'),(10957,10957,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:30','2024-05-24 14:50:30','dfbb8824-4b0d-4145-92da-f4045626f512'),(10958,10958,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:50:30','2024-05-24 14:50:30','4ab9b2bb-de6f-48b4-8bdb-4ef7f73affa1'),(10959,10959,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:31','2024-05-24 14:50:31','4f28891c-b19f-4339-a00b-eb6fdd45853a'),(10960,10960,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:31','2024-05-24 14:50:31','006a85a9-61e6-4b28-83e1-e33bd6817ea5'),(10961,10961,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:31','2024-05-24 14:50:31','75083323-adde-4074-adb3-405d3104edff'),(10962,10962,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:31','2024-05-24 14:50:31','290a4872-a41d-4b14-b7ec-f6573393a57d'),(10963,10963,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:32','2024-05-24 14:50:32','8ceb1ed9-1a96-456c-819d-f159bf83ce05'),(10964,10964,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:32','2024-05-24 14:50:32','094caf2d-9c36-4e40-9884-b7343215afc4'),(10965,10965,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:33','2024-05-24 14:50:33','da763db7-3e34-4be6-85fd-9c5f153900fd'),(10966,10966,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:33','2024-05-24 14:50:33','bd6b5c3d-5cc1-4cc2-8275-d6eccbc041f3'),(10967,10967,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:34','2024-05-24 14:50:34','9f793889-fe77-455d-95c8-865b3571736e'),(10968,10968,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:34','2024-05-24 14:50:34','aeb37fe4-1d17-444a-83f5-c7db559e0a5f'),(10969,10969,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:35','2024-05-24 14:50:35','e0f978e8-acbb-41c6-8fb9-029cc25e0749'),(10970,10970,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:35','2024-05-24 14:50:35','12a8dbb0-fe5b-43ae-8a84-21e75a397560'),(10971,10971,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:35','2024-05-24 14:50:35','9247e227-478b-43df-84b4-5dfa90d4f816'),(10972,10972,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, pu\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:35','2024-05-24 14:50:35','1f115db1-d3b6-4964-a34c-8444cb572655'),(10973,10973,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:36','2024-05-24 14:50:36','3669e849-a1fd-4112-b372-89ada93430db'),(10974,10974,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:36','2024-05-24 14:50:36','79583608-ea93-4686-9bfe-4eb74e1b37ac'),(10975,10975,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:38','2024-05-24 14:50:38','eb79a24e-0dc2-4653-a2a7-b9b82a15e1ab'),(10976,10976,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:38','2024-05-24 14:50:38','1fe435c1-a387-468d-9bed-4dea0ce8731e'),(10977,10977,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:38','2024-05-24 14:50:38','046a309e-1472-464d-acea-5cfc958b1348'),(10978,10978,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:38','2024-05-24 14:50:38','8afe69fe-b35c-4ade-ba4f-1cf4bdc6347f'),(10979,10979,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:39','2024-05-24 14:50:39','344e873c-26a6-4caa-9850-d4bc30457979'),(10980,10980,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:39','2024-05-24 14:50:39','f93ee2a9-572c-4753-9f8b-f4aa9cc5dcf3'),(10981,10981,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:39','2024-05-24 14:50:39','053a1b72-4b04-4f3b-a30f-2d7166003d1a'),(10982,10982,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public heal\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:39','2024-05-24 14:50:39','4b31c14e-9076-4e4e-8488-205ea083ff71'),(10983,10983,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:40','2024-05-24 14:50:40','34714fef-c6b8-4714-9efb-ab24bc68baaa'),(10984,10984,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:40','2024-05-24 14:50:40','892a0a75-f9ee-4c83-93f9-557dffac907c'),(10985,10985,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:40','2024-05-24 14:50:40','3bce5998-feb3-449f-ad01-ae55a8562fc5'),(10986,10986,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:40','2024-05-24 14:50:40','5b87b810-5dec-48f3-9f99-d23ee79906c7'),(10987,10987,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:40','2024-05-24 14:50:40','e1425afd-f2b7-4224-8645-e832c4e47d9e'),(10988,10988,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:50:40','2024-05-24 14:50:40','3039e75a-9a22-4457-a95f-4c1fa30aa117'),(10989,10989,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:40','2024-05-24 14:50:40','92ab1c46-930e-4ec3-b156-337c03284b42'),(10990,10990,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about Environ\"}',1,'2024-05-24 14:50:40','2024-05-24 14:50:40','a7131de0-7a29-44bd-b38d-c439e164e02f'),(10991,10991,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:41','2024-05-24 14:50:41','06f71a08-e079-414a-8062-2bb340ca9e9e'),(10992,10992,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:50:41','2024-05-24 14:50:41','55393909-5fa8-4de4-9be0-a524cde274c1'),(10993,10993,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:42','2024-05-24 14:50:42','588f9b40-711b-406a-8d1f-f1e8f102be8a'),(10994,10994,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about Environmen\"}',1,'2024-05-24 14:50:42','2024-05-24 14:50:42','e4b4c62c-4545-499e-b2c5-9f0ddca7660d'),(10995,10995,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:42','2024-05-24 14:50:42','ff45775b-cc7a-41f5-9f3b-6332c99b6eb6'),(10996,10996,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:42','2024-05-24 14:50:42','cad1c179-e0ac-45fb-b16e-425ea5bcb494'),(10997,10997,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:42','2024-05-24 14:50:42','c866d9da-f906-436e-ac86-862ce4dea67d'),(10998,10998,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professional\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:42','2024-05-24 14:50:42','d818186f-140a-440e-810b-10536870d3b1'),(10999,10999,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:43','2024-05-24 14:50:43','73de9db6-554b-46c4-92c4-1b422327137a'),(11000,11000,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:50:43','2024-05-24 14:50:43','475c607c-47a3-49f1-8d51-27f1bc5e01cf'),(11001,11001,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:43','2024-05-24 14:50:43','e0838e5b-1fce-4285-8054-2d8fd2102f04'),(11002,11002,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environ\"}',1,'2024-05-24 14:50:43','2024-05-24 14:50:43','2b3b8d22-5409-4c94-9028-5f3683dce502'),(11003,11003,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:44','2024-05-24 14:50:44','3983fa41-c2fe-4cfb-ace8-4b2e2c44dfd9'),(11004,11004,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:44','2024-05-24 14:50:44','b42d0cc9-4ef9-452c-b677-8e9aa63d2dd5'),(11005,11005,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:45','2024-05-24 14:50:45','88641834-2ea0-4419-ac8a-f689aa500bae'),(11006,11006,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:50:45','2024-05-24 14:50:45','b9497551-bb31-40c0-a1b8-4193512fefe3'),(11007,11007,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:46','2024-05-24 14:50:46','57feeba8-5e52-4f27-99ec-a641129b1a7f'),(11008,11008,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\"}',1,'2024-05-24 14:50:46','2024-05-24 14:50:46','a360aee8-578d-486d-9b61-4fe6fc747435'),(11009,11009,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:46','2024-05-24 14:50:46','5c1d84a5-b05a-4dac-94cb-ef1ef555a839'),(11010,11010,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:46','2024-05-24 14:50:46','a6744efb-9a68-4a81-bfe0-dfd4002c4360'),(11011,11011,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:47','2024-05-24 14:50:47','f0635a19-a310-41d8-9519-66dbb946341f'),(11012,11012,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:50:47','2024-05-24 14:50:47','7791f3e0-6550-4a8e-aa0e-065bdea499a1'),(11013,11013,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:48','2024-05-24 14:50:48','2be11d21-5093-4e72-8262-61e076e51e69'),(11014,11014,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:48','2024-05-24 14:50:48','8016d098-e2d1-4993-bda9-ad9ed68e5755'),(11015,11015,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:49','2024-05-24 14:50:49','c04703e2-7396-4491-a5cf-cdc4a445b713'),(11016,11016,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:49','2024-05-24 14:50:49','a991483f-a8f8-4003-bfd5-cb5afbea0ae4'),(11017,11017,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:50','2024-05-24 14:50:50','eda2f4e9-a104-4008-b272-5c50fd3a008c'),(11018,11018,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:50','2024-05-24 14:50:50','7a7d31b2-6c4e-42a0-99bf-964d56f5fa2d'),(11019,11019,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:51','2024-05-24 14:50:51','9feffe8d-9424-4fbb-bb95-6c27e9af01f5'),(11020,11020,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:51','2024-05-24 14:50:51','792c0b0a-b311-4739-8e45-1bf7d1e2f69f'),(11021,11021,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:52','2024-05-24 14:50:52','3551b8f6-3809-4f6d-a208-064e9fcd97d3'),(11022,11022,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:52','2024-05-24 14:50:52','116cca5e-c177-4df1-9658-6415e9c78b28'),(11023,11023,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:53','2024-05-24 14:50:53','e388c822-eb6e-432e-b375-fbff574958cb'),(11024,11024,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:53','2024-05-24 14:50:53','1c012257-f983-42dd-962b-2347bc372076'),(11025,11025,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:54','2024-05-24 14:50:54','b36cae7f-bed7-4179-9bd4-273eda3fec8a'),(11026,11026,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:54','2024-05-24 14:50:54','49733f12-57df-48ff-af72-96ae98575b47'),(11027,11027,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:55','2024-05-24 14:50:55','5cf35507-181a-4002-8acf-94b113f8b04f'),(11028,11028,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:55','2024-05-24 14:50:55','b8b60108-a73f-44a5-a0a5-c595928d6307'),(11029,11029,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:56','2024-05-24 14:50:56','cb5d8602-ed43-4e21-b915-386be204e9a0'),(11030,11030,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:56','2024-05-24 14:50:56','e6977929-9256-40d1-9802-0765b78c792d'),(11031,11031,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:57','2024-05-24 14:50:57','efd0cf0e-d921-4f76-876e-38fedfc7ae0c'),(11032,11032,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:57','2024-05-24 14:50:57','506bc942-fd2b-4fcb-aff0-a664ecbfeb5b'),(11033,11033,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:58','2024-05-24 14:50:58','f9c6efeb-a867-4230-9c39-26f345b584aa'),(11034,11034,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:50:58','2024-05-24 14:50:58','eac2d0bc-bd5f-4d5d-a822-fad52964b499'),(11035,11035,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:58','2024-05-24 14:50:58','6f9f5264-a54b-47c0-97b2-879380aec06c'),(11036,11036,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae. At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</p>\"}',1,'2024-05-24 14:50:58','2024-05-24 14:50:58','7b152794-3239-43bd-a940-137fd0097f5d'),(11037,11037,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:50:59','2024-05-24 14:50:59','bd0b9e94-44bb-41fe-bb42-777f68e49c0b'),(11038,11038,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:50:59','2024-05-24 14:50:59','c77a927c-f48f-46b8-90ca-df968ff24447'),(11039,11039,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:00','2024-05-24 14:51:00','9c933090-be0a-4820-b2b5-27cc98050633'),(11040,11040,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:00','2024-05-24 14:51:00','aa90b86b-7433-46a6-8599-cf5534c0c2db'),(11041,11041,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:01','2024-05-24 14:51:01','780cd904-91f6-49f3-b978-e281c05e4ef9'),(11042,11042,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:01','2024-05-24 14:51:01','18eda19f-5b71-46b8-ae11-9c2ecb8e8ce5'),(11043,11043,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:02','2024-05-24 14:51:02','cab054ff-cb29-4d90-a6d3-84c263394704'),(11044,11044,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:51:02','2024-05-24 14:51:02','593f250f-f132-4855-8fcf-38b89e5e4ee0'),(11045,11045,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:02','2024-05-24 14:51:02','d09e8ba1-4505-43ef-bf53-21e5c4a852b1'),(11046,11046,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><p>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae. At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</p>\"}',1,'2024-05-24 14:51:02','2024-05-24 14:51:02','ce92b2a9-a192-4b85-8853-8067f50c3b72'),(11047,11047,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:03','2024-05-24 14:51:03','15b410aa-f914-4bc6-a81a-2a9ce685bfcf'),(11048,11048,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:03','2024-05-24 14:51:03','2c12783c-4652-4483-8723-98db917f6240'),(11049,11049,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:03','2024-05-24 14:51:03','173237e8-0793-402f-aeb4-b3f7133ab967'),(11050,11050,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:51:03','2024-05-24 14:51:03','9652fdc5-cedd-42f8-b6fc-8308323d3512'),(11051,11051,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:03','2024-05-24 14:51:03','cf8fb6cf-0d71-4484-a35c-482a379484b8'),(11052,11052,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:51:03','2024-05-24 14:51:03','a3164ebf-8b00-4d2e-a1cb-699e1c0dda49'),(11053,11053,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:04','2024-05-24 14:51:04','4c807af7-5cf1-4fe9-af1a-3dd39f9d2d5c'),(11054,11054,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:51:04','2024-05-24 14:51:04','f45202ec-7d55-4f2f-87db-10e3e7b4c77d'),(11055,11055,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:04','2024-05-24 14:51:04','7dd9d72e-2be2-475e-9e14-f69f09f4b641'),(11056,11056,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae. At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:51:04','2024-05-24 14:51:04','23ca48c1-a294-403e-ad36-48f32dbb9b41'),(11057,11057,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:05','2024-05-24 14:51:05','b24676aa-4d47-4ff5-8601-4be57bebb888'),(11058,11058,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:05','2024-05-24 14:51:05','718bf93a-63b9-4435-b5a5-3b82b73d9d85'),(11059,11059,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:06','2024-05-24 14:51:06','483c07fd-4a47-4268-a6b4-e72520946627'),(11060,11060,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:51:06','2024-05-24 14:51:06','18abe9ba-15f4-4dea-93d6-742b89cc6e19'),(11061,11061,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:06','2024-05-24 14:51:06','4b54b21b-18bc-49ff-bfe4-d08be0e18f06'),(11062,11062,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:51:06','2024-05-24 14:51:06','73472d78-73ae-4191-b2d2-fca3b853d577'),(11063,11063,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:07','2024-05-24 14:51:07','c8a46770-0004-4c70-b4f9-8f4b7c1a5c6f'),(11064,11064,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:07','2024-05-24 14:51:07','80693124-b5bc-4979-859b-a8e0ea7d4031'),(11065,11065,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:09','2024-05-24 14:51:09','4913ba61-c5c0-4e3a-8538-003f38b6b535'),(11066,11066,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:09','2024-05-24 14:51:09','5575933f-b270-4fa3-b110-cd647ee32813'),(11067,11067,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:10','2024-05-24 14:51:10','58cd31d5-f081-4a50-80d8-17be9ae9b6d2'),(11068,11068,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:10','2024-05-24 14:51:10','a226a3df-c664-4c14-80f7-142d5c6b19cb'),(11069,11069,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:11','2024-05-24 14:51:11','7e7a24c6-521f-4393-acd9-7efbbbb417fc'),(11070,11070,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:11','2024-05-24 14:51:11','73069c47-4100-4886-a3a5-ab079aa672dd'),(11071,11071,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:11','2024-05-24 14:51:11','34939daa-7eea-4a7a-aa0e-98764826252e'),(11072,11072,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:51:11','2024-05-24 14:51:11','9af1717f-4511-449a-9a4a-419acbeb17ef'),(11073,11073,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:12','2024-05-24 14:51:12','7037dc8c-0a27-4d2b-bf93-d235c31dbf9b'),(11074,11074,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li> At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:51:12','2024-05-24 14:51:12','39a89e2d-54bc-4570-bb2c-79e3c02187da'),(11075,11075,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:13','2024-05-24 14:51:13','4707af2d-f50a-4759-9f6b-1fd2afdc5a5f'),(11076,11076,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:13','2024-05-24 14:51:13','a759e07f-3a74-4b9a-8a7a-852c639f62b1'),(11077,11077,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:13','2024-05-24 14:51:13','9903aaa9-55e0-4126-b15c-265d5acc3fb6'),(11078,11078,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:51:13','2024-05-24 14:51:13','a25c0c00-3a18-41a7-abc7-cfeb538e7bd8'),(11079,11079,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:13','2024-05-24 14:51:13','f4b173b5-536f-4067-9afc-8ee6686a5dae'),(11080,11080,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:51:13','2024-05-24 14:51:13','79b61627-4b63-4ba6-a1ae-076fc73385f3'),(11081,11081,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:13','2024-05-24 14:51:13','23dee3eb-76a3-49a1-ab5e-4d56fd9efef1'),(11082,11082,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:51:13','2024-05-24 14:51:13','fcfe1041-b918-4130-9884-d61662284dde'),(11083,11083,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:13','2024-05-24 14:51:13','35e304d9-8918-450e-988f-421b42d4353b'),(11084,11084,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\"}',1,'2024-05-24 14:51:13','2024-05-24 14:51:13','bc088460-eef3-48ad-ba5a-23ebdee67ef4'),(11085,11085,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:15','2024-05-24 14:51:15','614526ca-61f1-4c40-91a0-c478ac274844'),(11086,11086,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:15','2024-05-24 14:51:15','d3a74f32-2d57-45d2-98b0-af1473addbe4'),(11087,11087,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:16','2024-05-24 14:51:16','b8d15ef9-b875-43fc-a86e-181e3fe728fc'),(11088,11088,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:16','2024-05-24 14:51:16','e9264872-7f66-4510-8ba8-8248fb028e91'),(11089,11089,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:17','2024-05-24 14:51:17','2765aeec-7ecb-4b4e-a2a9-e06b6cb6805a'),(11090,11090,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:17','2024-05-24 14:51:17','4b2c97db-9ea8-442f-a255-de04ce0ce8bb'),(11091,11091,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:18','2024-05-24 14:51:18','2059e6bb-5312-4bc3-99bc-9eb1ca5d4feb'),(11092,11092,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:18','2024-05-24 14:51:18','ebe4a6bc-9340-420b-99c1-268dad30dbbe'),(11093,11093,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:18','2024-05-24 14:51:18','17e8b00a-3af9-4357-8a48-2691bb7d48bc'),(11094,11094,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:19','2024-05-24 14:51:19','b9807e10-62a8-4c2b-8b7a-5248eb796627'),(11095,11095,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:20','2024-05-24 14:51:20','4233fcb7-210a-4009-a00e-1a344d740941'),(11096,11096,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:20','2024-05-24 14:51:20','92aa1488-5d02-4297-afe0-2f25d7be6ac9'),(11097,11097,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:21','2024-05-24 14:51:21','15dba7fb-741f-4db4-920c-37c9522ebb16'),(11098,11098,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:21','2024-05-24 14:51:21','9306f836-2e23-44ad-9bdc-c4ee96a0187d'),(11099,11099,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:22','2024-05-24 14:51:22','e825ddfe-b81c-41cc-871c-39bc109718f3'),(11100,11100,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:22','2024-05-24 14:51:22','89447cd3-32f7-4013-b4a4-c991c48942de'),(11101,11101,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:23','2024-05-24 14:51:23','d585cccd-0814-4408-97c9-ff9b0c524a96'),(11102,11102,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:23','2024-05-24 14:51:23','91f52b23-b49c-4000-ae10-f41a58ef2d70'),(11103,11103,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:24','2024-05-24 14:51:24','3cb6902b-6c6a-4de4-9608-4c050805d6ba'),(11104,11104,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:24','2024-05-24 14:51:24','7303bc90-2a01-4126-9a29-1f380154e679'),(11105,11105,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:24','2024-05-24 14:51:24','f7648625-c92f-4a2c-b977-7e5e9f2751c7'),(11106,11106,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:51:24','2024-05-24 14:51:24','7bdac96b-65c8-4c7e-8d1d-ae46c1e0db36'),(11107,11107,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:24','2024-05-24 14:51:24','3cb41c0a-d237-4b91-8de8-413d85b2cbbe'),(11108,11108,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:51:24','2024-05-24 14:51:24','f158a34b-6205-4d35-ab62-fe8e37f4bb08'),(11109,11109,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:26','2024-05-24 14:51:26','05268928-3e68-4534-9735-a5fc91f6fdec'),(11110,11110,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:26','2024-05-24 14:51:26','02f7edef-bf5b-488e-b313-759f2c7d425c'),(11111,11111,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:26','2024-05-24 14:51:26','50e67561-4c21-435f-b5a6-cbf03e509393'),(11112,11112,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:51:26','2024-05-24 14:51:26','7f548313-7119-4f01-b48d-ef0ff4a1dd83'),(11113,11113,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:26','2024-05-24 14:51:26','d0d56f8b-d5a0-46e7-b519-6698d2753315'),(11114,11114,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\"}',1,'2024-05-24 14:51:26','2024-05-24 14:51:26','58b7a60d-90ac-4f3d-9778-50747c564c58'),(11115,11115,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:27','2024-05-24 14:51:27','a19a8e69-d4bb-477f-bd86-77bcc2f16f2e'),(11116,11116,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:27','2024-05-24 14:51:27','27053c3d-19a8-49fe-9ce9-9ca16e059c6c'),(11117,11117,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:28','2024-05-24 14:51:28','177ca6fe-5b51-4cc7-b7c8-3f4b04185f8d'),(11118,11118,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:51:28','2024-05-24 14:51:28','80480a9b-a164-4aee-8c68-261bbf30a367'),(11119,11119,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:28','2024-05-24 14:51:28','91c25354-b3cf-41d6-b075-10ced164b3b7'),(11120,11120,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\"}',1,'2024-05-24 14:51:28','2024-05-24 14:51:28','dd47efa2-e130-470f-9aff-ed68859c2ddb'),(11121,11121,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:29','2024-05-24 14:51:29','f4b3e15f-4399-4e06-a79e-e4fbe845103c'),(11122,11122,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:29','2024-05-24 14:51:29','b709cc76-db85-41bc-b693-eee3f418291f'),(11123,11123,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:30','2024-05-24 14:51:30','27a36a50-9db8-45db-8734-77032627ce47'),(11124,11124,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:30','2024-05-24 14:51:30','ecc9ca13-319b-473a-9f91-3c3b60d0ca35'),(11125,11125,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:31','2024-05-24 14:51:31','88bd9842-151a-4af8-b8cf-d605e1a1b6c8'),(11126,11126,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:51:31','2024-05-24 14:51:31','a5a4f0c4-13bb-4671-85f1-d9cf6b8f7374'),(11127,11127,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:31','2024-05-24 14:51:31','e67c5791-3ad6-4fe8-9849-46ef39ede709'),(11128,11128,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:51:31','2024-05-24 14:51:31','0b3722bb-a654-4b6e-b2f9-d9cb13823c55'),(11129,11129,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:33','2024-05-24 14:51:33','d4415fd9-7239-4afb-bea1-7044dff8a2db'),(11130,11130,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:33','2024-05-24 14:51:33','77aa56ae-1732-4120-9d8d-7057016a5bd2'),(11131,11131,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:34','2024-05-24 14:51:34','e371fb47-583f-4655-957f-3d4a0ab87ec1'),(11132,11132,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:34','2024-05-24 14:51:34','13cc0ded-3c94-444f-9903-a8e6db286dbf'),(11133,11133,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:35','2024-05-24 14:51:35','89bc1442-9b46-485f-af70-6f9aab731cff'),(11134,11134,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:35','2024-05-24 14:51:35','a1192e9a-c0c5-4cae-9b4a-3560d44172bd'),(11135,11135,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:36','2024-05-24 14:51:36','36deb830-a9a7-4f0e-b59e-42388c2a616b'),(11136,11136,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:36','2024-05-24 14:51:36','5c06d720-85cd-45d1-99ee-a8885f748ada'),(11137,11137,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:37','2024-05-24 14:51:37','66d95d6f-067c-4326-81ef-37cc1b2829d5'),(11138,11138,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:37','2024-05-24 14:51:37','752aa174-718d-495a-ad7e-7e0692bc8c3f'),(11139,11139,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:38','2024-05-24 14:51:38','2a26ccd2-cb70-4663-8a5e-8194fb3c4e83'),(11140,11140,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:38','2024-05-24 14:51:38','a1ec89d4-be9a-41b1-86ad-585052a4de2f'),(11141,11141,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:39','2024-05-24 14:51:39','74cf2c9b-7ee4-418d-be3d-9846ec6b42e2'),(11142,11142,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:39','2024-05-24 14:51:39','0b59789c-50e1-44e1-bdfb-053f593961c1'),(11143,11143,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:40','2024-05-24 14:51:40','8607081a-bd05-409a-8c47-e76ccf96c4f7'),(11144,11144,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:40','2024-05-24 14:51:40','e38bc9af-9c20-4077-82d4-5f2d21b4b87f'),(11145,11145,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:40','2024-05-24 14:51:40','0fc21738-830d-4808-84b0-f6610832c29d'),(11146,11146,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:51:40','2024-05-24 14:51:40','840ec70a-c9e5-437f-8f08-d6fe35818690'),(11147,11147,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:40','2024-05-24 14:51:40','90b2d25f-b03c-4def-afc4-78d049b87d04'),(11148,11148,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:51:40','2024-05-24 14:51:40','6c4f1600-5d41-491f-82e3-54f50003ebf5'),(11149,11149,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:41','2024-05-24 14:51:41','45e55f28-7c44-48b9-b079-b310a5b06a58'),(11150,11150,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:41','2024-05-24 14:51:41','63274ec0-b4eb-4705-b50a-ddccee2bfb53'),(11151,11151,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:42','2024-05-24 14:51:42','b28dbc7d-c9b4-442e-aa29-ef3d87536d8d'),(11152,11152,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:42','2024-05-24 14:51:42','d203ad20-3537-411c-85ce-9c73ecd3802d'),(11153,11153,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:43','2024-05-24 14:51:43','8ed044fe-86fa-4174-bb58-ed1d60fb0390'),(11154,11154,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:43','2024-05-24 14:51:43','6706e2a4-293d-4892-8461-7fc0ed1ebbf7'),(11155,11155,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:44','2024-05-24 14:51:44','f1c11e87-ed55-4a28-a2ba-576700044299'),(11156,11156,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:44','2024-05-24 14:51:44','c355d325-9335-48f2-86b3-944d11aca528'),(11157,11157,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:45','2024-05-24 14:51:45','5e11ca51-8bdf-40c7-aa0d-ce1840348f4d'),(11158,11158,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:45','2024-05-24 14:51:45','54c9b41e-4286-4a6a-8666-1f9a63398d8c'),(11159,11159,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:46','2024-05-24 14:51:46','dfeba81f-2f1a-471d-97f4-3ff141d75aa2'),(11160,11160,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:46','2024-05-24 14:51:46','d4d9f4fc-7457-427c-a8b6-ea1086421b10'),(11161,11161,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:47','2024-05-24 14:51:47','aee274b9-a3c0-416c-a105-b1d80aa3b00f'),(11162,11162,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:47','2024-05-24 14:51:47','2d828e28-89ad-4555-8be4-d598af53f5bc'),(11163,11163,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:48','2024-05-24 14:51:48','0916f8bd-a493-4154-907e-339640e48a81'),(11164,11164,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:48','2024-05-24 14:51:48','1877bb59-6e24-49b8-bddb-459f97f70324'),(11165,11165,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:48','2024-05-24 14:51:48','a8f08d16-af64-4778-9d4c-c13e9bb2fc80'),(11166,11166,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:51:48','2024-05-24 14:51:48','095e7c83-ac7e-48af-a9cf-112a8627f9af'),(11167,11167,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:48','2024-05-24 14:51:48','4d43945c-3b03-4840-b1b1-a0c7d6be4a9e'),(11168,11168,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"p\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:51:48','2024-05-24 14:51:48','782d3514-5185-421e-a0a5-af800595d666'),(11169,11169,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:49','2024-05-24 14:51:49','34e7389e-9bc4-4d6d-8ffd-0d91e5916625'),(11170,11170,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:49','2024-05-24 14:51:49','9f700bcc-9513-4a84-aa3d-312850ffb2d1'),(11171,11171,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:49','2024-05-24 14:51:49','3654b44f-2eec-4f77-a5da-4fdca38813cc'),(11172,11172,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:51:49','2024-05-24 14:51:49','f79626b0-cd4f-4133-8687-0de02a8c4ed7'),(11173,11173,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:49','2024-05-24 14:51:49','5b1cf503-5e57-4791-bdb9-501af0dc0402'),(11174,11174,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public h\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:51:49','2024-05-24 14:51:49','0d03ade1-184a-43e5-85c5-0ff5dcb84b81'),(11175,11175,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:50','2024-05-24 14:51:50','5d8cda01-4913-4d98-aa64-6fad544a7fb8'),(11176,11176,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:50','2024-05-24 14:51:50','dce1b2fc-0586-4d39-873f-9eaeb24b86d5'),(11177,11177,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:50','2024-05-24 14:51:50','a2f297c8-b2fc-41f1-a89a-6e0022353701'),(11178,11178,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:51:50','2024-05-24 14:51:50','a182f17e-b536-4220-88ac-244b4c74a0f6'),(11179,11179,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:50','2024-05-24 14:51:50','1a98fc16-589e-4c2c-b9d1-1258b4cc7340'),(11180,11180,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health p\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:51:50','2024-05-24 14:51:50','0436e9a1-548b-4f11-ba0a-1fcbf5c726ba'),(11181,11181,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:51','2024-05-24 14:51:51','4f88cfd3-0f40-4e77-8a44-201f3b860317'),(11182,11182,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:51','2024-05-24 14:51:51','14eed359-a69b-49ea-abf2-f86cda65bb30'),(11183,11183,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:51','2024-05-24 14:51:51','950b38b0-452f-40a4-9f6d-1a2c78b839e8'),(11184,11184,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:51:51','2024-05-24 14:51:51','c9807e23-3095-43af-8dd0-942890eb9253'),(11185,11185,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:51','2024-05-24 14:51:51','8abb3312-2411-45b3-a094-74cf56323998'),(11186,11186,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health profess\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:51:51','2024-05-24 14:51:51','20a4a1d3-5e55-42de-91b3-17fc6c27442d'),(11187,11187,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:52','2024-05-24 14:51:52','c14612e3-3de7-4849-9988-bc2157fb5f89'),(11188,11188,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:52','2024-05-24 14:51:52','8a6162c1-8e94-40de-8f8e-0a75a7093933'),(11189,11189,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:52','2024-05-24 14:51:52','e709d591-e052-41b3-85ef-257a2114dbeb'),(11190,11190,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:51:53','2024-05-24 14:51:53','54dc9b30-e6a9-45be-b63a-da535746bb4d'),(11191,11191,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:53','2024-05-24 14:51:53','09d652b9-a06b-494c-a945-e80ea8646e5f'),(11192,11192,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:51:53','2024-05-24 14:51:53','0caf95bb-58eb-4d67-8551-6f171cf491f8'),(11193,11193,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:54','2024-05-24 14:51:54','3b950303-d9e1-448d-b834-c4312b9a817c'),(11194,11194,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:54','2024-05-24 14:51:54','584ef3ef-9e6e-4fbf-b441-c1efe3511e09'),(11195,11195,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:55','2024-05-24 14:51:55','c8993662-a682-46f5-99e1-0743f20dd8a6'),(11196,11196,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:55','2024-05-24 14:51:55','a9ab5901-e84c-42ca-a201-891338e6ae4f'),(11197,11197,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:56','2024-05-24 14:51:56','6be4b9b4-b7b7-4a2d-ad6c-207ce929abcd'),(11198,11198,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:56','2024-05-24 14:51:56','85b467a1-16cf-454a-864c-31328175788c'),(11199,11199,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:57','2024-05-24 14:51:57','229c1d99-70b3-4997-8413-84605aef6ec7'),(11200,11200,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:57','2024-05-24 14:51:57','62c63232-b74b-4e36-88e5-ffaaa16c9968'),(11201,11201,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:58','2024-05-24 14:51:58','5e73245d-62b0-43c7-89e7-9ab650011729'),(11202,11202,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:58','2024-05-24 14:51:58','89089ad6-7783-49f9-b5f0-e6207b6434e8'),(11203,11203,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:51:59','2024-05-24 14:51:59','e9cb0ea0-8815-43b0-9cbc-ca80fc1a1155'),(11204,11204,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:51:59','2024-05-24 14:51:59','64e8c94b-e67a-4d70-bc6d-e4d313d6c72f'),(11205,11205,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:00','2024-05-24 14:52:00','d5e90b7a-b9ae-4375-97ab-40c7edf016ff'),(11206,11206,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:00','2024-05-24 14:52:00','e46cecac-9644-4883-90da-d7ab5603acb1'),(11207,11207,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:00','2024-05-24 14:52:00','18aeccf6-26b6-46de-8861-f1b59cff6277'),(11208,11208,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:00','2024-05-24 14:52:00','fa00240a-f334-4ed6-a319-28c7c30df21a'),(11209,11209,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:02','2024-05-24 14:52:02','445c08ee-3ac2-4482-b847-0a6f57dfdc67'),(11210,11210,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:02','2024-05-24 14:52:02','1a2b796d-a6b5-48cc-8fc4-f088ede5a994'),(11211,11211,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:02','2024-05-24 14:52:02','855b0046-9128-4554-9671-7b5db8f88226'),(11212,11212,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:02','2024-05-24 14:52:02','19f3f574-a1de-480e-8769-b954e017a99c'),(11213,11213,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:02','2024-05-24 14:52:02','39c2fd62-5f0d-4043-ba85-52cbd62a99e5'),(11214,11214,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:02','2024-05-24 14:52:02','874b079b-b826-4f66-b3a3-bd95a95ba83a'),(11215,11215,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:03','2024-05-24 14:52:03','9447da3a-506d-405e-8df7-61d1c1477eb6'),(11216,11216,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:03','2024-05-24 14:52:03','514733f1-0760-42f4-a6df-5be7b2c6cde2'),(11217,11217,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:03','2024-05-24 14:52:03','c4c80d66-5566-40df-ad66-a88c1df721d6'),(11218,11218,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:03','2024-05-24 14:52:03','cbe98709-ddda-4b18-819d-b2c6a8f3e929'),(11219,11219,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:03','2024-05-24 14:52:03','56ddbe4e-4f12-4e12-b4ad-5b4be1b9d949'),(11220,11220,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:52:03','2024-05-24 14:52:03','e4d5bb0b-a118-4aee-8dee-304a2eb83649'),(11221,11221,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:04','2024-05-24 14:52:04','9d4e7a6e-0bf4-4517-a285-e7fda39ada95'),(11222,11222,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:04','2024-05-24 14:52:04','44b66439-05f3-479a-b6bb-da5cf7519724'),(11223,11223,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:05','2024-05-24 14:52:05','ea7091c1-ddb4-4cd6-b23d-3616ed4f168b'),(11224,11224,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:05','2024-05-24 14:52:05','1fada025-3b76-4dcb-8fd5-a000b4aab09c'),(11225,11225,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:05','2024-05-24 14:52:05','bf24054a-b752-4e79-86a0-5caa5a53a5c1'),(11226,11226,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:05','2024-05-24 14:52:05','7622976e-aec3-4122-b0f5-e4505d5eee82'),(11227,11227,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:05','2024-05-24 14:52:05','b8a86e5b-c392-4a2d-9e1f-91bb7ac70690'),(11228,11228,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:52:05','2024-05-24 14:52:05','c8877206-effd-462c-8a86-abe33c5baa82'),(11229,11229,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:06','2024-05-24 14:52:06','417d43ea-06cd-4c85-9387-fed9631e0758'),(11230,11230,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:06','2024-05-24 14:52:06','61d063d6-fb53-4479-ab95-5d60a936966b'),(11231,11231,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:07','2024-05-24 14:52:07','ef9152bb-52c9-4bb9-bcba-d549664dc11b'),(11232,11232,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:07','2024-05-24 14:52:07','886e7e6d-678c-49ab-bdd2-b49388ade9de'),(11233,11233,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:08','2024-05-24 14:52:08','770f9e3e-b763-4203-9b3f-2c04064e508a'),(11234,11234,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:08','2024-05-24 14:52:08','2187ce18-bfa7-4acb-9d03-883015c74b30'),(11235,11235,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:09','2024-05-24 14:52:09','b76bec53-75db-4359-8f89-996eac2c26d2'),(11236,11236,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:09','2024-05-24 14:52:09','8743fb38-9780-4ab2-a41e-8d3854c0d7f2'),(11237,11237,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:11','2024-05-24 14:52:11','d7512541-67f1-46b2-93f1-1c3547665f17'),(11238,11238,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:11','2024-05-24 14:52:11','a2a060b6-0407-461b-ad34-f6a823d5aacd'),(11239,11239,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:11','2024-05-24 14:52:11','56414f42-55d6-428b-bb6b-426037baab4e'),(11240,11240,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:52:11','2024-05-24 14:52:11','b79f12cf-c1b8-4939-bdfc-880426304914'),(11241,11241,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:12','2024-05-24 14:52:12','308fb3b0-1036-4061-b2aa-7ad3dca920c2'),(11242,11242,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:12','2024-05-24 14:52:12','8e203864-d7c6-4afb-910a-6ee07e9d8f82'),(11243,11243,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:12','2024-05-24 14:52:12','75d5a3c5-5c75-4950-a819-65f5c75e4b39'),(11244,11244,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:12','2024-05-24 14:52:12','ed873666-dde2-4142-b833-0dd201aa267d'),(11245,11245,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:12','2024-05-24 14:52:12','d5b8a733-5b39-410f-a028-058ccf7be125'),(11246,11246,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:12','2024-05-24 14:52:12','18483cde-78ed-4c4e-9795-6e6790231f06'),(11247,11247,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:14','2024-05-24 14:52:14','4358b416-ef05-4654-b1d5-c99a53ace3ec'),(11248,11248,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:14','2024-05-24 14:52:14','ec6064a0-de4a-4fc1-be70-d839d8461cc6'),(11249,11249,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:14','2024-05-24 14:52:14','bf32bf1e-4037-4b35-8cff-8dac5e6bfcaf'),(11250,11250,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false}',1,'2024-05-24 14:52:14','2024-05-24 14:52:14','7db761e0-59fd-421a-9651-a01001ce83f5'),(11251,11251,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:14','2024-05-24 14:52:14','a110a517-4b91-4d83-a8f8-cafd5de10f48'),(11252,11252,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:14','2024-05-24 14:52:14','7ece3706-e675-49fb-b7e4-f3d8fb52bc33'),(11253,11253,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:14','2024-05-24 14:52:14','ecf7c27c-b768-4dac-810f-333bb949016a'),(11254,11254,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\"}',1,'2024-05-24 14:52:14','2024-05-24 14:52:14','f3cf2e5c-afaf-43c2-8bd9-a14f3defe148'),(11255,11255,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:15','2024-05-24 14:52:15','48e66f09-4e1e-4e19-b973-487dafa1b5b3'),(11256,11256,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:15','2024-05-24 14:52:15','e39bfd75-e5ef-4ef6-8c21-72c7bf1b9695'),(11257,11257,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:16','2024-05-24 14:52:16','8b0d768f-0936-425c-bcef-c7145ea6bc4f'),(11258,11258,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:16','2024-05-24 14:52:16','5b198b46-ae3a-4ab0-9fbd-d6cb01e89345'),(11259,11259,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:16','2024-05-24 14:52:16','ca7a661a-d2bd-4972-ad65-022241ce9789'),(11260,11260,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:16','2024-05-24 14:52:16','8e5ee4fd-5f7c-4011-aeab-7150e5438028'),(11261,11261,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:18','2024-05-24 14:52:18','b7884310-ac1f-4a7e-b295-238b127bb5e8'),(11262,11262,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:18','2024-05-24 14:52:18','0773d8ba-a381-44df-802f-8d68e7bb0bb1'),(11263,11263,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:18','2024-05-24 14:52:18','ff0d61d2-8793-4519-a6f4-0693781d195a'),(11264,11264,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:18','2024-05-24 14:52:18','3fb2dcfc-0f3a-41a9-8d07-300a710a3a2d'),(11265,11265,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:19','2024-05-24 14:52:19','4d8fca89-0f6e-4d38-a4d5-b1a9f1f39720'),(11266,11266,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:19','2024-05-24 14:52:19','cd571611-c98e-44e5-829e-8c08bb63b207'),(11267,11267,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:19','2024-05-24 14:52:19','bcd58a3f-707a-4c09-8a32-747bba1dfbd1'),(11268,11268,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:19','2024-05-24 14:52:19','bc01fb36-71f1-4ccf-9583-c9c550617f56'),(11269,11269,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:19','2024-05-24 14:52:19','33ba6535-b8ec-42cf-84c5-71e4876fd8c6'),(11270,11270,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:19','2024-05-24 14:52:19','0890677b-8def-4f23-84ca-f753d6ea4dac'),(11271,11271,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:19','2024-05-24 14:52:19','f28e5493-fe03-4fc1-9496-a70ca97d0561'),(11272,11272,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\"}',1,'2024-05-24 14:52:19','2024-05-24 14:52:19','42634f41-0904-45da-a507-c0982e275e4a'),(11273,11273,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:21','2024-05-24 14:52:21','4f8d8ca9-8692-47c6-b6d5-52edc68b0f19'),(11274,11274,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:21','2024-05-24 14:52:21','1812191d-7925-4f2e-b83e-78012b81c969'),(11275,11275,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:21','2024-05-24 14:52:21','259c07a3-78e5-4972-a1e3-304a2335deda'),(11276,11276,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:21','2024-05-24 14:52:21','a9b81674-2b6d-4c47-8ba1-4862d2d46a20'),(11277,11277,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:21','2024-05-24 14:52:21','50f4ca24-0fda-4331-a768-5b651d9912a1'),(11278,11278,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true}',1,'2024-05-24 14:52:21','2024-05-24 14:52:21','f66f121c-1ac0-47d3-b140-92aaa8e9b9ae'),(11279,11279,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:22','2024-05-24 14:52:22','efdbf723-4bf2-4743-9fa3-0b2d195ec284'),(11280,11280,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:22','2024-05-24 14:52:22','c67093e2-be9f-4aba-b871-f7f02e62a65a'),(11281,11281,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:23','2024-05-24 14:52:23','5087eb5a-aaee-47e9-b434-7cba00eeebd9'),(11282,11282,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:23','2024-05-24 14:52:23','3a09e500-83f5-4716-b27a-37d4f18673a3'),(11283,11283,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:23','2024-05-24 14:52:23','91cd52d3-6d2a-440d-a3d0-0db75265d74b'),(11284,11284,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:23','2024-05-24 14:52:23','3391644b-1ab8-47b4-951b-c0fb0cd98182'),(11285,11285,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:24','2024-05-24 14:52:24','3adae236-b10d-4437-a88a-601f8f22690a'),(11286,11286,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:24','2024-05-24 14:52:24','53e6b405-e271-4817-a11f-aef6107b2526'),(11287,11287,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:24','2024-05-24 14:52:24','2d0c110a-7977-4473-b2ce-0a498f7e7afe'),(11288,11288,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"clinicians, public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"WHO’s health topics page on Ebola Virus Disease\", \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.who.int/health-topics/ebola#tab=tab_1\"}',1,'2024-05-24 14:52:24','2024-05-24 14:52:24','5f32ba35-5849-4ff2-b5ff-a08fc4c22401'),(11289,11289,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:24','2024-05-24 14:52:24','98222203-97f2-4604-b416-9f1eed39c989'),(11290,11290,1,NULL,NULL,NULL,'{\"0640481e-1b5e-4db5-b7d6-df2b008c94ea\": \"public health professionals\", \"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s Top 10 Ebola Response Planning Tips: Ebola Readiness Self-Assessment for State and Local Public Health Officials\", \"3b4f9fb0-6aaf-45c4-8857-4016b8e61d5e\": {\"date\": \"2024-05-24 07:00:00\"}, \"b94b64c8-6724-4663-a7a4-381dc658d14d\": \"https://www.cdc.gov/vhf/ebola/outbreaks/preparedness/planning-tips-top10.html\"}',1,'2024-05-24 14:52:24','2024-05-24 14:52:24','34b33a64-4d7b-442c-b018-f90ec5d166a7'),(11291,11291,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:24','2024-05-24 14:52:24','a337da67-efdd-4cb0-b1e5-372017dd510a'),(11292,11292,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": false, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"CDC’s State & Territorial Health Department Directories\"}',1,'2024-05-24 14:52:24','2024-05-24 14:52:24','d543988a-c051-459f-bfb8-04f1aacb5f05'),(11293,11293,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:26','2024-05-24 14:52:26','19838cf4-42d5-4888-a5bd-21bbade7e481'),(11294,11294,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:26','2024-05-24 14:52:26','fb8a8289-38a2-464e-85a7-72a685baa5b9'),(11295,11295,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:26','2024-05-24 14:52:26','417ce0da-2a7d-4834-94ea-23fa20f516b1'),(11296,11296,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:26','2024-05-24 14:52:26','15b0c9d3-f59f-4928-b415-e9f67f70f6fc'),(11297,11297,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:27','2024-05-24 14:52:27','8308754a-31be-4212-93fa-b2bda4ff0ed4'),(11298,11298,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:27','2024-05-24 14:52:27','52ddfa40-05ea-4c1c-b30a-17a314ea7700'),(11299,11299,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:28','2024-05-24 14:52:28','cfd9cbc3-e20e-4868-8693-78a94a65c765'),(11300,11300,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:28','2024-05-24 14:52:28','1e7ab647-9736-4853-b0b3-8002d4bab884'),(11301,11301,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:28','2024-05-24 14:52:28','e2631c7f-1d10-47b0-a05c-91989797313b'),(11302,11302,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:28','2024-05-24 14:52:28','53882ad2-37c7-4f21-80f0-d221e31aa330'),(11303,11303,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:29','2024-05-24 14:52:29','7144d613-a96c-45a4-a531-2e185dc9b426'),(11304,11304,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:29','2024-05-24 14:52:29','c4770e92-b8e4-424b-a671-0ca67e0ed40e'),(11305,11305,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:29','2024-05-24 14:52:29','5cc9cacc-5d11-42d7-abc9-642244a84cde'),(11306,11306,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:29','2024-05-24 14:52:29','28c2b4ff-e788-4e1e-90b3-1a6d434c5981'),(11307,11307,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:29','2024-05-24 14:52:29','6365b3de-9faa-4010-a723-898c7659657d'),(11308,11308,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:29','2024-05-24 14:52:29','7688de81-a9ca-4e25-97fd-3fe1d6a39f39'),(11309,11309,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:30','2024-05-24 14:52:30','e145281e-1b7e-4b52-8d20-023919f15e5b'),(11310,11310,1,NULL,NULL,NULL,'{\"0b7e4dc2-d30e-430c-b1ae-8b2049ebb012\": true, \"1b8a06bc-592e-405a-95f0-448e5a7207f9\": \"Recommended Actions in Fungal Disease Outbreak Investigations\"}',1,'2024-05-24 14:52:30','2024-05-24 14:52:30','10a192f8-fa28-4a89-a094-9ae661bac47d'),(11311,11311,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:30','2024-05-24 14:52:30','46104613-1894-4e89-9b89-6ccbcbb11897'),(11312,11312,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:30','2024-05-24 14:52:30','b4d8aa3d-8799-4129-95ad-8745b7b2755a'),(11313,11313,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:31','2024-05-24 14:52:31','884ea827-209b-4fd6-a7d4-e3d1f55746fb'),(11314,11314,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:31','2024-05-24 14:52:31','a5c7997c-4c01-467f-926e-502a713e6973'),(11315,11315,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:32','2024-05-24 14:52:32','7d680f2e-ed0e-4a86-af9f-72f0e9bc50a2'),(11316,11316,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:32','2024-05-24 14:52:32','f7c76142-807a-4d25-8cef-9add040c8f29'),(11317,11317,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:32','2024-05-24 14:52:32','bcb614a0-95ee-45b0-aba0-c8d1c68661d6'),(11318,11318,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Patients sick with EVD may develop symptoms anywhere from 2 to 21 days after contact with the virus, with an average of 8 to 10 days. The course of the illness typically progresses from “dry” symptoms initially (such as fever, aches and pains, and fatigue), and then progresses to “wet” symptoms (such as diarrhea and vomiting) as the person becomes sicker.</p>\"}',1,'2024-05-24 14:52:32','2024-05-24 14:52:32','f7dd2df6-aa0b-410e-832f-02fc06469f53'),(11319,11319,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:34','2024-05-24 14:52:34','15afb71b-d63e-4145-b2ce-21c5d96f3bcb'),(11320,11320,1,NULL,NULL,NULL,'{\"c9374286-f051-4a4a-a20b-da25d3c319ff\": \"<p>Environmentally ubiquitous fungi (e.g., Aspergillus, Mucormycetes) are a cause of invasive infections, especially among immunocompromised persons, that can be associated with substantial morbidity and mortality. Outbreaks of fungal infections among at-risk patients in healthcare settings have been linked to construction, water leaks, insufficient air filtration, non-sterile medical supplies, deficient device reprocessing, dental procedures, contaminated linens, contaminated food and supplements, and other sources of mold spores in the air or on surfaces.</p>\", \"f394434c-cdd6-422c-857c-73fdb47ec55d\": \"About Environmental Fungi\"}',1,'2024-05-24 14:52:34','2024-05-24 14:52:34','de0ff312-34f6-42a1-bc72-2da1378c3818'),(11321,11321,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:34','2024-05-24 14:52:34','70a1ccbf-4753-4913-a841-a699c4efcb53'),(11322,11322,1,NULL,NULL,NULL,'{\"209d1b3f-bacb-40ce-abd0-d60b14d7d09f\": \"Read more about environmental fungi\", \"52169a58-6acc-41b7-85e5-d98a2a750451\": \"<p>Key Points: </p><ul><li>There is no national-level public health disease surveillance for invasive infections with environmental fungi, such as Aspergillus or Mucormycetes, to aid in determining whether disease incidence in a healthcare facility is greater than expected. Approaches to healthcare facility surveillance include reviewing microbiology records for positive fungal culture results, and, if possible, reviewing histopathology specimens with evidence of tissue invasion by fungal hyphae.</li><li>At-risk patients often have complicated medical histories with many different potential sources of exposure, and the incubation period for non-cutaneous infection is not well established; thus, it can be challenging to distinguish colonization from clinical infection and to determine whether exposure occurred within or outside the healthcare facility. </li><li>Investigation is warranted even when it is unclear whether an increase in the number of infections represents a true outbreak, particularly if cases have onset &gt;1 week after admission, appear to cluster in time or place, or occur among patients who share common healthcare exposures. </li><li>Investigation should include an observational environmental assessment (i.e., evaluation of potential environmental sources such as the heating, ventilation and air conditioning system) using a standardized tool (example in resources below) performed in coordination among public health, infection prevention, facilities management and engineering, and environmental services staff. Environmental sampling can be difficult to interpret and should only be performed in the context of an epidemiologic investigation and with a predefined sampling strategy.</li></ul>\"}',1,'2024-05-24 14:52:34','2024-05-24 14:52:34','9cc7776b-7968-44ce-a3eb-3cddf3ddac05'),(11323,11323,1,NULL,NULL,NULL,NULL,1,'2024-05-24 14:52:34','2024-05-24 14:52:34','e549efbc-f07a-43ea-b702-3ff0f0b6f269'),